Section 57

EurekaMag PDF full texts Chapter 56,827


Sun, G-Joo.; Choi, S-Woo.; Jung, S-Hyun.; Katoch, A.; Kim, S.Sub. 2013: V-groove SnO2 nanowire sensors: fabrication and Pt-nanoparticle decoration. Nanotechnology 24(2): 025504
Rajkumar, N.; McMullin, J.N. 1995: V-groove gratings on silicon for infrared beam splitting. Applied Optics 34(14): 2556-2559
Turunen, J.; Noponen, E. 1996: V-groove gratings on silicon for infrared beam splitting: comment. Applied Optics 35(5): 807-808
Khalifeh, A.; Autorino, R.; Hillyer, S.P.; Kaouk, J.H. 2012: V-hilar suture renorrhaphy during robotic partial nephrectomy for renal hilar tumors: preliminary outcomes of a novel surgical technique. Urology 80(2): 466-471
Scheel, T.; Gursche, A.; Zacher, J.; Häupl, T.; Berek, C. 2011: V-region gene analysis of locally defined synovial B and plasma cells reveals selected B cell expansion and accumulation of plasma cell clones in rheumatoid arthritis. Arthritis and Rheumatism 63(1): 63-72
MacCarthy, T.; Kalis, S.L.; Roa, S.; Pham, P.; Goodman, M.F.; Scharff, M.D.; Bergman, A. 2009: V-region mutation in vitro, in vivo, and in silico reveal the importance of the enzymatic properties of AID and the sequence environment. Proceedings of the National Academy of Sciences of the United States of America 106(21): 8629-8634
Sumita, T.; Sairyo, K.; Shibuya, I.; Kitahama, Y.; Kanamori, Y.; Matsumoto, H.; Koga, S.; Kitagawa, Y.; Dezawa, A. 2013: V-rod technique for direct repair surgery of pediatric lumbar spondylolysis combined with posterior apophyseal ring fracture. Asian Spine Journal 7(2): 115-118
Koning, A.H.J.; Rousian, M.; Verwoerd-Dikkeboom, C.M.; Goedknegt, L.; Steegers, E.A.P.; van der Spek, P.J. 2009: V-scope: design and implementation of an immersive and desktop virtual reality volume visualization system. Studies in Health Technology and Informatics 142: 136-138
Mahajan, R.; Rohit, M.K.; Talwar, K.K. 2009: V-sense episode in a biventricular pacemaker device: what is the likely mechanism?. Pacing and Clinical Electrophysiology: Pace 32(2): 245-247
Arcieri, L.; Cantinotti, M.; Pak, V.; Bernabei, M.; Assanta, N.; Murzi, B. 2014: V-shape reduction plasty to reduce the neoaortic root-ascending aorta discrepancy in children undergoing arterial switch operation. Journal of Cardiac Surgery 29(3): 410-412
Achelle, S.; Nouira, I.; Pfaffinger, B.; Ramondenc, Y.; Plé, N.; Rodríguez-López, J.án. 2009: V-shaped 4,6-bis(arylvinyl)pyrimidine oligomers: synthesis and optical properties. Journal of Organic Chemistry 74(10): 3711-3717
Tasior, M.; Poronik, Y.M.; Vakuliuk, O.; Sadowski, B.ło.; Karczewski, M.; Gryko, D.T. 2014: V-shaped bis-coumarins: synthesis and optical properties. Journal of Organic Chemistry 79(18): 8723-8732
Toll, A.í; Vincent, M.-C.; Calvas, P.; Pujol, R.M. 2007: V-shaped hyperpigmented linear lesions, patchy hypotrichosis, and teeth abnormalities in a young girl. Pediatric Dermatology 24(5): 551-554
Lee, S.H.; Lim, G.; Moon, W.; Shin, H.; Kim, C.-W. 2008: V-shaped metal-oxide-semiconductor transistor probe with nano tip for surface electric properties. Ultramicroscopy 108(10): 1094-1100
Seltmann, J.; Müller, K.; Klein, S.; Lehmann, M. 2011: V-shaped nematogens with the "magic bent angle". Chemical Communications 47(23): 6680-6682
Okamoto, T.; Mitsui, C.; Yamagishi, M.; Nakahara, K.; Soeda, J.; Hirose, Y.; Miwa, K.; Sato, H.; Yamano, A.; Matsushita, T.; Uemura, T.; Takeya, J. 2013: V-shaped organic semiconductors with solution processability, high mobility, and high thermal durability. Advanced Materials 25(44): 6392-6397
Shin, D.H.; Shim, S.-Y.; Kim, M.J.; Oh, C.S.; Lee, M.-H.; Jung, S.B.; Lee, G.I.; Chai, J.-Y.; Seo, M. 2014: V-shaped pits in regions of ancient Baekje kingdom paleoparasitologically confirmed as likely human-waste reservoirs. Korean Journal of Parasitology 52(5): 569-573
Osaka, M.; Watanabe, E.; Murata, H.; Fuwamoto, Y.; Nanba, S.; Sakai, K.; Katoh, T. 2010: V-shaped trough in autonomic activity is a possible precursor of life-threatening cardiac events. Circulation Journal: Official Journal of the Japanese Circulation Society 74(9): 1906-1915
Casey, A.K.; Schwalm, E.L.; Hays, B.N.; Frantom, P.A. 2013: V-type allosteric inhibition is described by a shift in the rate-determining step for α-isopropylmalate synthase from Mycobacterium tuberculosis. Biochemistry 52(39): 6737-6739
Granov, N.; Kacila, M.; Mujicic, E.; Hadzimehmedagic, A.; Custovic, F.; Kulic, M. 2012: V-type mini sternotomy in aortic valve replacement. Medical Archives 66(3): 213-214
Schmidt, C.; Breyer, F.; Blum, M.-M.; Thiermann, H.; Worek, F.; John, H. 2014: V-type nerve agents phosphonylate ubiquitin at biologically relevant lysine residues and induce intramolecular cyclization by an isopeptide bond. Analytical and Bioanalytical Chemistry 406(21): 5171-5185
Mehling, I.; Hessmann, M.H.; Hofmann, A.; Rommens, P.M. 2008: V-y flap for restoration of the fingertip. Operative Orthopadie und Traumatologie 20(2): 103-110
Sanders, R.D.; Absalom, A.; Sleigh, J.W. 2014: V. 'for now we see through a glass, darkly': the anaesthesia syndrome. British Journal of Anaesthesia 112(5): 790-793
Morison, R. 1903: V. a Case of Ascites due to Liver Cirrhosis treated by Operation. Annals of Surgery 38(3): 361-366
Crile, G.W. 1898: V. A Case of Complete Cross Lesion of the Spinal Cord due to a Fractured Dislocation. The Fifth Cervical Vertebra being Displaced Forward upon the Sixth. Annals of Surgery 28(5): 639-645
Perkins, G.W. 1890: V. A Case of Fracture or the Styloid Processes of the Ulna and the Radius by Indirect Violence. Annals of Surgery 12(2): 134-135
Roberts, J.B. 1897: V. a Case of Persistent Thyro-Glossal Duct or of Congenital Laryngeal Diverticulum successfully treated by Excision. Annals of Surgery 25(6): 711-715
Mayo, W.J. 1897: V. a Case of Vaginal Anus, the Result of a Hysterectomy, Cured by Ileocolostomy. Annals of Surgery 26(5): 634-636
Eliot, E. 1914: V. a Consideration of Certain Coexisting Lesions of the Gall-Bladder and Kidney. Annals of Surgery 59(5): 679-689
Jepson, W. 1898: V. a Means of Regulating Inflation of the Bladder preliminary to Suprapubic Cystotomy. Annals of Surgery 28(3): 358-365
Dunham, T. 1893: V. A Method for Obtaining a Skin-Flap from the Scalp and a Permanent Buried Vascular Pedicle for Covering Defects of the Face. Annals of Surgery 17(6): 677-679
Hadra, B.E. 1898: V. a Method for facilitating Enucleation of Tumors of the Thyroid Gland. Annals of Surgery 28(6): 737-740
Pilcher, P.M. 1909: V. a new Cystoscope for Catheterizing the Ureters by the Indirect Method. Annals of Surgery 49(2): 218-224
Bacon, J.B. 1893: V. A New Method of Treating Non-malignant Strictures of the Rectum by Transplantation of Intestine. Annals of Surgery 17(5): 576-581
Gallagher, J.R.; Brouha, L. 1943: V. a Simple Method of Evaluating Fitness in Boys: the Step Test. Yale Journal of Biology and Medicine 15(6): 769-779
Schumann, E.A. 1911: V. a Study of Carcinoma Mastitoides. Annals of Surgery 54(1): 69-77
Heo, J.; Yu, S-Young.; Yi, J.; Nam, Y-Seon.; Son, D.Thai.; Oh, J.; Lee, J-Koo. 2018: Wealth gradient-based divergence in the prevalence of underweight among women by marital status in Quoc Oai district, Vietnam. Global Health Action 11(1): 1449430
Heinik, J. 2010: V. A. Kral and the origins of benign senescent forgetfulness and mild cognitive impairment. International Psychogeriatrics 22(3): 395-402
Wilson, C. 1908: V. Acute Dilatation of the Stomach Complicating Typhoid Fever. Annals of Surgery 48(5): 678-679
Laffer, W.B. 1908: V. Acute Dilatation of the Stomach and Arterio-Mesenteric Ileus. Annals of Surgery 47(4): 532-557
Bruce, H.A. 1911: V. Acute Diverticulitis. Annals of Surgery 53(5): 682-685
Hotchkiss, L.W. 1901: V. Acute Intestinal Obstruction following Appendicitis. A Report of Three Cases Successfully Operated upon. Annals of Surgery 34(5): 660-677
Dowd, C.N. 1912: V. Acute Phlegmonous Inflammation of the Large Intestine. Annals of Surgery 56(4): 579-581
Cumston, C.G. 1896: V. Amputation of the Foot with a Dorsal Flap. Annals of Surgery 24(6): 706-712
Pedersen, V.C. 1909: V. An Irrigating Sound of the Standard and Beniqué Type: Also an Irrigating Tunnelled and Grooved Sound for the Dilatation Treatment of Stricture of the Male Urethra. Annals of Surgery 50(4): 770-781
McGraw, T.A. 1909: V. Aneurisms in Young people. Annals of Surgery 50(1): 59-65
Delatour, H.B. 1905: V. Angulation at the Sigmoid. Annals of Surgery 42(5): 678-686
Stetten, d.W. 1913: V. Angulation of the Junction of the Hepatic and Common Ducts after Cholecystostomy, Simulating Common Duct Obstruction. Annals of Surgery 57(2): 182-187
Hubbard, J.C. 1906: V. Arteriovenous Anastomosis. Annals of Surgery 44(4): 559-562
Shinohara, Y.; Yanagihara, T.; Abe, K.; Yoshimine, T.; Fujinaka, T.; Chuma, T.; Ochi, F.; Nagayama, M.; Ogawa, A.; Suzuki, N.; Katayama, Y.; Kimura, A.; Kayama, T. 2011: V. Asymptomatic cerebrovascular diseases. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 20(4 Suppl): S116-S128
Pilcher, L.S. 1910: V. Atlo - Axoid Fracture - Dislocation. Annals of Surgery 51(2): 208-211
Janeway, H.H. 1910: V. Autoplastic Transplantation of Bone. Annals of Surgery 52(2): 217-228
Lyman, C.B. 1906: V. Backward Dislocation of the Second Carpo-Metacarpal Articulation. Annals of Surgery 43(6): 905-906
Warbasse, J.P. 1892: V. Boisleux on Intraligamentous Elytrotomy. Annals of Surgery 16(6): 556-563
Wyller, V.Bruun. 2013: V. Bruun Wyller replies. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 133(15): 1553
Sherrill, J.G. 1906: V. Cancer of the Gall-Bladder and Ducts. Annals of Surgery 44(6): 866-891
Erdmann, J.F. 1906: V. Cardio Spasm: With Report of an Operative Case. Annals of Surgery 43(2): 224-230
Booth-LaForce, C.; Groh, A.M.; Burchinal, M.R.; Roisman, G.I.; Owen, M.T.; Cox, M.J. 2014: V. Caregiving and contextual sources of continuity and change in attachment security from infancy to late adolescence. Monographs of the Society for Research in Child Development 79(3): 67-84
Hopkins, W.B. 1885: V. Case of Compound Depressed Fracture of Skull, with Wound of the Longitudinal Sinus. Note on the Construction of the Trephine. Annals of Surgery 2(7): 65-70
Groner, F.J. 1885: V. Case of Fracture of Femur Complicated with Sacro-iliac Dislocation. Annals of Surgery 1(5): 463-464
Chavasse, T.F. 1896: V. Case of Interscapulo-Thoracic Amputation for Injury. Annals of Surgery 24(2): 182-187
Schwinn, J. 1896: V. Case of Operative Injury to the Thoracic Duct at the Root of the Neck. Annals of Surgery 23(5): 582-584
Beach, H.H. 1896: V. Case of Pelvic Tumor formed by a Calcified Meckel's Diverticulum uniting the Ileum and Bladder. Annals of Surgery 24(4): 484-487
McCosh, A.J. 1896: V. Case of Sternal Dislocation of Second and Third Costal Cartilages and of Clavicle, with Fracture of Fourth and Fifth Cartilages. Annals of Surgery 23(3): 279-281
Fagge, C.H. 1905: V. Cases of Intussusception in Children treated by Laparotomy. Annals of Surgery 41(3): 407-414
Mixter, S.J. 1901: V. Cases of Laceration of the Spleen and of the Kidney followed by Recovery after Removal of the Injured Organ. Annals of Surgery 33(6): 713-714
Carnett, J.B. 1910: V. Cervical Subcutaneous Cavernous Haemangeioma: With Report of Two Cases. Annals of Surgery 51(1): 65-75
Caddy, A. 1899: V. Chondrocarcinoma of the Testicle. Annals of Surgery 30(2): 210-212
Loux, H.R.; Coplin, W.M. 1902: V. Chronic Phagedaena due to Mixed Infection. Annals of Surgery 35(5): 586-597
Mayo, W.J.; Mayo, C.H. 1895: V. Clinical Report.-I. Complete Section of the Vas Deferens, End-to-End Union; II. Acute Suppuration of Knee-Joint: Open Treatment; III. Gastro-Enterostomy by the Murphy Button: Anastomoses by this Method. Annals of Surgery 21(1): 35-44
Rosengren, K.S.; Gutiérrez, I.T.; Schein, S.S. 2014: V. Cognitive models of death. Monographs of the Society for Research in Child Development 79(1): 83-96
Curl, H.C. 1905: V. Combined Volvulus and Hernia through a recent Mesenteric Slit: Resection of Five and One-Half Feet of Intestine; Death on Ninth Day. Annals of Surgery 42(2): 207-208.1
Perkins, J.W. 1893: V. Complete Dislocation of Patella, Reduced by Arthrotomy After Six Years. Annals of Surgery 18(6): 654-657
Winslow, R. 1900: V. Complete External Dislocation at the Elbow. Annals of Surgery 31(5): 595-599
Fowler, G.R. 1885: V. Compound Comminuted Fracture of the Patella: Wire Sutures: Necrosis of Upper Fragment: Final Recovery with Useful Limb. Annals of Surgery 2(9): 246-250
Freiberg, A.H. 1899: V. Congenital Deformity due to Malposition of the Scapula. Annals of Surgery 29(5): 584-592
Hammond, L.J. 1911: V. Considerations Relating to the Pathogenesis and Diagnosis of Surgical Diseases of the Pancreas. Annals of Surgery 54(6): 798-805
Rixford, E. 1912: V. Contribution to the Etiology of Congenital Dislocation of the Hip. Annals of Surgery 56(6): 854-866
Marcy, H.O. 1897: V. Contribution to the History of Operative Interference for the Relief of Obstruction of the Common Choledoch Duct by Biliary Calculi. Annals of Surgery 25(1): 80-85
Maclaren, A. 1896: V. Contribution to the Statistics of Foreign Bodies in the Peritoneal Cavity. Annals of Surgery 24(3): 365-370.1
Binnie, J.F. 1898: V. Contribution to the Study of Appendicitis Obliterans. Annals of Surgery 27(5): 618-625
Wainwright, J.M. 1903: V. Contribution to the Subject of Perineal Prostatectomy. Annals of Surgery 37(5): 711-715
Niemack, J. 1905: V. Contribution to the Surgery of Gastric Ulcer. Annals of Surgery 41(1): 44-50
Kawai, M.; Yamagami, Y. 2013: V. Current status of chemotherapy for carcinoma of the ampulla open Vater. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(10): 1314-1317
Shober, J.B. 1909: V. Cystitis and Ulceration of the Bladder in Women. Annals of Surgery 49(6): 777-784
Bayne, J.K. 1946: V. D. Medical Bulletin. United States. Army. Forces in the European Theater. Office of the Theater Chief Surgeon 1(1): 13-16
Anonymous 1944: V. D. education in the factory. British Journal of Venereal Diseases 20(4): 173
Weil, R. 1913: V. Desensitization: its Theoretical and Practical Significance. Journal of Medical Research 29(2): 233-249
Smith, E.A. 1909: V. Diagnosis and Treatment of Carcinoma of the Caecum: With a Report of Two Cases Treated by Resection of the Caecum. Annals of Surgery 50(3): 562-570
Sonuga-Barke, E.J.; Schlotz, W.; Kreppner, J. 2010: V. Differentiating developmental trajectories for conduct, emotion, and peer problems following early deprivation. Monographs of the Society for Research in Child Development 75(1): 102-124
North, N.L. 1887: V. Digital Amputations under Cocaine. Annals of Surgery 5(5): 417-418
McBurney, C. 1897: V. Direct Intra-Abdominal Finger-Compression of the Common Iliac Artery during Amputation at the Hip-Joint. Annals of Surgery 25(5): 610-613
Twenhofel, W.H. 1933: V. Division of Geology and Geography. Science 77(2009): 618-620
Summers, J.E. 1901: V. Double Ureter. Report of a Nephrectomy done upon a Young Child with this Condition Present. Annals of Surgery 33(1): 39-41
Deaderick, C. 1890: V. Downward Dislocation of the Patella. Annals of Surgery 11(2): 102-103
Gaskoin, G. 1879: A Case of Morphœa. Medico-Chirurgical Transactions 62: 169-175
Cotton, F.J. 1902: V. Elbow Fractures in Children. Fractures of the Lower End of the Humerus; Lesions and End Results, and their Bearing upon Treatment. Annals of Surgery 35(2): 242-269
Cobb, F. 1912: V. Epigastric Hernia, a Cause of Chronic Diarrhoea: With Report of a Case. Annals of Surgery 55(1): 66-70
Torrance, G. 1908: V. Excision of the Whole Left Lobe of the Liver for Sarcoma. Annals of Surgery 47(1): 33-36
Horsley, J.S.; Coleman, C.C. 1913: V. Experimental Devascularization of Intestine with and without Mechanical Obstruction. Annals of Surgery 57(4): 506-510
Watson, B.A. 1893: V. Expert Examinations and Testimony in Railway Cases. Annals of Surgery 17(1): 41-56
Byford, H.T. 1896: V. Extirpation of the Rectum per Vaginam, with Utilization of the Vagina to replace the lost Rectal Tissue. Annals of Surgery 24(5): 631-633
Faust, L.; Yaya, S.; Ekholuenetale, M. 2017: Wealth inequality as a predictor of HIV-related knowledge in Nigeria. Bmj Global Health 2(4): E000461
Gage, H.; Beal, H.W. 1908: V. Fibrinous Calculi in the Kidney. Annals of Surgery 48(3): 378-387
Walton, G.L. 1904: V. Fracture of the Base of the Skull: a Contribution Based on the Clinical and Pathological Records of Fifty Cases. Annals of Surgery 40(5): 654-668
Joy, H.M. 1896: V. Fracture of the Os Calcis, with Report of a Case of Comminuted Fracture with an Unique Method of Treatment. Annals of Surgery 24(1): 39-41
Fønnebø, V. 2014: V. Fønnebø replies. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 134(16): 1546
Hotchkiss, L.W. 1894: V. Gangrenous Cholecystitis. Annals of Surgery 19(2): 197-205
Cannon, W.B.; Blake, J.B. 1905: V. Gastro-enterostomy and Pyloroplasty: An Experimental Study by Means of the Röntgen Rays. Annals of Surgery 41(5): 686-711
Woolsey, G. 1896: V. Gunshot Wound of the Intestines, with Sixteen Perforations; Enterorrhaphy; Use of the Murphy Button; Recovery. Annals of Surgery 23(4): 423-426
Davis, B.B. 1895: V. Hernia in the Linea Alba. Annals of Surgery 21(4): 464-467
Jopson, J.H. 1904: V. Hernia of the Uterus through the Inguinal Canal. Annals of Surgery 40(1): 98-106
Wilkinson, L.R.; Ferraro, K.F.; Mustillo, S.A. 2019: Wealth in Middle and Later Life: Examining the Life Course Timing of Women's Health Limitations. Gerontologist 59(5): 902-911
Perkins, G.W. 1895: V. I. Case of Inguino-Labial Hernia; Ovary, Fallopian Tube, and Cornu of Uterus in Sac. II. Case of Hydronephrosis, of Thirty Years' Duration, with Calcification of the Inner Portion of the Wall of the Cyst. Annals of Surgery 21(6): 691-705
Mirskiĭ, M.B.; Gedroĭ, V.Ignat'evna. 2007: V. I. Gedreitz as the professor of surgery and the writer. Problemy Sotsial'noi Gigieny Zdravookhraneniia i Istorii Meditsiny 2007(6): 50-55
Bereziuk, N.M.; Dzhunkovskiĭ, V.Ia. 2010: V. Ia. Dzhunkovskiĭ--the first historian of the national medicine. Likars'ka Sprava 2010(7-8): 129-134
Steele, D.A. 1901: V. Ileus due to Mechanical Obstruction to the Faecal Current. Annals of Surgery 33(4): 449-456
Cumston, C.G. 1897: V. Incision of the Kidney in Cases of Uncomplicated Nephrolithiasis. Annals of Surgery 26(3): 320-328
Dudgeon, L.S.; Ross, A. 1910: V. Infections of the Urinary Tract due to Bacillus Coli and Allied Organisms: Further Observations on the Treatment of Acute and Chronic Conditions. Annals of Surgery 51(3): 355-361
Hawkes, F. 1899: V. Inflammation of the Bursa Gastrocnemio-Semimembranosa, with a Report of Four Cases of Enlargement and Distention of this Bursa treated by Excision. Annals of Surgery 30(1): 61-78
Halstead, A.E. 1906: V. Inguino-Properitoneal Hernia; Inguino-Interstitial Hernia: Report of Cases with Remarks. Annals of Surgery 43(5): 704-716
Ballman, A.A.; Byer, R.L.; Eimerl, D.; Feigelson, R.S.; Feldman, B.J.; Goldberg, L.S.; Menyuk, N.; Tang, C.L. 1987: V. Inorganic nonlinear materials for frequency conversion. Applied Optics 26(2): 224-227
Robinson, B. 1899: V. Inspection of the Abdominal Cavity and its Viscera in Post-Mortems. Annals of Surgery 29(6): 731-740
Schaefer, F.C. 1903: V. Instrument to Protect the Brain while doing Craniotomy with Gigli Saw. Annals of Surgery 37(4): 505-509
Thompson, J.E. 1898: V. Intestinal Obstruction caused by Meckel's Diverticulum. Annals of Surgery 27(4): 448-458
Bloodgood, J.C. 1903: V. Intestinal Obstruction following Operation for Reducible Left Inguinal Hernia due to a Loop of Small Intestine caught in Treitz's Fossa. Annals of Surgery 38(6): 806-811
Lamson, O.F. 1914: V. Intrathoracic Goitre: Report of Two Cases with Marked Displacement of Trachea. Annals of Surgery 59(2): 191-194
Husson, F.C. 1890: V. Jaffé on the Therapy of Habitual Scoliosis. Annals of Surgery 11(5): 364-369
Baldwin, J.F. 1903: V. Knife-blade Removed from Lung. Annals of Surgery 37(3): 360-361
Moynihan, B.G. 1908: V. Late Results after Operations for Benign Diseases of Stomach and Duodenum. Annals of Surgery 47(6): 873-884
Gillette, W.J. 1908: V. Ligation of the Left Common Iliac Artery, with Report of a Recent Case. Annals of Surgery 48(1): 22-24
Mayo, W.J. 1900: V. Malignant Diseases of the Stomach and Pylorus. Annals of Surgery 32(2): 251-277
Sawyer, P.E. 1912: V. Malignant Tumors of the Mesentery: With Report of a Case. Annals of Surgery 56(5): 694-696.1
Bullitt, J.B. 1900: V. Mammoth Ovarian Tumors. Annals of Surgery 31(1): 87-96
Frank, J. 1902: V. Mechanical versus Suture Methods for Intestinal Approximation. Annals of Surgery 35(1): 36-41
Hubbard, J.C. 1902: V. Meckel's Diverticulum Patent at the Navel. Annals of Surgery 35(4): 495-502
Satoh, T.; Shikama, A.; Nakamura, Y.; Akiyama, A.; Yoshikawa, H. 2013: V. Minimal invasiveness treatment for young women with ovarian cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(2): 182-185
Foxworthy, F.W. 1904: V. Modern Bullet Wounds. Annals of Surgery 40(6): 834-855
Bergsagel, P.L.; Chesi, M. 2013: V. Molecular classification and risk stratification of myeloma. Hematological Oncology 31(Suppl 1): 38-41
Vartanian, I.A. 2007: V. N. Chernigovsky and organisation of physiological investigations in the USSR. Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 93(2): 211-213
Tulsky, D.S.; Carlozzi, N.E.; Chevalier, N.; Espy, K.A.; Beaumont, J.L.; Mungas, D. 2013: V. NIH Toolbox Cognition Battery (CB): measuring working memory. Monographs of the Society for Research in Child Development 78(4): 70-87
Corson, E.R. 1907: V. Narath's Modification of Talma's Operation for Hepatic Cirrhosis. Annals of Surgery 46(6): 831-840
Lilienthal, H. 1911: V. Nephroureterectomy: Description of a Simple and Improved Method. Annals of Surgery 53(4): 521-524
Babcock, W.W. 1907: V. Nerve Disassociation; A New Method for the Surgical Relief of Certain Painful or Paralytic Affections of Nerve Trunks. Annals of Surgery 46(5): 686-693
Miller, A.H. 1899: V. Nitrous Oxide and Ether Anaesthesia by the Open Method. Annals of Surgery 30(6): 709-714
Powers, C.A. 1906: V. Non-Parasitic Cysts of the Spleen. Annals of Surgery 43(1): 48-60
Ware, M.W. 1911: V. Non-Prostatic Urinary Retention of the Senile Bladder. Annals of Surgery 53(1): 57-66
Wilcox, S.F. 1891: V. Note on Bromide of Ethyl as an Anaesthetic. Annals of Surgery 14(4): 294-295
Branch, J.R. 1911: V. Note on Penetrating Wounds of the Abdomen: Report of Cases Treated at the Macon, Ga., Hospital. Annals of Surgery 54(2): 164-166
Baldwin, J.F. 1902: V. Note on Synchronous Ligation of Both Internal Jugular Veins. Annals of Surgery 36(3): 394-396
Maclaren, A. 1908: V. Note on Syphilis of the Liver: With a Report of Three Cases in which Operation was Resorted to. Annals of Surgery 48(2): 186-191
Shepherd, F.J. 1892: V. Note on the Dissection of a Case of Lumbar Hernia. Annals of Surgery 16(2): 137
Hagner, F.R. 1910: V. Note on the Removal of Carcinoma of the Fundus of the Urinary Bladder. Annals of Surgery 52(5): 654-656
Boothby, W.M. 1912: V. Note on the Transplantation of Fresh Venous Segments. Annals of Surgery 56(3): 409-410
Pringle, J.H. 1908: V. Notes on the Arrest of Hepatic Hemorrhage Due to Trauma. Annals of Surgery 48(4): 541-549
Pilcher, P.M. 1912: V. Observations on the Diagnosis of Renal Tuberculosis, the Indications for Nephrectomy in its Treatment and the Technic of the Operation. Annals of Surgery 56(2): 292-304
Messer, A.I.; McLachlan, A.E. 1942: V. Observations on the Lipoid Reinforcement of Antigens in the Gonococcal Complement Fixation Test. British Journal of Venereal Diseases 18(1-2): 38-47
Robinson, B. 1897: V. Observations upon the Absorption of Fluids by the Peritoneum. Annals of Surgery 25(3): 332-350
Anonymous 1994: V. Occupational conjunctivitis (OC). Ocular Immunology and Inflammation 2 Suppl. 1: S35
Wong, R.; Palloni, A.; Soldo, B.J. 2007: Wealth in Middle and Old Age in Mexico: The Role of International Migration. International Migration Review 41(1): 127-151
Hosmer, A.J. 1904: V. on the use of an Electro-Magnet for Removal of a Foreign Body from a Bronchus. Annals of Surgery 40(3): 350-353
Abbe, R. 1902: V. on the use of the Abdominal Route for Approaching Rectal Tumors. Annals of Surgery 36(2): 222-227
Anonymous 1906: V. On the effect upon virulence of passage of B. pestis through rats by cutaneous inoculation without intermediate culture. Journal of Hygiene 6(4): 502-505
Baldwin, J.F. 1903: V. one Thousand Abdominal Closures by a new Method, without a Known Hernia. Annals of Surgery 38(5): 664-670
Haubold, H.A. 1904: V. Operative Removal of a Tumor of the Liver Report of a Case of Resection of the Liver for Gumma; Cholecystectomy. Annals of Surgery 39(2): 240-244
McGuire, H. 1895: V. Operative Treatment of Cancer of the Male Genitals. Annals of Surgery 22(4): 472-484
Hopkins, W.B. 1898: V. Osteotomoclasis: A Preliminary Note on a Modified Operation to Correct Curved Tibia. Annals of Surgery 28(1): 120-124
Noble, C.P. 1906: V. Overlapping the Aponeuroses in the Closure of Wounds of the Abdominal Wall, Including Umbilical, Ventral and Inguinal Herniae. Annals of Surgery 43(3): 349-358
Ransohoff, J. 1910: V. Pancreatic Hemorrhage and Acute Pancreatitis. Annals of Surgery 51(5): 670-681
Halsted, W.S. 1913: V. Partial Occlusion of the Thoracic and Abdominal Aortas by Bands of Fresh Aorta and of Fascia Lata. Annals of Surgery 58(2): 183-187
Mayo, W.J. 1913: V. Pathologic Data Obtained from Ulcers Excised from the Anterior Wall of the Duodenum. Annals of Surgery 57(5): 691-694
Robinson, B. 1900: V. Pathology of the Lymphatics of the Peritoneum. Annals of Surgery 31(2): 214-226
Pegram, J.C. 1905: V. Penetrating Bullet Wound of Abdomen passing through the Spleen, Stomach, Vertebra, and Spinal Cord: Laparotomy and Suture of Stomach Wounds; Recovery. Subsequent Laminectomy and Removal of Bullet from Spinal Cord; Recovery. Annals of Surgery 42(1): 83-89
Park, R. 1891: V. Peritonitis.-Tests for Antiseptics. (Fifth Mütter Lecture, Series of 1890-91). Annals of Surgery 14(1): 50-72
Lilienthal, H. 1910: V. Permanent Colostomy: An Improved Original Operative Method. Annals of Surgery 52(3): 384-387
Goldthwait, J.E. 1899: V. Permanent Dislocation of the Patella. The Report of a Case of Twenty Years' Duration, successfully treated by Transplantation of the Patella Tendons with the Tubercle of the Tibia. Annals of Surgery 29(1): 62-68
Whitla, W. 1895: V. Pharmaceutical Defects in the Present British Pharmacopoeia from the Medical Point of View. British Medical Journal 1(1783): 497-499
Farr, C.E. 1910: V. Preservation of the Submaxillary Branch of the Facial Nerve in Operations on the Neck. Annals of Surgery 52(4): 487-488.3
Elder, J.M. 1908: V. Primary Sarcoma of the Peritoneum. Annals of Surgery 48(6): 848-856
Rebert, M.A. 1904: V. Primary Spasm and Hypertrophy of the Pyloric Sphincter, and Resultant Enormous Dilatation of the Stomach: Relief by Pyloroplasty and Gastroplication. Annals of Surgery 40(2): 201-203
Wolf, H.E. 1905: V. Primary Urethral Calculus: With Report of a Case. Annals of Surgery 41(2): 242-248
Baran, E.; Wośko, G.; Walczyński, J.Z. 2008: V. Profiles of Polish forensic medicals-Jan Zygmunt Walczyński. Archiwum Medycyny Sadowej i Kryminologii 58(2-3): 110-116
Ransohoff, J. 1910: V. Prognosis and Operative Treatment of Fracture of the Base of the Skull: Based on an Analysis of 190 Cases. Annals of Surgery 51(6): 796-811
Squier, J.B. 1914: V. Rectovesical Echinococcus Cyst. Annals of Surgery 59(3): 396-401
Schley, W.S. 1913: V. Rectus Transplantation for Deficiency of Internal Oblique Muscle, in Certain Cases of Inguinal Hernia. Annals of Surgery 58(4): 473-478
Mayer, O.J. 1897: V. Remarks on Laminectomy, with Report of a Case done Sixteen Months after Fracture. Annals of Surgery 26(2): 207-218
Taylor, H.L. 1893: V. Remarks on the Management of Suppuration Complicating Tuberculous Disease of the Bones and Joints. Annals of Surgery 17(4): 423-429
Mynter, H. 1900: V. Remarks on the Technique of Prostatectomy, with Report of a Case. Annals of Surgery 32(4): 552-556
Pilcher, P.M. 1909: V. Renal Varix-Angiomatous Disease of the Papillae Renales. Annals of Surgery 49(5): 652-669
Alexander, E.G. 1913: V. Report of 105 Cases of Strangulated Hernia. Annals of Surgery 58(5): 639-646
Buchanan, J.J. 1897: V. Report of Cases of Circular Resection, respectively of Pylorus, Caecum with Ascending Colon, and Sigmoid Flexure. Annals of Surgery 26(6): 697-702
Weir, R.F. 1887: V. Report of Four Month's Operative Work at the New York Hospital (concluded). Annals of Surgery 6(1): 31-49
Bennett, A.L. 1900: V. Report of Results Obtained in the Treatment of Ununited Fractures with the Parkhill Clamp. Annals of Surgery 31(3): 327-331
Brown, F.T. 1896: V. Report of Two Successful Hip-Joint Amputations, the Second of which was Performed by a New Method. Annals of Surgery 23(2): 153-162.1
Montgomery, D.W. 1898: V. Report of a Case of Epithelioma of the Skin of the Face, with Unusual Course of Infection of Lymph-Nodes. Annals of Surgery 27(2): 193-198
Horwitz, O. 1895: V. Report of a Case of Impacted Urethral Calculus. Annals of Surgery 22(5): 655-660
Thorn, S.S. 1895: V. Report of a Case of Intracranial Trifacial Neurectomy. Annals of Surgery 21(3): 296-298
Cartledge, A.M.; Bullitt, J.B. 1906: V. Report of a Case of Intussusception Subjected to Operation: Colon Opened and Part of Intussusceptum Excised; Enterostomy for Fecal Drainage; Later Excision of Segment of Small Intestine and Enterorrhaphy for Suppression of Fecal Fistula; Ultimate Complete Recovery. Annals of Surgery 44(5): 674-677
Meisenbach, A.H. 1895: V. Report of a Case of Pathological Separation of the Lower Epiphysis of the Femur. Annals of Surgery 21(2): 157-165
Thomas, G.J. 1913: V. Report of a Case of Pelvic Kidney: Diagnosis Before Operation. Annals of Surgery 58(6): 809-811
Mayo, W.J. 1893: V. Report of a Case of Volvulus of the Sigmoid Flexure of the Colon Successfully Reduced after Abdominal Section. Annals of Surgery 18(1): 28-29
Peters, L. 1901: V. Resection of the Pendulous, Fat Abdominal Wall in Cases of Extreme Obesity. Annals of Surgery 33(3): 299-304
Stimson, L.A. 1896: V. Results and Methods of Surgical Operations at the New York Hospital from August 1, 1895, to January 31, 1896, and at the House of Relief from August 1, 1895, to March 10, 1896. Annals of Surgery 23(6): 717-732
Le Boutillier, W.G. 1899: V. Results and Methods of Treatment of Compound Fractures at the J. Hood Wright Memorial Hospital. Annals of Surgery 30(3): 297-316
Garceau, E. 1902: V. Results of Operations on the Kidney for Tuberculosis. Annals of Surgery 36(4): 515-527
Makins, G.H. 1911: V. Retroperitoneal and Mesenteric Cysts of a Simple Nature. Annals of Surgery 53(3): 355-363
Le Conte, R.G. 1908: V. Rupture of the Lung Without Costal Injury: With the Report of a Case. Annals of Surgery 47(3): 383-389
Hammond, L.J. 1901: V. Sacculated Aneurism of the Superior Profunda Humeri Artery. Annals of Surgery 34(3): 398-400.1
Coley, W.B. 1910: V. Sarcoma of the Clavicle: End-Results following Total Excision. Annals of Surgery 52(6): 776-796
Keenan, C.B. 1904: V. Sarcoma of the Tongue. Report of a Recent Case, with Analysis of Previously Recorded Cases. Annals of Surgery 39(6): 956-967
Wharton, H.R. 1898: V. Separation of the Upper Epiphysis of the Humerus. Annals of Surgery 28(4): 462-467
Fisher, J.M. 1906: V. Shortening of the Round Ligaments by Subperitoneal Ventro-Aponeurotic Fixation. Annals of Surgery 44(3): 404-408
Meyer, W. 1894: V. Simultaneous Ligation of Both Internal Iliac Arteries for Hypertrophy of the Prostate Gland (Bier's Method). Annals of Surgery 20(1): 44-51
Binnie, J.F. 1913: V. Snapping Hip (Hanche a Ressort; Schnellende Hufte). Annals of Surgery 58(1): 59-66
Harris, H.F. 1902: V. So-called Hypertrophic Tuberculosis of the Intestine. Annals of Surgery 36(5): 713-734
Sachs, H. 1942: V. Some Aspects of the Serology of Syphilis with Special Reference to its Theoretical and Practical Significance. British Journal of Venereal Diseases 18(3-4): 96-106
Cox, E.M. 1895: V. Some Considerations in the Operative Treatment of Fracture of the Patella, with Special Reference to Suture Material and the Use of Salt Solution. Annals of Surgery 22(6): 725-735
Freeman, L. 1897: V. Some Fractures of the Lower End of the Radius as seen by the Röntgen Rays. Annals of Surgery 25(4): 470-474
Meyer, W. 1910: V. Some Observations Regarding Thoracic Surgery on Human Beings. Annals of Surgery 52(1): 34-57
Dawbarn, R.H. 1903: V. Some Points in Ligation of Arteries. Annals of Surgery 37(1): 42-52
Dawbarn, R.H. 1897: V. Some Practical Points upon Fracture of the Thigh-Bone, especially in Babies. Annals of Surgery 26(4): 480-488
Tennant, C.E. 1911: V. Some Recent Mechanical Aids to Hollow Visceral Anastomosis. Annals of Surgery 54(4): 500-502
Rushmore, J.D. 1894: V. Some Surgical Thoughts on Appendicitis from a Clinical Stand-point. Annals of Surgery 19(5): 576-585
Bovee, J.W. 1900: V. Splenectomy for Congestive Hypertrophy. Annals of Surgery 31(6): 705-713
McCoy, J.C. 1911: V. Splenectomy for Rupture of Spleen: With Report of Four Cases. Annals of Surgery 54(5): 597-611
Park, R. 1904: V. Spontaneous Gangrene of the Hollow Viscera a Study of Mesenteric Occlusion. Annals of Surgery 39(4): 554-569
Bryan, R.C. 1909: V. Spontaneous Rupture of the Spleen in the Course of Typhoid Fever. Annals of Surgery 50(5): 856-874
Warbasse, J.P. 1894: V. Spontaneous Torsion of the Pedicle of Ovarian Tumors; with the Report of a Case of Rotated Ovarian Cyst with Extensive Intra-mural Haemorrhage. Annals of Surgery 19(4): 440-452
Walsh, J.F. 1896: V. Stretching of the Lingual Branch of the Fifth Nerve for the Relief of Neuralgia of the Tongue. Annals of Surgery 23(1): 48-53
Thompson, J.E. 1904: V. Stricture of the OEsophagus due to Typhoid Ulceration. Annals of Surgery 39(5): 683-689
Leggett, N.B.; Maury, J.W. 1907: V. Studies Upon the Function of the Pylorus and Stoma after Gastroenterostomy has been Performed. Annals of Surgery 46(4): 549-555
Monks, G.H. 1905: V. Studies in the Surgical Anatomy of the Small Intestine and its Mesentery. Annals of Surgery 42(4): 543-569
Bouffleur, A.I. 1899: V. Successful Removal of a Fibrosarcoma (Desmoid Fibroma) of the Abdominal Wall, involving the Iliac Vessels. Annals of Surgery 30(5): 587-595
Eliot, E. 1909: V. Suppurative Pericarditis. Annals of Surgery 49(1): 60-85
Mayo, C.H. 1912: V. Surgery of the Thymus Gland. Annals of Surgery 56(1): 77-82
Wolfenden, H.H. 1940: V. the Development and Characteristics of Governmental Health Insurance Plans in Europe and the British Empire: (Excluding Canada). Canadian Medical Association Journal 42(3): 276-280
Sweet, J.E. 1907: V. Technique of Blood Vessel Suture. Annals of Surgery 46(3): 350-357
Holmes, L.W. 1955: V. Telephone Tactics. Canadian Medical Association Journal 73(10): 844-845
Harrigan, A.H. 1913: V. Temporary Arrest of the Heart Beats Following Incision of the Pericardium for Suppurative Pericarditis. Annals of Surgery 57(3): 367-373
Wight, J.S. 1893: V. Ten Cases of Anchylosis of the Elbow Joint, after Treatment of Fracture of the Lower End of the Humerus, with the Fore-Arm in the Extended Position: Five Treated by Exsection, Four Treated by Infraction, and One Not Treated. Annals of Surgery 18(2): 218-226
Keen, W.W. 1897: V. The Advantages of the Trendelenburg Posture during all Operations involving directly or indirectly the Cavities of the Mouth, Nose, and the Trachea, with a Report of Two Cases of Epithelioma and Sarcoma of the Tonsil. Annals of Surgery 26(1): 96-102
Kramer, S.P. 1901: V. The Artificial Production of Connective Tissue by Means of Injection of Agar-Agar. Annals of Surgery 34(2): 273-275
Freeman, L. 1907: V. The Correction of Certain Forms of "Saddle-Nose.". Annals of Surgery 46(2): 206-209
Hemmeter, J.C. 1900: V. the Diagnosis of Cancer of the Stomach. Annals of Surgery 32(1): 96-122
Oliver, J.C. 1907: V. the End Results following Operations for Carcinoma of the Breast. Annals of Surgery 46(1): 51-56
Caulk, J.R. 1913: V. the Etiology of Kidney Cysts: Illustrated by a Cyst Due to Obstructive Calcareous Papillitis. Annals of Surgery 57(6): 840-859
Hartmann, H. 1914: V. the Function of the Gastro-Enterostomy Opening in Cases of Permeable Pylorus. Annals of Surgery 59(6): 832-840
Stratton, R.T. 1903: V. the Gradual Surgical Occlusion of Large Arteries: its Relative Advantages together with an Experimental Inquiry as to its Feasibility. Annals of Surgery 38(2): 256-264
Mayo, W.J. 1900: V. The Ileocaecal Orifice and its Bearing on Chronic Constipation, with Report of Two Cases relieved by Operation. Annals of Surgery 32(3): 364-368
Scholten, S.; Velten, J.; Neher, T.; Margraf, J.ür. 2017: Wealth, justice and freedom: Objective and subjective measures predicting poor mental health in a study across eight countries. Ssm - Population Health 3: 639-648
Bogniard, R.P.; Whipple, G.H. 1932: V. the Iron Content of Blood Free Tissues and Viscera : Variations Due to Diet, Anemia and Hemoglobin Injections. Journal of Experimental Medicine 55(4): 653-665
Brown, A.J. 1914: V. the Localization of Foreign Bodies Within the Tissues with a Description of a Method of Localization. Annals of Surgery 59(1): 65-70
Robinson, B. 1895: V. the Navel Loop. Annals of Surgery 22(3): 343-352
Fowler, G.R. 1891: V. the Operative Technique of Appendicitis. Annals of Surgery 13(4): 276-283
Cook, A.G. 1903: V. the Orbital Route for Removal of the Second Branch of the Fifth Nerve at the Foramen Rotundum. Annals of Surgery 37(6): 855-858
Fowler, G.R. 1893: V. the Present State of Knowledge as to Carcinoma. Annals of Surgery 17(4): 478-488
Fuller, E. 1905: V. The Question of Priority in the Adoption of the Method of Total Enucleation, Suprapubically, of the Hypertrophied Prostate. Annals of Surgery 41(4): 520-534
Oliver, J.C. 1903: V. The Question of Surgical Intervention in Cases of Injuries to the Spine. Annals of Surgery 37(2): 238-252
Hartwell, J.A. 1905: V. The Radical Treatment of Cancer of the Rectum: With Particular Reference to the Value of Inguinal Colostomy. Annals of Surgery 42(3): 399-444
Fuller, E. 1905: V. The Relation of Gonorrhoeal Rheumatism to Seminal Vesiculitis, and its Cure by Seminal Vesiculotomy: A Report of Four Cases. Annals of Surgery 41(6): 903-913
Schumann, E.A. 1913: V. the Relationship Between Gastric and Pancreatic Carcinoma. Annals of Surgery 58(3): 326-333
Maclaren, A. 1900: V. the Relationship between Cholecystitis, Jaundice and Gall-stones. Annals of Surgery 31(4): 443-449
Marro, A. 1911: V. the Restoration of Fecal Continence After Iliac Colostomy. Annals of Surgery 53(2): 250-267
Park, R. 1891: V. The Results of the Absorption of the Products of Wound Infection. (Fourth Mütter Lecture, Series of 1890-91). Annals of Surgery 13(6): 445-475
Beck, C. 1905: V. the Röntgen Method in Lithiasis of the Urinary Tract. Annals of Surgery 42(6): 864-873
Rogers, J. 1909: V. the Significance of Thyroidism and its Relation to Goitre. Annals of Surgery 50(6): 1025-1051
Keen, W.W. 1898: V. the Sterilization of Catgut by the Jefferson Method. Annals of Surgery 27(1): 49-52
Blake, J.A. 1902: V. the Surgical Aspects of the Status Lymphaticus. Annals of Surgery 35(6): 745-757
Elsberg, C.A. 1903: V. the Surgical Features of Perforation of the Intestine in Typhoid Fever in Children. Annals of Surgery 38(1): 71-96
O'conor, J. 1899: V. the Surgical Treatment of Acute Infective Arthritis and Cellulitis (Acute Articular Rheumatism). Annals of Surgery 29(4): 469-480
Murray, F.W. 1901: V. the Surgical Treatment of Amoebic Dysentery. Annals of Surgery 33(5): 574-581
Fowler, R.S. 1909: V. the Surgical Treatment of Internal Hydrocephalus. Annals of Surgery 49(3): 374-381
Mayo, W.J. 1906: V. the Technique of Gastrojejunostomy. Annals of Surgery 43(4): 537-542
Shepherd, F.J. 1903: V. The Treatment of Aneurism of the External Iliac Artery by Digital Compression. With Report of a Case. Annals of Surgery 38(4): 498-502
Link, G. 1911: V. the Treatment of Chronic Pancreatitis by Pancreatostomy: a new Operation. Annals of Surgery 53(6): 768-782
Gerster, A.G. 1910: V. the Treatment of Diffuse Progressive Free Peritonitis: a Study of Six Hundred and Nine Cases. Annals of Surgery 51(4): 490-515
Hotchkiss, L.W. 1906: V. the Treatment of Diffuse Suppurative Peritonitis, Following Appendicitis. Annals of Surgery 44(2): 197-208
Mason, J.M. 1908: V. The Treatment of Dislocation of the Shoulder-Joint Complicated by Fracture of the Upper Extremity of the Humerus, with an Analysis of Sixty-three Cases with Fracture at the Neck of the Humerus and Twenty-one Cases with Fracture of the Greater Tuberosity reported since 1894. Annals of Surgery 47(5): 672-705
Connell, F.G. 1904: V. The Treatment of Haematemesis by Gastro-Enterostomy: With Report of Case. Annals of Surgery 40(4): 500-509
Taylor, W.J. 1895: V. the Treatment of Tubercular Abscess. Annals of Surgery 22(1): 104-108
Macnamara, C. 1885: V. the use of Hare-Lip Pins for Fixing the Stomach in Gastrostomy. Annals of Surgery 1(4): 341-342
Hubbard, J.C. 1901: V. the Worsted Truss in Inguinal Hernia. Annals of Surgery 34(4): 523-526
Pontifex, M.B.; Kamijo, K.; Scudder, M.R.; Raine, L.B.; Khan, N.A.; Hemrick, B.; Evans, E.M.; Castelli, D.M.; Frank, K.A.; Hillman, C.H. 2014: V. The differential association of adiposity and fitness with cognitive control in preadolescent children. Monographs of the Society for Research in Child Development 79(4): 72-92
Lloyd, S. 1898: V. Total Excision of the Fibula for Sarcoma. Annals of Surgery 27(6): 741-744
Jones, R. 1916: V. Transplantation of Bone, and some Uses of the Bone Graft. British Medical Journal 2(2896): 1-5
Pilcher, P.M. 1914: V. Transvesical Prostatectomy in two Stages. Annals of Surgery 59(4): 500-543
Aldrich, C.J. 1902: V. Traumatic Rupture of the Mesenteric Arteries. Annals of Surgery 35(3): 342-344
Buchanan, J.J. 1900: V. Traumatic Rupture of the Small Intestine; Abdominal Section; Recovery. Annals of Surgery 32(5): 673-675
Eisendrath, D.N. 1902: V. Traumatic Rupture of the Spleen. Annals of Surgery 36(6): 921-926
Fauntleroy, A.M. 1913: V. Traumatic Rupture of the Spleen (Complete); Splenectomy. Annals of Surgery 57(1): 68-71
Balloch, E.A. 1902: V. Traumatic Rupture of the Spleen; Splenectomy; Death on the Sixth day. Annals of Surgery 36(1): 44-46
Andrews, E.W. 1901: V. Tuberculosis Herniosa and Appendicitis Tuberculosa. Annals of Surgery 34(6): 787-795
Winslow, R. 1895: V. two Cases of Gastrostomy for Cicatricial Stenosis of the OEsophagus. Annals of Surgery 21(5): 543-546
Horwitz, O. 1899: V. two Cases of Hypertrophy of the Penis; one due to Traumatism; the other, to Elephantiasis. Annals of Surgery 29(2): 167-174
Riggs, E.P. 1894: V. two Cases of Laminectomy for Fracture of the Vertebrae with Compression of the Cord. Annals of Surgery 19(6): 661-663
Mayo, W.J. 1911: V. Ulcer of the Stomach and Duodenum with Special Reference to the End Results. Annals of Surgery 54(3): 313-320
Freeman, L. 1904: V. Unilateral Haematuria from Chronic Nephritis. Recovery after Decapsulation of Kidney. Annals of Surgery 39(3): 370-374
Kelly, H.A. 1894: V. Uretero-Ureteral Anastomosis-Uretero-Ureterostomy. Annals of Surgery 19(1): 70-77
Manley, T.H. 1893: V. Urethrectomy, Partial or Complete, as a Method for Radical Treatment of Rupture of the Urethra, Fistula, or Organic Stricture. Annals of Surgery 17(2): 181-188
Horwitz, O. 1898: V. Value of Castration to Facilitate Detection of Stone in the Bladder, in the Presence of Prostatic Hypertrophy. Annals of Surgery 27(3): 329-332
Coley, W.B.; Chaffee, I.S. 1909: V. Volvulus of Giant Sigmoid Colon: Recurrent Attacks of Acute Obstruction; Relief by New Method. Annals of Surgery 50(2): 464-469
Wharton, H.R. 1901: V. Wounds of the Venous Sinuses of the Brain An Analysis of Seventy Cases. Annals of Surgery 34(1): 81-110
Anonymous 1938: V.-Carcinoma of Stomach. Proceedings of the Royal Society of Medicine 32(2): 72-73
James, W. 1937: V.-Fibrous Epulis between 2 and 1. Proceedings of the Royal Society of Medicine 30(10): 1249
Anonymous 1943: V.-Immunity to Viruses. Proceedings of the Royal Society of Medicine 36(9): 479-482
Niederer, P.F. 2010: V.1. Ultrasound imaging and Doppler flow velocity measurement. Studies in Health Technology and Informatics 152: 249-273
Niederer, P.F. 2010: V.2. X-ray-based medical imaging: X-ray projection technique, image subtraction method, direct digital X-ray imaging, computed tomography (CT). Studies in Health Technology and Informatics 152: 274-301
Niederer, P.F. 2010: V.3. Basic elements of nuclear magnetic resonance for use in medical diagnostics: Magnetic Resonance Imaging (MRI), magnetic resonance spectroscopy (MRS). Studies in Health Technology and Informatics 152: 302-320
Baharestani, M.; Amjad, I.; Bookout, K.; Fleck, T.; Gabriel, A.; Kaufman, D.; McCord, S.S.; Moores, D.C.; Olutoye, O.O.; Salazar, J.D.; Song, D.H.; Teich, S.; Gupta, S. 2009: V.A.C. Therapy in the management of paediatric wounds: clinical review and experience. International Wound Journal 6(Suppl 1): 1-26
Kilpadi, D.V.; Feeley, T.D.; Kiel, J.W. 2007: V.A.C. Therapy normalizes vascular response of injured tissue in full-thickness wounds in rabbits. Annals of Plastic Surgery 58(5): 555-560
Piff, P.K.; Moskowitz, J.P. 2018: Wealth, poverty, and happiness: Social class is differentially associated with positive emotions. Emotion 18(6): 902-905
García Manzanares, M.Elena.; Hidalgo Dóniga, C.; De Arriba Amado, S.; Sánchez Sánchez, D.; de la Fuente Guerrero, M.Luisa.; Pérez Consuegra, M.Magdalena.; Navarro Raya, A.; Ramón Pérez, M.Pilar.; Barrios Prieto, Mía.Mar. 2009: V.A.C. therapy application on perineum wound after a Miles operation or Miles resection. Revista de Enfermeria 32(12): 30-34
Sibbald, R.Gary.; Woo, K.Y. 2008: V.A.C. therapy in home care. International Wound Journal 5 Suppl. 2: Iii-Iiv
Leyva-Moral, J.M.; Caixal-Mata, C. 2009: Prevalence of bed sores in geriatrics nursing home residences. Revista de Enfermeria 32(1): 52-56
Mora, F.; Cassano, M.; Mora, R.; Gallina, A.M.; Ciprandi, G. 2009: V.A.S. in the follow-up of turbinectomy. Rhinology 47(4): 450-453
Shortal, H. 1947: V.D. BRIEFS: The Nurse as a Case Finder in Venereal Disease. Canadian Medical Association Journal 56(1): 85-86
Latraverse, V.; Ricard, P.M. 1944: Duodenoscopic Removal of a Bobbie-Pin Through a Gastrotomy in a Child 13 Months Old. Canadian Medical Association Journal 51(6): 560-562
Kaliman, P.A. 2007: V.N. Karazin Kharkov National University as the foundation of biochemistry in Ukraine. Ukrains'kyi Biokhimichnyi Zhurnal 79(1): 137-147
Nechaĭ, A.I.; Shamov, V.N. 2011: V.N. Shamov--famous military-field surgeon. Voenno-Meditsinskii Zhurnal 332(2): 84-86
Ritti-Dias, R.M.; Li, J.; Hollabaugh, K.M.; Stoner, J.A.; Montgomery, P.S.; Gardner, A.W. 2013: V.O2 Kinetics and clinical factors among patients with peripheral artery disease. Journal of Cardiopulmonary Rehabilitation and Prevention 33(6): 411-418
Uzbekova, D.G.; Kravkov, V.P. 2014: V.P. Kravkov as a sanitary physician of the Russian Imperial Army (to centenary of beginning of the First World War). Problemy Sotsial'noi Gigieny Zdravookhraneniia i Istorii Meditsiny 2014(4): 51-54
Chroustova, D.; Kubinyi, J.; Jansa, P.; Veprekova, L.; Trnka, J. 2011: V/P scan in diagnosis and follow-up of pulmonary embolism in 15-25-year-old females in relation to hormonal contraception use. Nuclear Medicine Review. Central and Eastern Europe 14(2): 63-67
Leblanc, M.; Paul, N. 2010: V/Q SPECT and computed tomographic pulmonary angiography. Seminars in Nuclear Medicine 40(6): 426-441
Laurence, I.J.; Redman, S.L.; Corrigan, A.J.G.; Graham, R.N.J. 2012: V/Q SPECT imaging of acute pulmonary embolus - a practical perspective. Clinical Radiology 67(10): 941-948
Roach, P. 2013: V/Q SPECT: the primary imaging test for suspected pulmonary embolism. Bmj 347: F5119
King, G.G.; Harris, B.; Mahadev, S. 2010: V/Q SPECT: utility for investigation of pulmonary physiology. Seminars in Nuclear Medicine 40(6): 467-473
Bailey, E.A.; Bailey, D.L.; Roach, P.J. 2010: V/Q imaging in 2010: a quick start guide. Seminars in Nuclear Medicine 40(6): 408-414
Roach, P.J.; Schembri, G.P.; Bailey, D.L. 2013: V/Q scanning using SPECT and SPECT/CT. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 54(9): 1588-1596
Ahmad, N.; Srinivasan, K.; Moudgil, H. 2011: V/Q scanning: a useful alternative to pulmonary CT angiography-- let's not forget it. Ajr. American Journal of Roentgenology 196(1): W107; Author Reply W108
Azdaki, N.; Maleki, M.H.; Kazemi, T.; Moezi, S.A.; Moghaddam, H.R.M. 2014: V/Q scans and computerized tomography pulmonary angiography in pulmonary emboli in pregnancy: Superiority for fetal or mother. Journal of Research in Medical Sciences: the Official Journal of Isfahan University of Medical Sciences 19(7): 683-684
Freeman, L.M.; Haramati, L.B. 2009: V/Q scintigraphy: alive, well and equal to the challenge of CT angiography. European Journal of Nuclear Medicine and Molecular Imaging 36(3): 499-504
Kilding, A.E.; Jones, A.M. 2008: V02 'overshoot' during moderate-intensity exercise in endurance-trained athletes: the influence of exercise modality. Respiratory Physiology and Neurobiology 160(2): 139-146
Zhang, J.; Lanuza, G.M.; Britz, O.; Wang, Z.; Siembab, V.C.; Zhang, Y.; Velasquez, T.; Alvarez, F.J.; Frank, E.; Goulding, M. 2014: V1 and v2b interneurons secure the alternating flexor-extensor motor activity mice require for limbed locomotion. Neuron 82(1): 138-150
Sincich, L.C.; Jocson, C.M.; Horton, J.C. 2010: V1 interpatch projections to v2 thick stripes and pale stripes. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 30(20): 6963-6974
Ales, J.M.; Yates, J.L.; Norcia, A.M. 2010: V1 is not uniquely identified by polarity reversals of responses to upper and lower visual field stimuli. Neuroimage 52(4): 1401-1409
Teich, A.F.; Qian, N. 2010: V1 orientation plasticity is explained by broadly tuned feedforward inputs and intracortical sharpening. Visual Neuroscience 27(1-2): 57-73
Masuda, Y.; Dumoulin, S.O.; Nakadomari, S.; Wandell, B.A. 2008: V1 projection zone signals in human macular degeneration depend on task, not stimulus. Cerebral Cortex 18(11): 2483-2493
Qin, J.; Liu, K.; Wang, P.S.; Liu, C. 2009: V1 receptor in ENS mediates the excitatory effect of vasopressin on circular muscle strips of gastric body in vitro in rats. Regulatory Peptides 157(1-3): 32-36
Huang, X.; Paradiso, M.A. 2008: V1 response timing and surface filling-in. Journal of Neurophysiology 100(1): 539-547
Mirijello, A.; Pola, R.; Saviano, L.; Landolfi, R. 2013: V1-V2-V3-V4 T wave inversion: left or right ventricle?. BMJ Case Reports
Zhou, C.; Zhou, Y.; Wang, J.; Feng, Y.; Wang, H.; Xue, J.; Chen, Y.; Ye, R.D.; Wang, M.-W. 2013: V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins. Biochemical Journal 451(2): 245-255
Keene, T.D.; D'Alessandro, D.M.; Krämer, K.W.; Price, J.R.; Price, D.J.; Decurtins, S.; Kepert, C.J. 2012: V16O38(CN)]9–: a soluble mixed-valence redox-active building block with strong antiferromagnetic coupling. Inorganic Chemistry 51(17): 9192-9199
Wutkowski, A.; Näther, C.; Kögerler, P.; Bensch, W. 2008: V16Sb4O42(H2O){VO(C6H14N2)2}4]: a terminal expansion to a polyoxovanadate archetype. Inorganic Chemistry 47(6): 1916-1918
Mohedano-Moriano, A.; Pro-Sistiaga, P.; Ubeda-Bañon, I.; de la Rosa-Prieto, C.; Saiz-Sanchez, D.; Martinez-Marcos, A. 2008: V1R and V2R segregated vomeronasal pathways to the hypothalamus. Neuroreport 19(16): 1623-1626
Stewart, R.; Lane, R.P. 2007: V1R promoters are well conserved and exhibit common putative regulatory motifs. Bmc Genomics 8: 253
Van Haren, F.M.P.; Mitchell, I. 2012: V1a receptor agonists: the search for clean and green alternatives to vasopressin. Critical Care Medicine 40(6): 1999-2000
Wang, B.; Li, F.; Huang, C.; Yang, X.; Qian, Y.; Xie, Y.; Zhou, X. 2014: V2 of tomato yellow leaf curl virus can suppress methylation-mediated transcriptional gene silencing in plants. Journal of General Virology 95(Part 1): 225-230
Costello-Boerrigter, L.C.; Boerrigter, G.; Burnett, J.C. 2007: V2 receptor antagonism with tolvaptan in heart failure. Expert Opinion on Investigational Drugs 16(10): 1639-1647
Yi, J.-H.; Shin, H.-J.; Kim, H.-J. 2011: V2 receptor antagonist; tolvaptan. Electrolyte and Blood Pressure: e and Bp 9(2): 50-54
Takahashi, K.; Makita, N.; Manaka, K.; Hisano, M.; Akioka, Y.; Miura, K.; Takubo, N.; Iida, A.; Ueda, N.; Hashimoto, M.; Fujita, T.; Igarashi, T.; Sekine, T.; Iiri, T. 2012: V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists. Journal of Biological Chemistry 287(3): 2099-2106
Schliebe, N.; Strotmann, R.; Busse, K.; Mitschke, D.; Biebermann, H.; Schomburg, L.; Köhrle, J.; Bär, J.ör.; Römpler, H.; Wess, J.ür.; Schöneberg, T.; Sangkuhl, K. 2008: V2 vasopressin receptor deficiency causes changes in expression and function of renal and hypothalamic components involved in electrolyte and water homeostasis. American Journal of Physiology. Renal Physiology 295(4): F1177-F1190
Decaux, G. 2007: V2-antagonists for the treatment of hyponatraemia. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 22(7): 1853-1855
Etzkorn, J.; Ade, M.; Hillebrecht, H. 2007: V2AlC, V4AlC3-x (x approximately 0.31), and V12Al3C8: synthesis, crystal growth, structure, and superstructure. Inorganic Chemistry 46(18): 7646-7653
Window, A.J.; Hentz, A.; Sheppard, D.C.; Parkinson, G.S.; Niehus, H.; Ahlbehrendt, D.; Noakes, T.C.Q.; Bailey, P.; Woodruff, D.P. 2011: V2O3(0001) surface termination: phase equilibrium. Physical Review Letters 107(1): 016105
Yan, J.; Sumboja, A.; Khoo, E.; Lee, P.S. 2011: V2O5 loaded on SnO2 nanowires for high-rate li ion batteries. Advanced Materials 23(6): 746-750
Menezes, W.G.; Reis, D.M.; Benedetti, Tânia.M.; Oliveira, M.M.; Soares, Jísa.F.; Torresi, R.M.; Zarbin, A.J.G. 2009: V2O5 nanoparticles obtained from a synthetic bariandite-like vanadium oxide: synthesis, characterization and electrochemical behavior in an ionic liquid. Journal of Colloid and Interface Science 337(2): 586-593
Sathiya, M.; Prakash, A.S.; Ramesha, K.; Tarascon, J.M.; Shukla, A.K. 2011: V2O5-anchored carbon nanotubes for enhanced electrochemical energy storage. Journal of the American Chemical Society 133(40): 16291-16299
Liu, Z.-W.; Wang, C.; Fan, W.-B.; Liu, Z.-T.; Hao, Q.-Q.; Long, X.; Lu, J.; Wang, J.-G.; Qin, Z.-F.; Su, D.S. 2011: V2O5/Ce0.6Zr0.4O2-Al2O3 as an efficient catalyst for the oxidative dehydrogenation of ethylbenzene with carbon dioxide. Chemsuschem 4(3): 341-345
Ohde, C.; Brandt, M.; Limberg, C.; Döbler, J.; Ziemer, B.; Sauer, J. 2008: V2O5/SiO2 surface inspired, silsesquioxane-derived oxovanadium complexes and their properties. Dalton Transactions 3: 326-331
Jin, W.; Chen, W.; Lu, Y.; Zhao, C.; Dai, Y. 2011: V2O5/polypyrrole core-shell nanotubes for gas sensor. Journal of Nanoscience and Nanotechnology 11(12): 10834-10838
Bichet, D.G. 2009: V2R mutations and nephrogenic diabetes insipidus. Progress in Molecular Biology and Translational Science 89: 15-29
Kimura, Y.; Satou, C.; Higashijima, S-Ichi. 2008: V2a and V2b neurons are generated by the final divisions of pair-producing progenitors in the zebrafish spinal cord. Development 135(18): 3001-3005
Berro, R.; Klasse, P.J.; Jakobsen, M.R.; Gorry, P.R.; Moore, J.P.; Sanders, R.W. 2012: V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc. Virology 427(2): 158-165
Bozek, K.; Thielen, A.; Sierra, S.; Kaiser, R.; Lengauer, T. 2009: V3 loop sequence space analysis suggests different evolutionary patterns of CCR5- and CXCR4-tropic HIV. Plos one 4(10): E7387
Montagna, C.; De Crignis, E.; Bon, I.; Re, M.C.; Mezzaroma, I.; Turriziani, O.; Graziosi, C.; Antonelli, G. 2014: V3 net charge: additional tool in HIV-1 tropism prediction. Aids Research and Human Retroviruses 30(12): 1203-1212
Monno, L.; Brindicci, G.; Saracino, A.; Punzi, G.; Cibelli, D.; Lagioia, A.; Angarano, G. 2010: V3 sequences and paired HIV isolates from 52 non-subtype B HIV type 1-infected patients. Aids Research and Human Retroviruses 26(3): 365-372
Posch, A.; Kohn, J.; Oh, K.; Hammond, M.; Liu, N. 2013: V3 stain-free workflow for a practical, convenient, and reliable total protein loading control in western blotting. Journal of Visualized Experiments: Jove 82: 50948
Hernández, D.; Miquel-Serra, L.; Docampo, M.ía.-J.é; Marco-Ramell, A.; Cabrera, J.; Fabra, A.; Bassols, A. 2011: V3 versican isoform alters the behavior of human melanoma cells by interfering with CD44/ErbB-dependent signaling. Journal of Biological Chemistry 286(2): 1475-1485
Huang, H.-T.; He, J.-L.; Zhang, B.-T.; Yang, J.-F.; Xu, J.-L.; Zuo, C.-H.; Tao, X.-T. 2010: V3+:YAG as the saturable absorber for a diode-pumped quasi-three-level dual-wavelength Nd:GGG laser. Optics Express 18(4): 3352-3357
Maeda, Y.; Terasawa, H.; Nakano, Y.; Monde, K.; Yusa, K.; Oka, S.; Takiguchi, M.; Harada, S. 2014: V3-independent competitive resistance of a dual-X4 HIV-1 to the CXCR4 inhibitor AMD3100. Plos one 9(2): E89515
Akgun, Z.; Atasoy, B.M.; Ozen, Z.; Yavuz, D.; Gulluoglu, B.; Sengoz, M.; Abacioglu, U. 2014: V30 as a predictor for radiation-induced hypothyroidism: a dosimetric analysis in patients who received radiotherapy to the neck. Radiation Oncology 9: 104
Sligte, I.G.; Scholte, H.Steven.; Lamme, V.A.F. 2009: V4 activity predicts the strength of visual short-term memory representations. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 29(23): 7432-7438
Herwig, C.; Limberg, C. 2008: V4O10: spectroscopic fingerprint of a well-defined, molecular metaloxo aggregate. Inorganic Chemistry 47(8): 2937-2939
Chen, D.; Hickner, M.A. 2013: V5+ degradation of sulfonated Radel membranes for vanadium redox flow batteries. Physical Chemistry Chemical Physics: Pccp 15(27): 11299-11305
Toshima, T.; Taketomi, A.; Ikegami, T.; Fukuhara, T.; Kayashima, H.; Yoshizumi, T.; Soejima, Y.; Shirabe, K.; Maehara, Y. 2012: V5-drainage-preserved right lobe grafts improve graft congestion for living donor liver transplantation. Transplantation 93(9): 929-935
McDonnell, K.; Betz, B.; Fullen, D.; Lao, C.D. 2011: V559A and N822i double KIT mutant melanoma with predictable response to imatinib?. Pigment Cell and Melanoma Research 24(2): 390-392
Bannykh, S.I.; Mirocha, J.; Nuno, M.; Lopategui, J.; Kandala, G. 2014: V600E BRAF mutation in pilocytic astrocytoma is associated with a more diffuse growth pattern but does not confer a more aggressive clinical behavior. Clinical Neuropathology 33(6): 388-398
Agaimy, A.; Terracciano, L.M.; Dirnhofer, S.; Tornillo, L.; Foerster, A.; Hartmann, A.; Bihl, M.P. 2009: V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours. Journal of Clinical Pathology 62(7): 613-616
Carragher, L.A.S.; Snell, K.R.; Giblett, S.M.; Aldridge, V.S.S.; Patel, B.; Cook, S.J.; Winton, D.J.; Marais, R.; Pritchard, C.A. 2010: V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. Embo Molecular Medicine 2(11): 458-471
Peys, N.; Ling, Y.; Dewulf, D.; Gielis, S.; De Dobbelaere, C.; Cuypers, D.; Adriaensens, P.; Van Doorslaer, S.; De Gendt, S.; Hardy, A.; Van Bael, M.K. 2013: V6O13 films by control of the oxidation state from aqueous precursor to crystalline phase. Dalton Transactions 42(4): 959-968
Matsushima, S.; Ohtsuka, K.; Ohnishi, H.; Fujiwara, M.; Nakamura, H.; Morii, T.; Kishino, T.; Goto, H.; Watanabe, T. 2014: V843I, a lung cancer predisposing EGFR mutation, is responsible for resistance to EGFR tyrosine kinase inhibitors. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 9(9): 1377-1384
Yang, H.; Zhang, H.; Xing, X. 2015: V876E mutation in CACNA1S gene associated with severe hypokalemic periodic paralysis in a Chinese woman. Journal of the Formosan Medical Association 114(4): 377-378
Boger-Megiddo, I.; Weiss, N.S.; Barnett, M.J.; Goodman, G.E.; Chen, C. 2008: V89L polymorphism of the 5alpha-reductase Type II gene (SRD5A2), endogenous sex hormones, and prostate cancer risk. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 17(2): 286-291
Tong, M.; Jin, Y.-Y.; Li, G.; Liu, S.-M.; Ji, C.-D. 2010: V89L polymorphism of the testosterone 5-alpha-reductase Ii gene and prognostic factors of prostate cancer. Zhonghua Nan Ke Xue 16(11): 990-993
Reid, L. 2011: V: valentine, violence, vagina.. Practising Midwife 14(2): 46
Aragon, B.R.; Pierce, R.A.; Jones, W.N. 2012: VA CMOPs: producing a pattern of quality and efficiency in government. Journal of the American Pharmacists Association: Japha 52(6): 810-815
Anonymous 2013: VA Dental Insurance Program--federalism. Direct final rule. Federal Register 78(204): 62441-62443
Anonymous 2014: VA Dental Insurance Program--federalism. Direct final rule; confirmation of effective date. Federal Register 79(54): 15541-15542
Anonymous 2013: VA Dental Insurance Program. Final rule. Federal Register 78(103): 32126-32131
Anonymous 2013: VA Health Professional Scholarship and Visual Impairment and Orientation and Mobility Professional Scholarship Programs. Final rule. Federal Register 78(161): 51067-51073
Anonymous 2013: VA Homeless Providers Grant and Per Diem Program. Final rule. Federal Register 78(37): 12600-12617
Holden, C. 1977: VA Hospital System Under Scrutiny. Science 198(4312): 36-37
Spratt, J.S. 1965: VA Hospitals. Science 148(3676): 1411
Segarra, J.M. 1965: VA Hospitals: Length of Stay. Science 149(3685): 708
Stelmack, J.A.; Tang, X.C.; Reda, D.J.; Stroupe, K.T.; Rinne, S.; Massof, R.W.; Stelmack, J.; Hines, E.; Massof, R.W.; Ellis, N.; Zablocki, C.J.; Rinne, S.; Hines, E.; Korwin, T.; Hines, E.; Reda, D.J.; Tang, X.Charlene.; Stroupe, K.T.; Lippe, D.; Wei, Y.; Tir, K.; Rachelle, M.; Ballinger, R.; Whitman, O.; Hurvitz, C.; Davis, S.; Morand, T.; Rogge, M.Colleen.; Swedelius, B.; Morand, T.; Thompson, C.; Joos, B.; Stelmack, J.; Rinne, S.; Korwin, T.; Houston, J.; Brahm, K.; LaCrosse, D.; Wurf, A.; Rose, K.; Ellis, N.; Seefeldt, C.; Wilcox, D.Thomas.;, 2012: VA LOVIT II: a protocol to compare low vision rehabilitation and basic low vision. Ophthalmic and Physiological Optics: the Journal of the British College of Ophthalmic Opticians 32(6): 461-471
Boone, J.T. 1953: VA Medical Care. California Medicine 78(6): 524-525
Nazi, K.M.; Turvey, C.L.; Klein, D.M.; Hogan, T.P.; Woods, S.S. 2015: VA OpenNotes: exploring the experiences of early patient adopters with access to clinical notes. Journal of the American Medical Informatics Association: Jamia 22(2): 380-389
Beck, L. 2013: VA Prosthetic and Sensory Aids Service—65 years of progress. Journal of rehabilitation research and development 50(1): xvii-xviii
Smucker Barnwell, S.V.; Juretic, M.A.; Hoerster, K.D.; Van de Plasch, R.; Felker, B.L. 2012: VA Puget Sound Telemental Health Service to rural veterans: a growing program. Psychological Services 9(2): 209-211
Holden, C. 1985: VA Re-reconsiders Twin Study. Science 227(4682): 37
Cook, J.M.; Dinnen, S.; Simiola, V.; Thompson, R.; Schnurr, P.P. 2014: VA Residential Provider Perceptions of Dissuading Factors to the Use of Two Evidence-Based PTSD Treatments. Professional Psychology Research and Practice 45(2): 136-142
Shaposhnikov, A.V. 2007: Precancerous gastric diseases. Klinicheskaia Meditsina 85(2): 4-9
Conn, J. 2010: VA bares all: Department to release internal quality dashboard, new website to public. Modern Healthcare 40(47): 14
Jameson, J.P.; Farmer, M.S.; Head, K.J.; Fortney, J.; Teal, C.R. 2011: VA community mental health service providers' utilization of and attitudes toward telemental health care: the gatekeeper's perspective. Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association 27(4): 425-432
Roberts, C. 2009: VA coordinator in the spotlight. Nephrology News and Issues 23(9): 26
Tully, P.J. 2013: Quality-of-Life measures for cardiac surgery practice and research: a review and primer. Journal of Extra-Corporeal Technology 45(1): 8-15
Rosen, G.M.; Spitzer, R.L. 2008: VA disability policies and posttraumatic morbidity. American Journal of Public Health 98(5): 775; Author Reply 775-6
Bidassie, B.; Davies, M.L.; Stark, R.; Boushon, B. 2014: VA experience in implementing Patient-Centered Medical Home using a breakthrough series collaborative. Journal of General Internal Medicine 29(Suppl 2): S563-S571
Lee, J. 2012: VA gets local for mental health. Modern Healthcare 42(37): 12
Leslie, D.L.; Goulet, J.; Skanderson, M.; Mattocks, K.; Haskell, S.; Brandt, C. 2011: VA health care utilization and costs among male and female veterans in the year after service in Afghanistan and Iraq. Military Medicine 176(3): 265-269
Gabrielian, S.; Yuan, A.H.; Andersen, R.M.; Rubenstein, L.V.; Gelberg, L. 2014: VA health service utilization for homeless and low-income Veterans: a spotlight on the VA Supportive Housing (VASH) program in greater Los Angeles. Medical Care 52(5): 454-461
Dickinson, K.C.; Sharma, R.; Duckart, J.P.; Corson, K.; Gerrity, M.S.; Dobscha, S.K. 2010: VA healthcare costs of a collaborative intervention for chronic pain in primary care. Medical Care 48(1): 38-44
Amdur, D.; Batres, A.; Belisle, J.; Brown, J.H.; Cornis-Pop, M.; Mathewson-Chapman, M.; Harms, G.; Hunt, S.C.; Kennedy, P.; Mahoney-Gleason, H.; Perez, J.; Sheets, C.; Washam, T. 2011: VA integrated post-combat care: a systemic approach to caring for returning combat veterans. Social Work in Health Care 50(7): 564-575
Mohamed, S.; Neale, M.; Rosenheck, R.A. 2009: VA intensive mental health case management in urban and rural areas: veteran characteristics and service delivery. Psychiatric Services 60(7): 914-921
Katon, J.; Reiber, G.; Rose, D.; Bean-Mayberry, B.; Zephyrin, L.; Washington, D.L.; Yano, E.M. 2013: VA location and structural factors associated with on-site availability of reproductive health services. Journal of General Internal Medicine 28(Suppl 2): S591-S597
Seal, K.H.; Maguen, S.; Cohen, B.; Gima, K.S.; Metzler, T.J.; Ren, L.; Bertenthal, D.; Marmar, C.R. 2010: VA mental health services utilization in Iraq and Afghanistan veterans in the first year of receiving new mental health diagnoses. Journal of Traumatic Stress 23(1): 5-16
Clifford, J.; Claflin, N. 2013: VA nurses: honoring and caring for America's heroes. American Nurse 45(6): 13
Lemke, S.; Schaefer, J.A. 2010: VA nursing home residents with substance use disorders: Mental health comorbidities, functioning, and problem behaviors. Aging and Mental Health 14(5): 593-602
Halford, S.; Pires, S.S.; Turton, M.; Zheng, L.; González-Menéndez, I.; Davies, W.L.; Peirson, S.N.; García-Fernández, J.é M.; Hankins, M.W.; Foster, R.G. 2009: VA opsin-based photoreceptors in the hypothalamus of birds. Current Biology: Cb 19(16): 1396-1402
Reiber, G.E.; Smith, D.G. 2010: VA paradigm shift in care of veterans with limb loss. Journal of Rehabilitation Research and Development 47(4): Vii-Vix
Traynor, K. 2014: VA pharmacy aims high for clinical practice. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 71(11): 888-889; 893
Traynor, K. 2007: VA pharmacy goes mobile. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(21): 2216-2218
Aspinall, S.L.; Banthin, J.S.; Good, C.B.; Miller, G.E.; Cunningham, F.E. 2009: VA pharmacy users: how they differ from other veterans. American Journal of Managed Care 15(10): 701-708
Johnson-Lawrence, V.; Zivin, K.; Szymanski, B.R.; Pfeiffer, P.N.; McCarthy, J.F. 2012: VA primary care-mental health integration: patient characteristics and receipt of mental health services, 2008-2010. Psychiatric Services 63(11): 1137-1141
Traylor, L. 2008: VA project helps families provide care. American Journal of Nursing 108(9 Suppl): 19
Lipson, L.; Eisen, S. 2011: VA research: committed to women who have "borne the battle" and beyond. Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health 21(4 Suppl): S67-S69
Anonymous 2010: VA strengthens critical patient-safety procedure. Two systems replace traditional paper-based informed-consent process with an electronic time-out checklist integrated into electronic records. Health Management Technology 31(4): 28-29
Anonymous 2010: VA study shows fewer patient deaths after OR team training. Or Manager 26(12): 1 9-1,11
Godleski, L.; Nieves, J.E.; Darkins, A.; Lehmann, L. 2008: VA telemental health: suicide assessment. Behavioral Sciences and the Law 26(3): 271-286
Conn, J. 2011: VA to update VistA EHR. Modern Healthcare 41(22): 17
Thompson, C.A. 2010: VA's Clinical Research Pharmacy wins quality award. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 67(3): 174-176
Austin, E.L.; Pollio, D.E.; Holmes, S.; Schumacher, J.; White, B.; Lukas, C.V.; Kertesz, S. 2014: VA's expansion of supportive housing: successes and challenges on the path toward Housing first. Psychiatric Services 65(5): 641-647
Bossert, W.H.; Dobalian, A. 2011: VA's involvement in the aftermath of the 9/11 attacks. Disaster Medicine and Public Health Preparedness 5(Suppl 2): S167
Kuehn, B.M. 2008: VA, military seek office-based PTSD care. JAMA 299(16): 1885-1886
Occhetta, P.; Visone, R.; Russo, L.; Cipolla, L.; Moretti, M.; Rasponi, M. 2015: VA-086 methacrylate gelatine photopolymerizable hydrogels: a parametric study for highly biocompatible 3D cell embedding. Journal of Biomedical Materials Research. Part a 103(6): 2109-2117
Haggstrom, D.A.; Rosenman, M.; Myers, L.J.; Teal, E.; Doebbeling, B.N. 2010: VA-INPC: Linking Department of Veterans Affairs (VA) and Indiana Network for Patient Care (INPC) data to assess surveillance testing among veterans with colorectal cancer. AMIA .. Annual Symposium Proceedings. AMIA Symposium 2010: 266-270
Van Olden, G.D.J. 2014: VA-LCP anterior clavicle plate: the anatomically precontoured fixation system with angular stability for clavicle shaft. Musculoskeletal Surgery 98(3): 217-223
Ayers, C.; Arch, J. 2013: VA-academic partnerships: challenges and rewards for new VA mental health investigators. Community Mental Health Journal 49(6): 709-713
Morse, L.R.; Giangregorio, L.; Battaglino, R.A.; Holland, R.; Craven, B.C.; Stolzmann, K.L.; Lazzari, A.A.; Sabharwal, S.; Garshick, E. 2009: VA-based survey of osteoporosis management in spinal cord injury. Pm and R: the Journal of Injury Function and Rehabilitation 1(3): 240-244
Bates, B.; Glasberg, J.; Hughes, K.; Katz, R.; Priefer, B.; Richards, L.; Ruff, R.; Sullivan, P.; Zartman, A.L.; Cassidy, C.; Lux, L.; Viswanathan, M.; Lohr, K.; Bowles, A.; Crumpton, S.; Lambert, K.; Alexander, D.N.; Duncan, P.W.; Lutz, B.; Degenhardt, E.; Klar, A.V.; D'Erasmo, M.; Fishman, R. 2010: VA/DOD Clinical practice guideline for the management of stroke rehabilitation. Journal of Rehabilitation Research and Development 47(9): 1-43
Cifu, D.; Hurley, R.; Peterson, M.; Cornis-Pop, M.; Rikli, P.A.; Ruff, R.L.; Scott, S.G.; Sigford, B.J.; Silva, K.A.; Tortorice, K.; Vanderploeg, R.D.; Withlock, W.; Bowles, A.; Cooper, D.; Drake, A.; Engel, C.; Simmers Geckle, L.; Helmick, K.; Hoge, C.; Jaffee, M.; Labutta, R.; Ling, G.; Lowe, L.; Mims, S.; Orman, D.T.; Solomon, B.E.; Stone, J.M.; Thomas, K.; Tolbert, M.; Williams, C.S.; Francis, J.; Cassidy, C.; Klar, A.; Degenhardt, E.; Susskind, O.; Cohen, J.; Kasten, J.J.; Radcliff, S.; Schlenger, W.E.; D'Erasmo, M.; Fishman, R.; Marko, J. 2009: VA/DoD Clinical Practice Guideline for Management of Concussion/Mild Traumatic Brain Injury. Journal of Rehabilitation Research and Development 46(6): Cp1
Wałęga, P.; Romaniszyn, M.ł; Nowak, W. 2014: VAAFT: a new minimally invasive method in the diagnostics and treatment of anal fistulas--initial results. Polski Przeglad Chirurgiczny 86(1): 7-10
Hu, H.; Huff, C.D.; Moore, B.; Flygare, S.; Reese, M.G.; Yandell, M. 2013: VAAST 2.0: improved variant classification and disease-gene identification using a conservation-controlled amino acid substitution matrix. Genetic Epidemiology 37(6): 622-634
Gomi, N.; Iwase, T.; Akiyama, F. 2012: VAB (vacuum-assisted breast biopsy system). Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 7): 302-305
Kim, H.-S.; Murakami, R.; Quintin, S.; Mori, M.; Ohkura, K.; Tamai, K.K.; Labouesse, M.; Sakamoto, H.; Nishiwaki, K. 2011: VAB-10 spectraplakin acts in cell and nuclear migration in Caenorhabditis elegans. Development 138(18): 4013-4023
Camps, I.; Arméstar, F.; Cuadrado, M.; Mesalles, E. 2009: VAC (vacuum-assisted closure) "covered" laparostomy to control abdominal compartmental syndrome in a case of emphysematous pancreatitis. Cirugia Espanola 86(4): 250-251
Wild, T.; Goetzinger, P.; Telekey, B. 2007: VAC and fistula formation. Colorectal Disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland 9(6): 572-573
Singh, S.; Mackey, S.; Soldin, M. 2008: VAC it - Some techniques on the application of VAC dressings. Annals of the Royal College of Surgeons of England 90(2): 161-162
Alvarez, F.J.; Hosoya, K.; Lara-Garcia, A.; Kisseberth, W.; Couto, G. 2013: VAC protocol for treatment of dogs with stage III hemangiosarcoma. Journal of the American Animal Hospital Association 49(6): 370-377
De Caridi, G.; Serra, R.; Massara, M.; Barone, M.; Grande, R.; Butrico, L.; Mastroroberto, P.; de Franciscis, S.; Monaco, F. 2016: VAC therapy for the treatment of complex wounds after cardio-thoracic surgery. International Wound Journal 13(5): 759-762
De Caridi, G.; Massara, M.; Greco, M.; Pipitò, N.; Spinelli, F.; Grande, R.; Butrico, L.; de Franciscis, S.; Serra, R. 2016: VAC therapy to promote wound healing after surgical revascularisation for critical lower limb ischaemia. International Wound Journal 13(3): 336-342
Henderson, A.M.; James, J.W.; White, G.A.; Briggs, W.E.; Gundrum, F.F.; Simmons, S.E. 1915: Progress or Retrogression?. California State Journal of Medicine 13(10): 377-378
Pinzón-Rondón, Ángela.María.; Cifuentes, L.B.; Zuluaga, C.; Botero, J.Carlos.; Pinzon-Caicedo, M. 2018: Wealth, Social Protection Programs, and Child Labor in Colombia: A Cross-sectional Study. International Journal of Health Services: Planning Administration Evaluation 48(3): 535-548
Poland, G.A.; Leary, M.Lowell. 2010: VACCINE in the 21st century: what's next?. Vaccine 28(6): 1437
Johnson, A.E.; Le, I.P.; Andresen, B.T.; Stodola, J.; Dewey, G.L.; Dean, S.B.; Resau, J.; Haak, P.; Ruch, T.; Sartor, A.; Lazdins, I.; Barney, C.C.; Burnatowska-Hledin, M.A. 2012: VACM-1/cul5 expression in vascular tissue in vivo is induced by water deprivation and its expression in vitro regulates aquaporin-1 concentrations. Cell and Tissue Research 349(2): 527-539
Alvarez-Pasquín, M.J.; Heijbel, H.; Yarwood, J.; Van Damme, P.; Aksakal, F.N.; Andrén, S.; Aronsson, B.; Bechini, A.; Bejersten, M.; Blennow, M.; Bergsaker, M.; Boccalini, S.; Bonanni, P.; Czumbel, I.; Fu, C.; Gerhardsen, T.I.; Grgic-Vitek, M.; Habersaat, K.; Haugen, I.L.; Kerbo, N.; Kraigher, A.; Lundin, H.; Mayer, M.A.; Muchl, R.; Netterlid, E.; Navarro, J.A.; Nökleby, H.; Pistol, A.; Muniz, H.Pors.; Robinson, M.; Stanescu, A.; Stefanoff, P.; Tuells, J.; Vladimirova, N.; Vorsters, A. 2009: VACSATC (vaccine safety: attitudes, training and communication): why such a project?. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 14(16)
Bhurtel, D.Raj.; Losa, I. 2010: VACTERL (vertebral anomalies, anal atresia or imperforate anus, cardiac anomalies, tracheoesophageal fistula, renal and limb defect) spectrum presenting with portal hypertension: a case report. Journal of Medical Case Reports 4: 128
Carli, D.; Garagnani, L.; Lando, M.; Fairplay, T.; Bernasconi, S.; Landi, A.; Percesepe, A. 2014: VACTERL (vertebral defects, anal atresia, tracheoesophageal fistula with esophageal atresia, cardiac defects, renal and limb anomalies) association: disease spectrum in 25 patients ascertained for their upper limb involvement. Journal of pediatrics 164(3): 458-62.e1-2
Pandey, D.B.; Pednekar, S.J.; Chavan, S.A.; Korivi, D.; Shah, A.Kumar.; Kulkarni, U.P. 2011: VACTERL Association. Journal of the Association of Physicians of India 59: 447-449
Chen, R.Hung.; Hung, H-Yang.; Wang, N-Lu.; Shih, S-Lin.; Hwang, H-Kwei.; Chang, T-Yao.; Chen, P.H.; Chang, J-Hsing. 2016: VACTERL Association Complicated with Right-sided Congenital Diaphragmatic Hernia. Pediatrics and Neonatology 57(4): 347-350
Brosens, E.; Eussen, H.; van Bever, Y.; van der Helm, R.M.; Ijsselstijn, H.; Zaveri, H.P.; Wijnen, R.; Scott, D.A.; Tibboel, D.; de Klein, A. 2013: VACTERL Association Etiology: The Impact of de novo and Rare Copy Number Variations. Molecular Syndromology 4(1-2): 20-26
Keckler, S.J.; St Peter, S.D.; Valusek, P.A.; Tsao, K.; Snyder, C.L.; Holcomb, G.W.; Ostlie, D.J. 2007: VACTERL anomalies in patients with esophageal atresia: an updated delineation of the spectrum and review of the literature. Pediatric Surgery International 23(4): 309-313
Solomon, B.D.; Patel, A.; Cheung, S.Wai.; Pineda-Alvarez, D.E. 2011: VACTERL association and mitochondrial dysfunction. Birth Defects Research. Part A Clinical and Molecular Teratology 91(3): 192-194
Sandal, G.; Aslan, N.; Duman, L.; Ormeci, A.R. 2014: VACTERL association with a rare vertebral anomaly (butterfly vertebra) in a case of monochorionic twin. Genetic Counseling 25(2): 231-235
Al-Farqani, A.; Panduranga, P.; Al-Maskari, S.; Thomas, E. 2013: VACTERL association with double-chambered left ventricle: A rare occurrence. Annals of Pediatric Cardiology 6(2): 200-201
Chen, C-Ping.; Chang, T-Yao.; Chen, Y-Yung.; Chern, S-Rern.; Su, J-Wei.; Wang, W. 2013: VACTERL association with hydrocephalus in a fetus conceived by in vitro fertilization and embryo transfer. Taiwanese Journal of Obstetrics and Gynecology 52(4): 575-579
Sezer, R.Gonul.; Aydemir, Gökhan.; Bozaykut, A.; Paketci, C.; Aydinoz, S. 2012: VACTERL association: a new case with biotinidase deficiency and annular pancreas. Renal Failure 34(1): 123-125
Contreras-Omaña, R.; Aguilar-Lira, J.L. 2014: VACTERL syndrome. Revista de Gastroenterologia de Mexico 79(2): 147-148
Alter, B.P.; Rosenberg, P.S. 2013: VACTERL-H Association and Fanconi Anemia. Molecular Syndromology 4(1-2): 87-93
Salinas-Torres, V.M.; Ramos-Márquez, M.E.; Angulo-Castellanos, E. 2013: VACTERL-H association with tibial agenesis. Expansion of the clinical phenotype?. Anales de Pediatria 79(2): 125-127
Dane, B.; Kayaoğlu, Z.; Dane, C.; Aksoy, F. 2011: VACTERL-H syndrome: first trimester diagnosis. Journal of the Turkish German Gynecological Association 12(4): 266-269
Solomon, B.D. 2011: VACTERL/VATER Association. Orphanet Journal of Rare Diseases 6: 56
Javed, M.; Shokrollahi, K. 2012: VACUETTE(®) for burn depth assessment--a simple and novel alternative use for a ubiquitous phlebotomy device. Burns: Journal of the International Society for Burn Injuries 38(7): 1084-1085
Schmid, S.; Azzopardi, E.; De Jaeger, X.; Prado, M.A.M.; Prado, V.F. 2011: VAChT knock-down mice show normal prepulse inhibition but disrupted long-term habituation. Genes Brain and Behavior 10(4): 457-464
Winge, R.; Berg, J.O.; Albret, R.; Krag, C. 2012: VAC® for external fixation of flail chest. Clinics and Practice 2(3): E65
Cavigelli-Brunner, A.; Schweiger, M.; Knirsch, W.; Stiasny, B.; Klingel, K.; Kretschmar, O.; Hübler, M. 2014: VAD as bridge to recovery in anthracycline-induced cardiomyopathy and HHV6 myocarditis. Pediatrics 134(3): E894-E899
Zervas, K.; Mihou, D.; Katodritou, E.; Pouli, A.; Mitsouli, C.H.; Anagnostopoulos, A.; Delibasi, S.; Kyrtsonis, M.C.; Anagnostopoulos, N.; Terpos, E.; Zikos, P.; Maniatis, A.; Dimopoulos, M.A. 2007: VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek Myeloma Study Group. Annals of Oncology: Official Journal of the European Society for Medical Oncology 18(8): 1369-1375
Steckl, P.D.; Samaritan, G.; Martinez, L.; Gregg, M.G. 2014: VAD: an under-recognized cause of stroke in the young. Journal of the Medical Association of Georgia 103(1): 16-17
Cheng, A.; Swartz, M.F.; Massey, H.T. 2013: VADoscopy: a novel intraoperative technique to evaluate HeartMate Ii left ventricular assist device inflow obstruction and thrombosis. Asaio Journal 59(6): 671-674
Nunez, C. 2013: VAE surveillance helps clinicians improve outcomes. What the CDC's new ventilator-associated event protocol means. Health Management Technology 34(8): 16-17
Mounkoro, N.; Téguété, I.; Traoré, Y.; Diarra, I.; Sissoko, S.; Diallo, F.; Traoré, M.; Dolo, A. 2005: Vaginal Hysterectomy in the Department of Obstetrics and Gynecology of the Point "g" Hospital. Le Mali medical 20(1-2): 48-50
Anonymous 1947: VAGOTOMY for peptic ulcer. California medicine 66(6): 372
Anonymous 1947: VAGUE abdominal pain and leukocytosis. Postgraduate medicine 1(1): 74
Powell, D.R.; Seemann, T. 2013: VAGUE: a graphical user interface for the Velvet assembler. Bioinformatics 29(2): 264-265
Schmidt, J.; Gröller, M.E.; Bruckner, S. 2013: VAICo: visual analysis for image comparison. IEEE Transactions on Visualization and Computer Graphics 19(12): 2090-2099
Robson, A.W. 1898: Valedictory Presidential Address on Extrauterine Gestation: Delivered before the British Gynaecological Society on January 13th, 1898. British Medical Journal 1(1935): 285-288
Landsman, T.; De MARTINO, M.F. 1947: Some areas of caution for the psychology student. American Psychologist 2(4): 145-147
Ahmed, A.; Perry, G.J.; Husain, A. 2007: VALIDD should not invalidate angiotensin-receptor blockers. Lancet 369(9579): 2053-2054
Ching, K.K.L. 2010: VALO light curing unit. Hda now 2010: 14
Amor, A.J. 1948: Nursing and the industrial environment. Nursing Times 44(7): 114
Anonymous 1948: VALUE of antenatal exercises. New Zealand Medical Journal 47(260): 378-381
Anonymous 1945: VALUE of anterior-oblique roentgenograms in diagnosis of primary atypical pneumonia. Bulletin of the U.S. Army Medical Department. United States. Army. Medical Department 4: 641
Anonymous 1945: VALUE of convalescent reconditioning. journal of military medicine in the Pacific 1(1): 34-36
Smith, L.; Trent, A.; Brewer, J. 2007: A growing problem. Imprint 54(2): 8
Finkelstein, S.M.; Speedie, S.M.; Zhou, X.; Ratner, E.; Potthoff, S. 2006: VALUE: Virtual Assisted Living Umbrella for the Elderly -- user patterns. Conference Proceedings: . Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2006: 3294-3296
Gurdak, E.; Green, F.M.; Rakowska, P.D.; Seah, M.P.; Salter, T.L.; Gilmore, I.S. 2014: VAMAS interlaboratory study for desorption electrospray ionization mass spectrometry (DESi MS) intensity repeatability and constancy. Analytical Chemistry 86(19): 9603-9611
Ferlito, M.; Fulton, W.B.; Zauher, M.A.; Marbán, E.; Steenbergen, C.; Lowenstein, C.J. 2010: VAMP-1, VAMP-2, and syntaxin-4 regulate ANP release from cardiac myocytes. Journal of Molecular and Cellular Cardiology 49(5): 791-800
Benagiano, V.; Lorusso, L.; Flace, P.; Girolamo, F.; Rizzi, A.; Bosco, L.; Cagiano, R.; Nico, B.; Ribatti, D.; Ambrosi, G. 2011: VAMP-2, SNAP-25A/B and syntaxin-1 in glutamatergic and GABAergic synapses of the rat cerebellar cortex. Bmc Neuroscience 12: 118
Gorący, J.ła.; Gorący, I.; Kaczmarczyk, M.; Parczewski, M.ło.; Cyryłowski, L.; Brykczyński, M.ła.; Peregud-Pogorzelska, M.łg.; Ciechanowicz, A. 2011: VAMP-8 gene variant is associated with increased risk of early myocardial infarction. Archives of Medical Science: Ams 7(3): 440-443
Tiwari, N.; Wang, C-Chun.; Brochetta, C.; Ke, G.; Vita, F.; Qi, Z.; Rivera, J.; Soranzo, M.Rosa.; Zabucchi, G.; Hong, W.; Blank, U. 2008: VAMP-8 segregates mast cell-preformed mediator exocytosis from cytokine trafficking pathways. Blood 111(7): 3665-3674
Rao, M.; Song, W.; Jiang, A.; Shyr, Y.; Lev, S.; Greenstein, D.; Brantley-Sieders, D.; Chen, J. 2012: VAMP-associated protein B (VAPB) promotes breast tumor growth by modulation of Akt activity. Plos one 7(10): E46281
Lvov, A.; Chikvashvili, D.; Michaelevski, I.; Lotan, I. 2008: VAMP2 interacts directly with the N terminus of Kv2.1 to enhance channel inactivation. Pflugers Archiv: European Journal of Physiology 456(6): 1121-1136
Tajika, Y.; Murakami, T.; Sato, M.; Kubota, F.; Yorifuji, H. 2008: VAMP2 is expressed in myogenic cells during rat development. Developmental Dynamics: An Official Publication of the American Association of Anatomists 237(7): 1886-1892
Tajika, Y.; Takahashi, M.; Hino, M.; Murakami, T.; Yorifuji, H. 2010: VAMP2 marks quiescent satellite cells and myotubes, but not activated myoblasts. Acta Histochemica et Cytochemica 43(4): 107-114
Pulido, I.és.R.; Jahn, R.; Gerke, V. 2011: VAMP3 is associated with endothelial weibel-palade bodies and participates in their Ca(2+)-dependent exocytosis. Biochimica et Biophysica Acta 1813(5): 1038-1044
Kean, M.J.; Williams, K.C.; Skalski, M.; Myers, D.; Burtnik, A.; Foster, D.; Coppolino, M.G. 2009: VAMP3, syntaxin-13 and SNAP23 are involved in secretion of matrix metalloproteinases, degradation of the extracellular matrix and cell invasion. Journal of Cell Science 122(Part 22): 4089-4098
Shitara, A.; Shibui, T.; Okayama, M.; Arakawa, T.; Mizoguchi, I.; Sakakura, Y.; Shakakura, Y.; Takuma, T. 2013: VAMP4 is required to maintain the ribbon structure of the Golgi apparatus. Molecular and Cellular Biochemistry 380(1-2): 11-21
Szalinski, C.M.; Labilloy, A.ál.; Bruns, J.R.; Weisz, O.A. 2014: VAMP7 modulates ciliary biogenesis in kidney cells. Plos one 9(1): E86425
Chen, Y.; Meng, D.; Wang, H.; Sun, R.; Wang, D.; Wang, S.; Fan, J.; Zhao, Y.; Wang, J.; Yang, S.; Huai, C.; Song, X.; Qin, R.; Xu, T.; Yun, D.; Hu, L.; Yang, J.; Zhang, X.; Chen, H.; Chen, J.; Chen, H.; Lu, D. 2015: VAMP8 facilitates cellular proliferation and temozolomide resistance in human glioma cells. Neuro-Oncology 17(3): 407-418
Pushparaj, P.N.; Tay, H.K.; Wang, C.-C.; Hong, W.; Melendez, A.J. 2009: VAMP8 is essential in anaphylatoxin-induced degranulation, TNF-alpha secretion, peritonitis, and systemic inflammation. Journal of Immunology 183(2): 1413-1418
Cosen-Binker, L.I.; Binker, M.G.; Wang, C.-C.; Hong, W.; Gaisano, H.Y. 2008: VAMP8 is the v-SNARE that mediates basolateral exocytosis in a mouse model of alcoholic pancreatitis. Journal of Clinical Investigation 118(7): 2535-2551
Kondkar, A.A.; Bray, M.S.; Leal, S.M.; Nagalla, S.; Liu, D.J.; Jin, Y.; Dong, J.F.; Ren, Q.; Whiteheart, S.W.; Shaw, C.; Bray, P.F. 2010: VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. Journal of Thrombosis and Haemostasis: Jth 8(2): 369-378
Perez-Rovira, A.; MacGillivray, T.; Trucco, E.; Chin, K.S.; Zutis, K.; Lupascu, C.; Tegolo, D.; Giachetti, A.; Wilson, P.J.; Doney, A.; Dhillon, B. 2011: VAMPIRE: Vessel assessment and measurement platform for images of the REtina. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2011: 3391-3394
Huse, S.M.; Mark Welch, D.B.; Voorhis, A.; Shipunova, A.; Morrison, H.G.; Eren, A.Murat.; Sogin, M.L. 2014: VAMPS: a website for visualization and analysis of microbial population structures. Bmc Bioinformatics 15: 41
Naramoto, S.; Nodzyłski, T.; Dainobu, T.; Takatsuka, H.; Okada, T.; Friml, J.ři.; Fukuda, H. 2014: VAN4 encodes a putative TRS120 that is required for normal cell growth and vein development in Arabidopsis. Plant and Cell Physiology 55(4): 750-763
Jayaswal, V.; Schramm, S.-J.; Mann, G.J.; Wilkins, M.R.; Yang, Y.H. 2013: VAN: an R package for identifying biologically perturbed networks via differential variability analysis. Bmc Research Notes 6: 430
Brinkrolf, C.; Janowski, S.J.; Kormeier, B.; Lewinski, M.; Hippe, K.; Borck, D.; Hofestädt, R. 2014: VANESA - a software application for the visualization and analysis of networks in system biology applications. Journal of Integrative Bioinformatics 11(2): 239
Sanchez-Alvarez, L.; Visanuvimol, J.; McEwan, A.; Su, A.; Imai, J.H.; Colavita, A. 2011: VANG-1 and PRKL-1 cooperate to negatively regulate neurite formation in Caenorhabditis elegans. Plos Genetics 7(9): E1002257
Reynolds, A.; McDearmid, J.R.; Lachance, S.; De Marco, P.; Merello, E.; Capra, V.; Gros, P.; Drapeau, P.; Kibar, Z. 2010: VANGL1 rare variants associated with neural tube defects affect convergent extension in zebrafish. Mechanisms of Development 127(7-8): 385-392
Lei, Y-Ping.; Zhang, T.; Li, H.; Wu, B-Lin.; Jin, L.; Wang, H-Yan. 2010: VANGL2 mutations in human cranial neural-tube defects. New England Journal of Medicine 362(23): 2232-2235
Williams, B.B.; Cantrell, V.A.; Mundell, N.A.; Bennett, A.C.; Quick, R.E.; Jessen, J.R. 2012: VANGL2 regulates membrane trafficking of MMP14 to control cell polarity and migration. Journal of Cell Science 125(Part 9): 2141-2147
Wilburne, M.; Schlichter, J.G.; Simon, A.J. 1947: The effect of acetylcholine on the heart; an electrocardiographic study in the dog. Archives Internationales de Pharmacodynamie et de Therapie 76(1): 63-71
Brasch, S.; Linsen, L.; Fuellen, G. 2009: VANLO--interactive visual exploration of aligned biological networks. Bmc Bioinformatics 10: 327
Rohn, H.; Junker, A.; Hartmann, A.; Grafahrend-Belau, E.; Treutler, H.; Klapperstück, M.; Czauderna, T.; Klukas, C.; Schreiber, F. 2012: VANTED v2: a framework for systems biology applications. Bmc Systems Biology 6: 139
Farnier, M.; Perevozskaya, I.; Taggart, W.V.; Kush, D.; Mitchel, Y.B. 2008: VAP Ii analysis of lipoprotein subclasses in mixed hyperlipidemic patients on treatment with ezetimibe/simvastatin and fenofibrate. Journal of Lipid Research 49(12): 2641-2647
Benson, S.; Johnson, A.; Petera, C. 2013: VAP free for 1000 days, it can be done. Critical Care Nursing Quarterly 36(4): 421-424
Scamperle, A.; Verginella, F.; Zuliani, M.; Berlot, G. 2014: VAP incidence in cardiac arrest survivors treated with TH and SDD: our experience. Resuscitation 85(4): E51
Polverino, E.; Ferrer, M. 2010: VAP surveillance: role of non-quantitative culture of endotracheal aspirates (NQC-ETA). Minerva Anestesiologica 76(8): 572-574
Koc-Zorawska, E.; Malyszko, J.; Zbroch, E.; Malyszko, J.; Mysliwiec, M. 2013: VAP-1 in peritoneally dialyzed patients. Postepy Higieny i Medycyny Doswiadczalnej 67: 1340-1344
Koc-Zorawska, E.; Malyszko, J.; Malyszko, J.S.; Mysliwiec, M. 2012: VAP-1, a novel molecule linked to endothelial damage and kidney function in kidney allograft recipients. Kidney and Blood Pressure Research 36(1): 242-247
Nakao, S.; Noda, K.; Zandi, S.; Sun, D.; Taher, M.; Schering, A.; Xie, F.; Mashima, Y.; Hafezi-Moghadam, A. 2011: VAP-1-mediated M2 macrophage infiltration underlies IL-1β- but not VEGF-A-induced lymph- and angiogenesis. American Journal of Pathology 178(4): 1913-1921
Hernandez-Guillamon, M.; Solé, M.; Delgado, P.; García-Bonilla, L.; Giralt, D.; Boada, C.; Penalba, A.; García, S.; Flores, A.; Ribó, M.; Alvarez-Sabin, J.é; Ortega-Aznar, A.; Unzeta, M.; Montaner, J. 2012: VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke. Cerebrovascular Diseases 33(1): 55-63
Coulombe, C.; Poitras, C.; Nordell-Markovits, A.; Brunelle, Mène.; Lavoie, M-André.; Robert, Fçois.; Jacques, P-Étienne. 2014: VAP: a versatile aggregate profiler for efficient genome-wide data representation and discovery. Nucleic Acids Research 42(Web Server Issue): W485-W493
Michael, K. 2008: VAP: just how good a benchmark is it really?. Healthcare Benchmarks and Quality Improvement 15(3): 32-33
Martinière, A.; Macia, J.-L.; Bagnolini, G.; Jridi, C.; Bak, A.él.; Blanc, S.ép.; Drucker, M. 2011: VAPA, an innovative "virus-acquisition phenotyping assay" opens new horizons in research into the vector-transmission of plant viruses. Plos one 6(8): E23241
Han, S.M.; El Oussini, H.; Scekic-Zahirovic, J.; Vibbert, J.; Cottee, P.; Prasain, J.K.; Bellen, H.J.; Dupuis, L.; Miller, M.A. 2013: VAPB/ALS8 MSP ligands regulate striated muscle energy metabolism critical for adult survival in caenorhabditis elegans. Plos Genetics 9(9): E1003738
Baron, Y.; Pedrioli, P.G.; Tyagi, K.; Johnson, C.; Wood, N.T.; Fountaine, D.; Wightman, M.; Alexandru, G. 2014: VAPB/ALS8 interacts with FFAT-like proteins including the p97 cofactor FAF1 and the ASNA1 ATPase. Bmc Biology 12: 39
Hirano, M. 2008: VAPB: new genetic clues to the pathogenesis of ALS. Neurology 70(14): 1161-1162
Goyal, S.; Gupta, G.; Qin, H.; Upadya, M.H.; Tan, Y.J.; Chow, V.T.K.; Song, J. 2012: VAPC, an human endogenous inhibitor for hepatitis C virus (HCV) infection, is intrinsically unstructured but forms a "fuzzy complex" with HCV NS5B. Plos one 7(7): E40341
Liang, Y.; Rowland, E.B.; Rowland, G.B.; Perman, J.A.; Antilla, J.C. 2007: VAPOL phosphoric acid catalysis: the highly enantioselective addition of imides to imines. Chemical Communications 43: 4477-4479
Rovira-Vallbona, E.; Monteiro, I.; Bardají, A.; Serra-Casas, E.; Neafsey, D.E.; Quelhas, D.; Valim, C.; Alonso, P.; Dobaño, C.; Ordi, J.; Menéndez, C.; Mayor, A. 2013: VAR2CSA signatures of high Plasmodium falciparum parasitemia in the placenta. Plos one 8(7): E69753
Emmons, S.F. 1904: VARAeLE AUCTORITATIS. Science 20(512): 537
Hillebrenner, M.G.; Swain, J.A.; Zuckerman, B. 2011: VARC consensus report: the FDA perspective. European Heart Journal 32(2): 138-139
Kurian, A.; Anitha, C.A.; Nybe, E.V. 2001: Variability and Character Association in Rose Coloured Leadwort (Plumbago Rosea Linn.). Ancient Science of Life 21(2): 92-95
Medina, I.; De Maria, A.; Bleda, M.; Salavert, F.; Alonso, R.; Gonzalez, C.Y.; Dopazo, J. 2012: VARIANT: Command Line, Web service and Web interface for fast and accurate functional characterization of variants found by Next-Generation Sequencing. Nucleic Acids Research 40(Web Server Issue): W54-W58
Cockerell, T.D. 1915: VARIATION IN OEligNOTHERA HEWETTi. Science 42(1095): 908-909
Haynes, H.W. 1904: VARIAe AUCTORITATIS. Science 20(516): 683
Rapallo, A. 2009: VARICELLA: a variable-cell direct space method for structure determination from powder diffraction data. Journal of Chemical Physics 131(4): 044113
Eastman, C.R. 1904: VARLAe AUCTORITATIS. Science 20(502): 215-217
Darty, K.év.; Denise, A.; Ponty, Y. 2009: VARNA: Interactive drawing and editing of the RNA secondary structure. Bioinformatics 25(15): 1974-1975
Hesketh, G.G.; Pérez-Dorado, I.; Jackson, L.P.; Wartosch, L.; Schäfer, I.B.; Gray, S.R.; McCoy, A.J.; Zeldin, O.B.; Garman, E.F.; Harbour, M.E.; Evans, P.R.; Seaman, M.N.J.; Luzio, J.P.; Owen, D.J. 2014: VARP is recruited on to endosomes by direct interaction with retromer, where together they function in export to the cell surface. Developmental Cell 29(5): 591-606
Chae, Y.S.; Lee, S.J.; Moon, J.H.; Kang, B.W.; Kim, J.G.; Sohn, S.K.; Jung, J.H.; Park, H.Y.; Park, J.Y.; Kim, H.J.; Lee, S.-W. 2011: VARS2 V552V variant as prognostic marker in patients with early breast cancer. Medical Oncology 28(4): 1273-1280
Diodato, D.; Melchionda, L.; Haack, T.B.; Dallabona, C.; Baruffini, E.; Donnini, C.; Granata, T.; Ragona, F.; Balestri, P.; Margollicci, M.; Lamantea, E.; Nasca, A.; Powell, C.A.; Minczuk, M.; Strom, T.M.; Meitinger, T.; Prokisch, H.; Lamperti, C.; Zeviani, M.; Ghezzi, D. 2014: VARS2 and TARS2 mutations in patients with mitochondrial encephalomyopathies. Human Mutation 35(8): 983-989
Apostolico, A.; Comin, M.; Parida, L. 2010: VARUN: discovering extensible motifs under saturation constraints. Ieee/Acm Transactions on Computational Biology and Bioinformatics 7(4): 752
Dalca, A.V.; Rumble, S.M.; Levy, S.; Brudno, M. 2010: VARiD: a variation detection framework for color-space and letter-space platforms. Bioinformatics 26(12): I343-I349
Faiz, K.W. 2014: VAS--visual analog scale. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 134(3): 323
Wingler, K.; Altenhoefer, S.A.; Kleikers, P.W.M.; Radermacher, K.A.; Kleinschnitz, C.; Schmidt, H.H.H.W. 2012: VAS2870 is a pan-NADPH oxidase inhibitor. Cellular and Molecular Life Sciences: Cmls 69(18): 3159-3160
Ho, E.D.; Cao, Q.; Lee, S.D.; Yip, K.Y. 2014: VAS: a convenient web portal for efficient integration of genomic features with millions of genetic variants. Bmc Genomics 15: 886
Yasui, Y.; Kohchi, T. 2014: Vascular Plant One-Zinc Finger1 and Voz2 Repress the Flowering Locus C Clade Members to Control Flowering time in Arabidopsis. Bioscience Biotechnology and Biochemistry 78(11): 1850-1855
Yamaguchi, M.; Goué, N.; Igarashi, H.; Ohtani, M.; Nakano, Y.; Mortimer, J.C.; Nishikubo, N.; Kubo, M.; Katayama, Y.; Kakegawa, K.; Dupree, P.; Demura, T. 2010: VASCULAR-RELATED NAC-DOMAIN6 and VASCULAR-RELATED NAC-DOMAIN7 effectively induce transdifferentiation into xylem vessel elements under control of an induction system. Plant Physiology 153(3): 906-914
Yamaguchi, M.; Mitsuda, N.; Ohtani, M.; Ohme-Takagi, M.; Kato, K.; Demura, T. 2011: VASCULAR-RELATED NAC-DOMAIN7 directly regulates the expression of a broad range of genes for xylem vessel formation. Plant Journal: for Cell and Molecular Biology 66(4): 579-590
Steinkellner, G.; Rader, R.; Thallinger, G.G.; Kratky, C.; Gruber, K. 2009: VASCo: computation and visualization of annotated protein surface contacts. Bmc Bioinformatics 10: 32
Hoyos, A.E.; Millard, J.A. 2007: VASER-assisted high-definition liposculpture. Aesthetic Surgery Journal 27(6): 594-604
Zhang, Y.-T.; Xu, L.-H.; Lu, Q.; Liu, K.-P.; Liu, P.-Y.; Ji, F.; Liu, X.-M.; Ouyang, D.-Y.; He, X.-H. 2014: VASP activation via the Gα13/RhoA/PKA pathway mediates cucurbitacin-B-induced actin aggregation and cofilin-actin rod formation. Plos one 9(4): E93547
Kris, A.S.; Kamm, R.D.; Sieminski, A.L. 2008: VASP involvement in force-mediated adherens junction strengthening. Biochemical and Biophysical Research Communications 375(1): 134-138
Neel, N.F.; Barzik, M.; Raman, D.; Sobolik-Delmaire, T.; Sai, J.; Ham, A.J.; Mernaugh, R.L.; Gertler, F.B.; Richmond, A. 2009: VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis. Journal of Cell Science 122(Part 11): 1882-1894
Hansen, S.D.; Mullins, R.Dyche. 2010: VASP is a processive actin polymerase that requires monomeric actin for barbed end association. Journal of Cell Biology 191(3): 571-584
Defawe, O.D.; Kim, S.; Chen, L.; Huang, D.; Kenagy, R.D.; Renné, T.; Walter, U.; Daum, G.ün.; Clowes, A.W. 2010: VASP phosphorylation at serine239 regulates the effects of NO on smooth muscle cell invasion and contraction of collagen. Journal of Cellular Physiology 222(1): 230-237
Chen, B.Y. 2014: VASP-E: specificity annotation with a volumetric analysis of electrostatic isopotentials. Plos Computational Biology 10(8): E1003792
Chen, B.Y.; Honig, B. 2010: VASP: a volumetric analysis of surface properties yields insights into protein-ligand binding specificity. Plos Computational Biology 6(8)
Compter, A.; van der Worp, H.B.; Schonewille, W.J.; Vos, J.A.; Algra, A.; Lo, T.H.; Mali, W.P.T.M.; Moll, F.L.; Kappelle, L.J. 2008: VAST: Vertebral Artery Stenting Trial. Protocol for a randomised safety and feasibility trial. Trials 9: 65
Fan, J.-G.; Farrell, G.C. 2008: VAT fat is bad for the liver, SAT fat is not!. Journal of Gastroenterology and Hepatology 23(6): 829-832
Dallas, J.; Kollef, M. 2009: VAT vs VAP: are we heading toward clarity or confusion?. Chest 135(2): 252-255
Mori, F.; Tanigawa, K.; Endo, K.; Minamiguchi, K.; Abe, M.; Yamada, S.; Miyoshi, K. 2011: VAT-1 is a novel pathogenic factor of progressive benign prostatic hyperplasia. Prostate 71(14): 1579-1586
Samouda, H.; Dutour, A.; Chaumoitre, K.; Panuel, M.; Dutour, O.; Dadoun, F.éd.ér. 2013: VAT=TAAT-SAAT: innovative anthropometric model to predict visceral adipose tissue without resort to CT-Scan or DXA. Obesity 21(1): E41-E50
Cocchini, G.; Gregg, N.; Beschin, N.; Dean, M.; Della Sala, S. 2010: VATA-L: visual-analogue test assessing anosognosia for language impairment. Clinical Neuropsychologist 24(8): 1379-1399
Della Sala, S.; Cocchini, G.; Beschin, N.; Cameron, A. 2009: VATA-m: Visual-Analogue Test assessing Anosognosia for motor impairment. Clinical Neuropsychologist 23(3): 406-427
Jain, M.K.; Mahant, S.; Mahant, P.D.; Dhanotiy, A. 2009: VATER association with multiple ribs anomalies. Journal of the Association of Physicians of India 57: 332-333
Reutter, H.; Ludwig, M. 2013: VATER/VACTERL Association: Evidence for the Role of Genetic Factors. Molecular Syndromology 4(1-2): 16-19
Bartels, E.; Schulz, A.C.; Mora, N.W.; Pineda-Alvarez, D.E.; Wijers, C.H.W.; Marcelis, C.M.; Stressig, Rüdiger.; Ritgen, J.; Schmiedeke, E.; Mattheisen, M.; Draaken, M.; Hoffmann, P.; Hilger, A.C.; Dworschak, G.C.; Baudisch, F.; Ludwig, M.; Bagci, S.; Müller, A.; Gembruch, U.; Geipel, A.; Berg, C.; Bartmann, P.; Nöthen, M.M.; van Rooij, I.A.L.M.; Solomon, B.D.; Reutter, H.M. 2012: VATER/VACTERL association: identification of seven new twin pairs, a systematic review of the literature, and a classical twin analysis. Clinical Dysmorphology 21(4): 191-195
Nunes, N.; Karandikar, S.; Cooper, S.; Jaganathan, R.; Irani, S. 2009: VATER/VACTERL syndrome (vertebra/anus/cardiac/trachea/esophogus/radius/renal/limb anomalies) with a noncommunicating functioning uterine horn and a unicornuate uterus: a case report. Fertility and Sterility 91(5): 1957.E11-2
Begum, S.; Hansen, H.Jessen.; Papagiannopoulos, K. 2014: VATS anatomic lung resections-the European experience. Journal of Thoracic Disease 6 Suppl. 2: S203-S210
Rocco, G. 2013: VATS and Uniportal VATS: a glimpse into the future. Journal of Thoracic Disease 5 Suppl. 3: S174
Ambrogi, V.; Mineo, T.Claudio. 2014: VATS biopsy for undetermined interstitial lung disease under non-general anesthesia: comparison between uniportal approach under intercostal block vs. three-ports in epidural anesthesia. Journal of thoracic disease 6(7): 888-895
Panagopoulos, N.; Papavasileiou, G.; Koletsis, E.; Kastanaki, M.; Anastasiou, N. 2014: VATS bullectomy and apical pleurectomy for spontaneous pneumothorax in a young patient with Swyer-James-Mc Leod syndrome: case report presentation and literature review focusing on surgically treated cases. Journal of cardiothoracic surgery 9: 13
Granato, F.; Voltolini, L.; Spina, D.; Paladini, P.; Gallazzi, M.; Gotti, G. 2009: VATS for congenital lobar emphysema: a case report. Minerva Chirurgica 64(1): 111-115
Prisadov, G.; Uchikov, A.; Atliev, K.; Paskalev, G.; Dimitrov, I.; Bonev, P.; Batashki, A. 2010: VATS in patients with solitary periferal pulmonary tumors. Khirurgiia 2010(4-5): 5-9
Willekes, L.; Boutros, C.; Goldfarb, M.A. 2008: VATS intraoperative tattooing to facilitate solitary pulmonary nodule resection. Journal of cardiothoracic surgery 3: 13
Xu, M.; Liu, C.; Luo, J.; Guo, M. 2013: VATS left upper lobe posterior segmentectomy. Journal of Thoracic Disease 5 Suppl. 3: S317-S318
Zhao, X.; Qian, L.; Wang, J. 2013: VATS left upper lobectomy. Journal of Thoracic Disease 5 Suppl. 3: S296-S297
Krueger, T.; Perentes, J.Y.; Peters, S.; Ris, H-B.; Gonzalez, M. 2012: VATS lobectomy for early-stage primary lung cancer. Revue Medicale Suisse 8(346): 1337-1341
Grogan, E.L.; Jones, D.R. 2008: VATS lobectomy is better than open thoracotomy: what is the evidence for short-term outcomes?. Thoracic surgery clinics 18(3): 249-258
Wright, G.M. 2012: VATS lobectomy lymph node management. Annals of cardiothoracic surgery 1(1): 51-55
McNiel, A.; Blackmon, S. 2008: VATS lobectomy to treat early-stage non-small cell lung cancer. JAAPA: official journal of the American Academy of Physician Assistants 21(9): 31
Rocco, G. 2005: VATS lung biopsy: the uniportal technique. Multimedia manual of cardiothoracic surgery: MMCTS 2005(121): mmcts.2004.000356
Wright, G.M. 2012: VATS lymph node dissection. Annals of cardiothoracic surgery 1(1): 102-103
Tschopp, J-M.; Schnyder, J-M.; Froudarakis, M.; Astoul, P. 2009: VATS or simple talc poudrage under medical thoracoscopy for recurrent spontaneous pneumothorax. European Respiratory Journal 33(2): 442-443
Neragi-Miandoab, S.; Linden, P.A.; Ducko, C.T.; Bueno, R.; Richards, W.G.; Sugarbaker, D.J.; Jaklitsch, M.T. 2008: VATS pericardiotomy for patients with known malignancy and pericardial effusion: survival and prognosis of positive cytology and metastatic involvement of the pericardium: a case control study. International Journal of Surgery 6(2): 110-114
Ke, L.; Tian, J.; Sun, X. 2013: VATS right middle lobectomy. Journal of Thoracic Disease 5 Suppl. 3: S319-S320
Phan, K.; Yan, T.D. 2014: VATS segmentectomy for pulmonary metastasis. Annals of cardiothoracic surgery 3(2): 192-193
Petersen, Ré.Horsleben.; Hansen, H.Jessen. 2014: VATS segmentectomy utilizing the Copenhagen approach. Annals of cardiothoracic surgery 3(2): 211-212
Csiszkó, A.; Herr, Görgy.; Sz Kiss, Sándor.; Hallay, J.; Gyöngyösi, Zán.; Szentkereszty, Z. 2013: VATS therapy of chylothorax caused by leiomyomatosis complicated with tuberous sclerosis complex. Journal of minimal access surgery 9(2): 84-86
Keating, C.P.; Kong, Y.X.; Tay, V.; Knight, S.R.; Clarke, C.Peter.; Wright, G.M. 2011: VATS thymectomy for nonthymomatous myasthenia gravis: standardized outcome assessment using the myasthenia gravis foundation of America clinical classification. Innovations 6(2): 104-109
Melfi, F.M.A.; Fanucchi, O.; Davini, F.; Mussi, A. 2014: VATS-based approach for robotic lobectomy. Thoracic Surgery Clinics 24(2): 143-9 V
Di Napoli, G.; Ronzini, M.; Paradies, G. 2014: VATS: first step in the parapneumonic empyema*. Il Giornale di chirurgia 35(5-6): 146-148
Avidan, N.; Le Panse, R.; Harbo, H.F.; Bernasconi, P.; Poulas, K.; Ginzburg, E.; Cavalcante, P.; Colleoni, L.; Baggi, F.; Antozzi, C.; Truffault, F.éd.ér.; Horn-Saban, S.; Pöschel, S.; Zagoriti, Z.; Maniaol, A.; Lie, B.A.; Bernard, I.; Saoudi, A.; Illes, Z.; Casasnovas Pons, C.; Melms, A.; Tzartos, S.; Willcox, N.; Kostera-Pruszczyk, A.; Tallaksen, C.; Mantegazza, R.; Berrih-Aknin, S.; Miller, A. 2014: VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravis. Annals of Clinical and Translational Neurology 1(5): 329-339
Wakahashi, S.; Sudo, T.; Oka, N.; Ueno, S.; Yamaguchi, S.; Fujiwara, K.; Ohbayashi, C.; Nishimura, R. 2013: VAV1 represses E-cadherin expression through the transactivation of Snail and Slug: a potential mechanism for aberrant epithelial to mesenchymal transition in human epithelial ovarian cancer. Translational Research: the Journal of Laboratory and Clinical Medicine 162(3): 181-190
Fujikawa, K.; Iwata, T.; Inoue, K.; Akahori, M.; Kadotani, H.; Fukaya, M.; Watanabe, M.; Chang, Q.; Barnett, E.M.; Swat, W. 2010: VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans. Plos one 5(2): E9050
Aguilar, H.; Urruticoechea, A.; Halonen, P.; Kiyotani, K.; Mushiroda, T.; Barril, X.; Serra-Musach, J.; Islam, A.; Caizzi, L.; Di Croce, L.; Nevedomskaya, E.; Zwart, W.; Bostner, J.; Karlsson, E.; Pérez Tenorio, G.; Fornander, T.; Sgroi, D.C.; Garcia-Mata, R.; Jansen, M.P.H.M.; García, N.; Bonifaci, N.úr.; Climent, F.; Soler, M.ía.T.; Rodríguez-Vida, A.; Gil, M.; Brunet, J.; Martrat, G.; Gómez-Baldó, L.; Extremera, A.I.; Figueras, A.; Balart, J.; Clarke, R.; Burnstein, K.L.; Carlson, K.E.; Katzenellenbogen, J.A.; Vizoso, M.; Esteller, M.; Villanueva, A.; Rodríguez-Peña, A.B.; Bustelo, X.é R.; Nakamura, Y.; Zembutsu, H.; Stål, O.; Beijersbergen, R.L.; Pujana, M.A. 2014: VAV3 mediates resistance to breast cancer endocrine therapy. Breast Cancer Research: Bcr 16(3): R53
Slavotinek, A.M.; Chao, R.; Vacik, T.; Yahyavi, M.; Abouzeid, H.; Bardakjian, T.; Schneider, A.; Shaw, G.; Sherr, E.H.; Lemke, G.; Youssef, M.; Schorderet, D.F. 2012: VAX1 mutation associated with microphthalmia, corpus callosum agenesis, and orofacial clefting: the first description of a VAX1 phenotype in humans. Human Mutation 33(2): 364-368
Triozzi, P.L.; Borden, E.C. 2011: VB-111 for cancer. Expert Opinion on Biological Therapy 11(12): 1669-1676
Mendel, I.; Feige, E.; Yacov, N.; Salem, Y.; Levi, I.; Propheta-Meiran, O.; Shoham, A.; Ishai, E.; George, J.; Harats, D.; Breitbart, E. 2014: VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis. Clinical and Experimental Immunology 175(1): 126-137
Sharir-Ivry, A.; Shnerb, T.; Strajbl, M.; Shurki, A. 2010: VB/MM protein landscapes: a study of the S(N)2 reaction in haloalkane dehalogenase. Journal of Physical Chemistry. B 114(6): 2212-2218
Sharir-Ivry, A.; Shurki, A. 2008: VB/MM--the validity of the underlying approximations. Journal of Physical Chemistry. B 112(39): 12491-12497
Biggers, K.; Scheinfeld, N. 2008: VB4-845, a conjugated recombinant antibody and immunotoxin for head and neck cancer and bladder cancer. Current Opinion in Molecular Therapeutics 10(2): 176-186
Daunizeau, J.; Adam, V.; Rigoux, L. 2014: VBA: a probabilistic treatment of nonlinear models for neurobiological and behavioural data. Plos Computational Biology 10(1): E1003441
Wainer, N. 2008: VBAC & choice: many questions and a few answers. Midwifery Today with International Midwife 2008(86): 9
Silla, J.é M.; Freitas, M.P.; Cormanich, R.A.; Rittner, R. 2014: The reverse fluorine Perlin-like effect and related stereoelectronic interactions. Journal of Organic Chemistry 79(13): 6385-6388
Rennick, B. 2013: VBAC breech hospital birth: the story of Ezra. Midwifery Today with International Midwife 106: 34
Fineberg, A.E.; Tilton, Z.A. 2012: VBAC in the trenches: a community perspective. Clinical Obstetrics and Gynecology 55(4): 997-1004
Cohain, J.S. 2007: VBAC rupture and birth weight. Midwifery Today with International Midwife 83: 50
Raja, J.Farzand.; Bangash, K.Tasneem.; Mahmud, G. 2013: VBAC scoring: successful vaginal delivery in previous one caesarean section in induced labour. Jpma. Journal of the Pakistan Medical Association 63(9): 1147-1151
Bridle, L. 2010: VBAC to the future. Practising Midwife 13(9): 29-30
Reid, A.J. 1986: VBAC: Is it Safe for your Patients?. Canadian Family Physician Medecin de Famille Canadien 32: 2123-2127
Rosine, N. 2007: VBAC: a mother's story. Practising Midwife 10(5): 28 30
Signore, C. 2012: VBAC: what does the evidence show?. Clinical Obstetrics and Gynecology 55(4): 961-968
Ying, F.; Chang, X.; Su, P.; Wu, W. 2012: VBEFP: a valence bond approach that incorporates effective fragment potential method. Journal of Physical Chemistry. a 116(7): 1846-1853
Rutter, J.M. 2012: VBF bungalows. Veterinary Record 171(16): 408
Anonymous 2012: VBF fellowships for 'extraordinary' care. Veterinary Record 171(5): 111
Tang, T.; Walsh, S.R.; Prytherch, D.R.; Lees, T.; Varty, K.; Boyle, J.R. 2007: VBHOM, a data economic model for predicting the outcome after open abdominal aortic aneurysm surgery. British Journal of Surgery 94(6): 717-721
Hadjianastassiou, V. 2007: VBHOM, a data economic model for predicting the outcome after open abdominal aortic aneurysm surgery (Br J Surg 2007; 94: 717-721). British Journal of Surgery 94(10): 1308; Author Reply 1308-9
Fairman, K.A.; Curtiss, F.R. 2012: VBID, the PPACA, and FREEE medications: Did politics trump the evidence about cost sharing?. Journal of managed care pharmacy: JMCP 18(2): 146-155
Lin, C.-H.; Chen, C.-M.; Lu, M.-K.; Tsai, C.-H.; Chiou, J.-C.; Liao, J.-R.; Duann, J.-R. 2013: VBM Reveals Brain Volume Differences between Parkinson's Disease and Essential Tremor Patients. Frontiers in Human Neuroscience 7: 247
Shen, S.; Szameitat, A.J.; Sterr, A. 2007: VBM lesion detection depends on the normalization template: a study using simulated atrophy. Magnetic Resonance Imaging 25(10): 1385-1396
Pereira, J.M.S.; Acosta-Cabronero, J.; Pengas, G.; Xiong, L.; Nestor, P.J.; Williams, G.B. 2013: VBM with viscous fluid registration of gray matter segments in SPM. Frontiers in Aging Neuroscience 5: 30
Konrad, A.; Vucurevic, G.; Musso, F.; Winterer, G. 2012: VBM-DTi correlates of verbal intelligence: a potential link to Broca's area. Journal of Cognitive Neuroscience 24(4): 888-895
Alleron, L.ët.; Khemiri, A.; Koubar, M.; Lacombe, C.; Coquet, L.; Cosette, P.; Jouenne, T.; Frere, J. 2013: VBNC Legionella pneumophila cells are still able to produce virulence proteins. Water Research 47(17): 6606-6617
Mulvany, C. 2011: VBP in the works: perspectives on CMS's proposed rule. Healthcare Financial Management: Journal of the Healthcare Financial Management Association 65(4): 36; 38
Warye, K. 2011: VBP will reward HAi reduction. Mlo: Medical Laboratory Observer 43(4): 58
Xu, Y.; Her, C. 2013: VBP1 facilitates proteasome and autophagy-mediated degradation of MutS homologue hMSH4. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 27(12): 4799-4810
Damsker, J.M.; Dillingham, B.C.; Rose, M.C.; Balsley, M.A.; Heier, C.R.; Watson, A.M.; Stemmy, E.J.; Jurjus, R.A.; Huynh, T.; Tatem, K.; Uaesoontrachoon, K.; Berry, D.M.; Benton, A.S.; Freishtat, R.J.; Hoffman, E.P.; McCall, J.M.; Gordish-Dressman, H.; Constant, S.L.; Reeves, E.K.M.; Nagaraju, K. 2013: VBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in mice. Plos one 8(5): E63871
Heier, C.R.; Damsker, J.M.; Yu, Q.; Dillingham, B.C.; Huynh, T.; Van der Meulen, J.H.; Sali, A.; Miller, B.K.; Phadke, A.; Scheffer, L.; Quinn, J.; Tatem, K.; Jordan, S.; Dadgar, S.; Rodriguez, O.C.; Albanese, C.; Calhoun, M.; Gordish-Dressman, H.; Jaiswal, J.K.; Connor, E.M.; McCall, J.M.; Hoffman, E.P.; Reeves, E.K.M.; Nagaraju, K. 2013: VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects. Embo Molecular Medicine 5(10): 1569-1585
Dillingham, B.C.; Knoblach, S.M.; Many, G.M.; Harmon, B.T.; Mullen, A.M.; Heier, C.R.; Bello, L.; McCall, J.M.; Hoffman, E.P.; Connor, E.M.; Nagaraju, K.; Reeves, E.K.M.; Damsker, J.M. 2015: VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis. Cellular and Molecular Neurobiology 35(3): 377-387
Alexander, J. 2008: VBP: considering the worst case scenario. Healthcare Financial Management: Journal of the Healthcare Financial Management Association 62(1): 32-33
Wu, W.; Shaik, S.; Saunders, W.H. 2010: VBSCF calculations on the bimolecular (E2) elimination reaction. the nature of the transition state. Journal of Organic Chemistry 75(11): 3722-3728
Su, P.; Wu, W.; Kelly, C.P.; Cramer, C.J.; Truhlar, D.G. 2008: VBSM: a solvation model based on valence bond theory. Journal of Physical Chemistry. a 112(50): 12761-12768
Stanley, A.C.; Dalton, J.E.; Rossotti, S.H.; MacDonald, K.P.; Zhou, Y.; Rivera, F.; Schroder, W.A.; Maroof, A.; Hill, G.R.; Kaye, P.M.; Engwerda, C.R. 2008: VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis. Plos Pathogens 4(9): E1000158
Eweiss, A.; Dogheim, Y.; Hassab, M.; Tayel, H.; Hammad, Z. 2009: VCAM-1 and eosinophilia in diffuse sino-nasal polyps. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 266(3): 377-383
Lu, X.; Mu, E.; Wei, Y.; Riethdorf, S.; Yang, Q.; Yuan, M.; Yan, J.; Hua, Y.; Tiede, B.J.; Lu, X.; Haffty, B.G.; Pantel, K.; Massagué, J.; Kang, Y. 2011: VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell 20(6): 701-714
Nell-Duxneuner, V.; Axmann, R.; Husar-Memmer, E.; Dallos, T.ás.; Datz, C.; Stadlmayr, A.; Aigner, E.; Englbrecht, M.; Schett, G.; Zwerina, J. 2013: VCAM-1 serum levels are associated with arthropathy in hereditary haemochromatosis. Annals of the Rheumatic Diseases 72(12): 2006-2010
Qu, Y.; Shi, X.; Zhang, H.; Sun, W.; Han, S.; Yu, C.; Li, J. 2009: VCAM-1 siRNA reduces neointimal formation after surgical mechanical injury of the rat carotid artery. Journal of Vascular Surgery 50(6): 1452-1458
Leus, N.G.J.; Morselt, H.ët.W.M.; Zwiers, P.J.; Kowalski, P.S.; Ruiters, M.H.J.; Molema, G.; Kamps, J.A.A.M. 2014: VCAM-1 specific PEGylated SAINT-based lipoplexes deliver siRNA to activated endothelium in vivo but do not attenuate target gene expression. International Journal of Pharmaceutics 469(1): 121-131
Yang, H.; Zhao, F.; Li, Y.; Xu, M.; Li, L.; Wu, C.; Miyoshi, H.; Liu, Y. 2013: VCAM-1-targeted core/shell nanoparticles for selective adhesion and delivery to endothelial cells with lipopolysaccharide-induced inflammation under shear flow and cellular magnetic resonance imaging in vitro. International Journal of Nanomedicine 8: 1897-1906
Serres, Sébastien.; Mardiguian, S.; Campbell, S.J.; McAteer, M.A.; Akhtar, A.; Krapitchev, A.; Choudhury, R.P.; Anthony, D.C.; Sibson, N.R. 2011: VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 25(12): 4415-4422
Rouleau, L.; Berti, R.; Ng, V.W.K.; Matteau-Pelletier, C.; Lam, T.; Saboural, P.; Kakkar, A.K.; Lesage, F.éd.ér.; Rhéaume, E.; Tardif, J.-C. 2013: VCAM-1-targeting gold nanoshell probe for photoacoustic imaging of atherosclerotic plaque in mice. Contrast Media and Molecular Imaging 8(1): 27-39
Sa, Q.; Ochiai, E.; Sengoku, T.; Wilson, M.E.; Brogli, M.; Crutcher, S.; Michie, S.A.; Xu, B.; Payne, L.; Wang, X.; Suzuki, Y. 2014: VCAM-1/α4β1 integrin interaction is crucial for prompt recruitment of immune T cells into the brain during the early stage of reactivation of chronic infection with Toxoplasma gondii to prevent toxoplasmic encephalitis. Infection and Immunity 82(7): 2826-2839
Seyedmajidi, M.; Shafaee, S.; Bijani, A.; Bagheri, S. 2013: VCAM1 and ICAM1 expression in oral lichen planus. International Journal of Molecular and Cellular Medicine 2(1): 34-40
Huang, J.; Zhang, J.; Li, H.; Lu, Z.; Shan, W.; Mercado-Uribe, I.; Liu, J. 2013: VCAM1 expression correlated with tumorigenesis and poor prognosis in high grade serous ovarian cancer. American Journal of Translational Research 5(3): 336-346
Kokovay, E.; Wang, Y.; Kusek, G.; Wurster, R.; Lederman, P.; Lowry, N.; Shen, Q.; Temple, S. 2012: VCAM1 is essential to maintain the structure of the SVZ niche and acts as an environmental sensor to regulate SVZ lineage progression. Cell Stem Cell 11(2): 220-230
Tsukasaki, K.; Utsunomiya, A.; Fukuda, H.; Shibata, T.; Fukushima, T.; Takatsuka, Y.; Ikeda, S.; Masuda, M.; Nagoshi, H.; Ueda, R.; Tamura, K.; Sano, M.; Momita, S.; Yamaguchi, K.; Kawano, F.; Hanada, S.; Tobinai, K.; Shimoyama, M.; Hotta, T.; Tomonaga, M. 2007: VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 25(34): 5458-5464
Muñoz, M.A.; Areche, C.; San-Martín, A.; Rovirosa, J.; Joseph-Nathan, P. 2009: VCD determination of the absolute configuration of stypotriol. Natural Product Communications 4(8): 1037-1040
Hatfield, M.P.D.; Murphy, R.F.; Lovas, S.án. 2010: VCD spectroscopic properties of the beta-hairpin forming miniprotein CLN025 in various solvents. Biopolymers 93(5): 442-450
Sadlej, J.; Dobrowolski, J.C.; Rode, J.E. 2010: VCD spectroscopy as a novel probe for chirality transfer in molecular interactions. Chemical Society Reviews 39(5): 1478-1488
Sato, H.; Yamagishi, A. 2013: VCD studies on chiral characters of metal complex oligomers. International Journal of Molecular Sciences 14(1): 964-978
Vass, E.; Strijowski, U.; Wollschläger, K.; Mándity, I.M.; Szilvágyi, G.; Jewgiński, M.; Gaus, K.; Royo, S.; Majer, Z.; Sewald, N.; Hollósi, M. 2010: VCD studies on cyclic peptides assembled from L-α-amino acids and a trans-2-aminocyclopentane- or trans-2-aminocyclohexane carboxylic acid. Journal of Peptide Science: An Official Publication of the European Peptide Society 16(11): 613-620
Merten, C.; Amkreutz, M.; Hartwig, A. 2010: VCD study of alpha-methylbenzyl amine derivatives: detection of the unchanged chiral motif. Chirality 22(8): 754-761
Felippe, L.G.; Batista, J.ão.M.; Baldoqui, D.C.; Nascimento, I.R.; Kato, M.J.; He, Y.; Nafie, L.A.; Furlan, M. 2012: VCD to determine absolute configuration of natural product molecules: secolignans from Peperomia blanda. Organic and Biomolecular Chemistry 10(21): 4208-4214
Dall'Olio, G.M.; Vahdati, A.R.; Bertranpetit, J.; Wagner, A.; Laayouni, H. 2015: VCF2Networks: applying genotype networks to single-nucleotide variants data. Bioinformatics 31(3): 438-439
Ling, Y.; Jin, Z.; Su, M.; Zhong, J.; Zhao, Y.; Yu, J.; Wu, J.; Xiao, J. 2014: VCGDB: a dynamic genome database of the Chinese population. Bmc Genomics 15: 265
Smith, N.E.; Deyrup, A.T.; Mariño-Enriquez, A.; Fletcher, J.A.; Bridge, J.A.; Illei, P.B.; Netto, G.J.; Argani, P. 2014: VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?. American Journal of Surgical Pathology 38(6): 858-863
Schleiss, M.R. 2009: VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection. Current Opinion in Molecular Therapeutics 11(5): 572-578
Bai, S.; Lu, B. 2014: VCMM: a visual tool for continuum molecular modeling. Journal of Molecular Graphics and Modelling 50: 44-49
Murakami, K.; Ichinohe, Y.; Koike, M.; Sasaoka, N.; Iemura, S-ichiro.; Natsume, T.; Kakizuka, A. 2013: VCP Is an integral component of a novel feedback mechanism that controls intracellular localization of catalase and H2O2 Levels. Plos one 8(2): E56012
Badadani, M.; Nalbandian, A.èl.; Watts, G.D.; Vesa, J.; Kitazawa, M.; Su, H.; Tanaja, J.; Dec, E.; Wallace, D.C.; Mukherjee, J.; Caiozzo, V.; Warman, M.; Kimonis, V.E. 2010: VCP associated inclusion body myopathy and paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. Plos one 5(10)
Wilbrey, A.L.; Haley, J.E.; Wishart, T.M.; Conforti, L.; Morreale, G.; Beirowski, B.; Babetto, E.; Adalbert, R.; Gillingwater, T.H.; Smith, T.; Wyllie, D.J.A.; Ribchester, R.R.; Coleman, M.P. 2008: VCP binding influences intracellular distribution of the slow Wallerian degeneration protein, Wld(S). Molecular and Cellular Neurosciences 38(3): 325-340
Gitcho, M.A.; Strider, J.; Carter, D.; Taylor-Reinwald, L.; Forman, M.S.; Goate, A.M.; Cairns, N.J. 2009: VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death. Journal of Biological Chemistry 284(18): 12384-12398
Yu, C-Chou.; Yang, J-Chin.; Chang, Y-Ching.; Chuang, J-Guang.; Lin, C-Wu.; Wu, M-Shiang.; Chow, L-Ping. 2013: VCP phosphorylation-dependent interaction partners prevent apoptosis in Helicobacter pylori-infected gastric epithelial cells. Plos one 8(1): E55724
Tresse, E.; Salomons, F.A.; Vesa, J.; Bott, L.C.; Kimonis, V.; Yao, T.-P.; Dantuma, N.P.; Taylor, J.P. 2010: VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 6(2): 217-227
Liu, Y.; Hei, Y.; Shu, Q.; Dong, J.; Gao, Y.; Fu, H.; Zheng, X.; Yang, G. 2012: VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma. Plos one 7(4): E35800
Albee, G.W. 1985: VCPPP update VCPPP award to be given to an article published in JPPR. Journal of Primary Prevention 6(2): 71-72
Cima, G. 2012: VCPR definition could change. Journal of the American Veterinary Medical Association 241(2): 164
He, Y-jin.; Lin, T-ting.; Zhu, L-min.; Luo, H.; Chang, J.; Zhang, H.; Zhang, H-mei. 2010: VCR-loaded nanoparticles as targeted delivery system for the treatment of orbital adenoid cystic carcinoma. Chinese Journal of Ophthalmology 46(9): 795-801
Imashuku, S.; Shioda, Y.; Tsunematsu, Y.; Imamura, T.; Morimoto, A. 2010: VCR/AraC chemotherapy and ND-CNS-LCH. Pediatric Blood and Cancer 55(1): 215-216
Hallmann, A. 2008: VCRPs, small cysteine-rich proteins, might be involved in extracellular signaling in the green alga Volvox. Plant Signaling and Behavior 3(2): 124-127
Kim, H.; Sung, S.; Cho, S.; Kim, T.-H.; Seo, K.; Kim, H. 2014: VCS: Tool for Visualizing Copy Number Variation and Single Nucleotide Polymorphism. Asian-Australasian Journal of Animal Sciences 27(12): 1691-1694
Kollmann, D.; Hogan, W.K.; Steidl, C.; Hibbs-Brenner, M.K.; Hedin, D.S.; Lichter, P.A. 2013: VCSEL based, wearable, continuously monitoring pulse oximeter. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2013: 4156-4159
Goldberg, L.; McIntosh, C.; Cole, B. 2011: VCSEL end-pumped passively Q-switched Nd:YAG laser with adjustable pulse energy. Optics Express 19(5): 4261-4267
Li, Y.; Wang, T.; Linke, R.A. 1996: VCSEL-array-based angle-multiplexed optoelectronic crossbar interconnects. Applied Optics 35(8): 1282-1295
Witzel, O.; Klein, A.; Meffert, C.; Wagner, S.; Kaiser, S.; Schulz, C.; Ebert, V. 2013: VCSEL-based, high-speed, in situ TDLAS for in-cylinder water vapor measurements in IC engines. Optics Express 21(17): 19951-19965
Guo, T.; Liu, F.; Du, F.; Zhang, Z.; Li, C.; Guan, B.-O.; Albert, J. 2013: VCSEL-powered and polarization-maintaining fiber-optic grating vector rotation sensor. Optics Express 21(16): 19097-19102
Alemie, G.Asres.; Balcha, S.Alemu. 2012: VCT clinic HIV burden and its link with HIV care clinic at the University of Gondar hospital. BMC public health 12: 1010
Coley, B.D. 2012: VCUG and the question of sedation. Pediatric Radiology 42(3): 284
Bates, D.Gregory. 2012: VCUG and the recurring question of sedation: preparation and catheterization technique are the key. Pediatric Radiology 42(3): 285-289
Cenydd, L.A.; John, N.W.; Phillips, N.I.; Gray, W.P. 2013: VCath: a tablet-based neurosurgery training tool. Studies in Health Technology and Informatics 184: 20-23
Wang, J.; Wang, X. 2012: VCells: simple and efficient superpixels using Edge-Weighted Centroidal Voronoi Tessellations. IEEE Transactions on Pattern Analysis and Machine Intelligence 34(6): 1241-1247
Pal, S.; Choudhury, L.H.; Parvin, T. 2012: VCl3 catalyzed imine-based multicomponent reactions for the facile access of functionalized tetrahydropyridines and β-amino carbonyls. Molecular Diversity 16(1): 129-143
Harris, J.F. 1948: VD control school. Surgeon's Circular Letter. United States. Far East Command. Medical Section 3(2): 9-12
Stewart, F.E. 1949: VD control; the problem and some answers. Hospital Corps Quarterly 22(3): 27-43
Bader, M. 1979: VD in China. Western Journal of Medicine 131(1): 65-66
Strino, F.; Parisi, F.; Kluger, Y. 2011: VDA, a method of choosing a better algorithm with fewer validations. Plos one 6(10): E26074
Veenman, L.; Shandalov, Y.; Gavish, M. 2008: VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis. Journal of Bioenergetics and Biomembranes 40(3): 199-205
Ramírez, C.M.; González, M.; Díaz, M.; Alonso, R.; Ferrer, I.; Santpere, G.; Puig, B.; Meyer, G.; Marin, R. 2009: VDAC and ERalpha interaction in caveolae from human cortex is altered in Alzheimer's disease. Molecular and Cellular Neurosciences 42(3): 172-183
Gałgańska, H.; Antoniewicz, M.; Budzińska, Młgorzata.; Gałgański, L.; Kmita, H. 2010: VDAC contributes to mRNA levels in Saccharomyces cerevisiae cells by the intracellular reduction/oxidation state dependent and independent mechanisms. Journal of Bioenergetics and Biomembranes 42(6): 483-489
Lemeshko, V.V. 2014: VDAC electronics: 1. VDAC-hexo(gluco)kinase generator of the mitochondrial outer membrane potential. Biochimica et Biophysica Acta 1838(5): 1362-1371
Lemeshko, V.V. 2014: VDAC electronics: 2. a new, anaerobic mechanism of generation of the membrane potentials in mitochondria. Biochimica et Biophysica Acta 1838(7): 1801-1808
Martel, C.éc.; Wang, Z.; Brenner, C. 2014: VDAC phosphorylation, a lipid sensor influencing the cell fate. Mitochondrion 19 Pt A: 69-77
Rostovtseva, T.K.; Bezrukov, S.M. 2008: VDAC regulation: role of cytosolic proteins and mitochondrial lipids. Journal of Bioenergetics and Biomembranes 40(3): 163-170
Rostovtseva, T.K. 2012: VDAC structure, function, and regulation of mitochondrial and cellular metabolism. Biochimica et Biophysica Acta 1818(6): 1437
Shoshan-Barmatz, V.; De Pinto, V.; Zweckstetter, M.; Raviv, Z.; Keinan, N.; Arbel, N. 2010: VDAC, a multi-functional mitochondrial protein regulating cell life and death. Molecular Aspects of Medicine 31(3): 227-285
Thinnes, F.P. 2009: VDAC-cored CaCC, CF patients best friend - finding novel therapeutics for CF. Molecular Genetics and Metabolism 97(1): 92-93
Aram, L.; Geula, S.; Arbel, N.; Shoshan-Barmatz, V. 2010: VDAC1 cysteine residues: topology and function in channel activity and apoptosis. Biochemical Journal 427(3): 445-454
Shoshan-Barmatz, V.; Mizrachi, D. 2012: VDAC1: from structure to cancer therapy. Frontiers in Oncology 2: 164
Majumder, S.; Fisk, H.A. 2013: VDAC3 and Mps1 negatively regulate ciliogenesis. Cell Cycle 12(5): 849-858
Anflous-Pharayra, K.; Lee, N.; Armstrong, D.L.; Craigen, W.J. 2011: VDAC3 has differing mitochondrial functions in two types of striated muscles. Biochimica et Biophysica Acta 1807(1): 150-156
Majumder, S.; Slabodnick, M.; Pike, A.; Marquardt, J.; Fisk, H.A. 2012: VDAC3 regulates centriole assembly by targeting Mps1 to centrosomes. Cell Cycle 11(19): 3666-3678
Sasaki, K.; Donthamsetty, R.; Heldak, M.; Cho, Y.-E.; Scott, B.T.; Makino, A. 2012: VDAC: old protein with new roles in diabetes. American Journal of Physiology. Cell Physiology 303(10): C1055-C1060
Spada, M.M.; Caselli, G.; Wells, A. 2012: A triphasic metacognitive formulation of problem drinking. Clinical Psychology and PsychoTherapy 20(6): 494-500
Shurrab, M.; Elitzur, Y.; Healey, J.S.; Gula, L.; Kaoutskaia, A.; Israel, C.; Lau, C.; Crystal, E. 2014: VDD vs DDD pacemakers: a meta-analysis. Canadian Journal of Cardiology 30(11): 1385-1391
Lygidakis, C.; Freund, T. 2013: VDGM:Vasco Da Gama Movement Awards, fund and web site. European journal of general practice 19(3): 203-204
Murray, J.M.; Messier, T.; Rivers, J.; O'Neill, J.P.; Walker, V.E.; Vacek, P.M.; Finette, B.A. 2012: VDJ recombinase-mediated TCR β locus gene usage and coding joint processing in peripheral T cells during perinatal and pediatric development. Journal of Immunology 189(5): 2356-2364
Bishop, T.C. 2009: VDNA: the virtual DNA plug-in for VMD. Bioinformatics 25(23): 3187-3188
Aslani, S.; Hossein-Nezhad, A.; Mirzaei, K.; Maghbooli, Z.; Afshar, A.N.; Karimi, F. 2011: VDR Foki polymorphism and its potential role in the pathogenesis of gestational diabetes mellitus and its complications. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 27(12): 1055-1060
Vasilopoulos, Y.; Sarafidou, T.; Kotsa, K.; Papadimitriou, M.; Goutzelas, Y.; Stamatis, C.; Bagiatis, V.; Tsekmekidou, X.; Yovos, J.G.; Mamuris, Z. 2013: VDR Taqi is associated with obesity in the Greek population. Gene 512(2): 237-239
Solomon, J.D.; Heitzer, M.D.; Liu, T.T.; Beumer, J.H.; Parise, R.A.; Normolle, D.P.; Leach, D.A.; Buchanan, G.; DeFranco, D.B. 2014: VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells. Molecular Cancer Research: Mcr 12(8): 1166-1180
Cozzolino, M. 2010: VDR and CaSR: from parathyroids to arteries. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 27(4): 334
Peric, M.; Koglin, S.; Dombrowski, Y.; Gross, K.; Bradac, E.; Ruzicka, T.; Schauber, J.ür. 2009: VDR and MEK-ERK dependent induction of the antimicrobial peptide cathelicidin in keratinocytes by lithocholic acid. Molecular Immunology 46(16): 3183-3187
Torkko, K.C.; van Bokhoven, A.; Mai, P.; Beuten, J.; Balic, I.; Byers, T.E.; Hokanson, J.E.; Norris, J.M.; Barón, A.E.; Lucia, M.S.; Thompson, I.M.; Leach, R.J. 2008: VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(10): 3223-3229
Kong, J.; Zhu, X.; Shi, Y.; Liu, T.; Chen, Y.; Bhan, I.; Zhao, Q.; Thadhani, R.; Li, Y.C. 2013: VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin-angiotensin system. Molecular Endocrinology 27(12): 2116-2125
Zhang, X.; Rahemtulla, F.; Zhang, P.; Thomas, H.F. 2011: VDR deficiency affects alveolar bone and cementum apposition in mice. Archives of Oral Biology 56(7): 672-677
Willems, H.M.E.; van den Heuvel, E.G.H.M.; Carmeliet, G.; Schaafsma, A.; Klein-Nulend, J.; Bakker, A.D. 2012: VDR dependent and independent effects of 1,25-dihydroxyvitamin D3 on nitric oxide production by osteoblasts. Steroids 77(1-2): 126-131
Cianciolo, G.; La Manna, G.; Cappuccilli, M.L.; Lanci, N.; Della Bella, E.; Cuna, V.; Dormi, A.; Todeschini, P.; Donati, G.; Alviano, F.; Costa, R.; Bagnara, G.P.; Stefoni, S. 2011: VDR expression on circulating endothelial progenitor cells in dialysis patients is modulated by 25(OH)D serum levels and calcitriol therapy. Blood Purification 32(3): 161-173
Małodobra-Mazur, Młgorzata.; Paduch, A.; Lebioda, A.; Konopacka, M.; Rogoliński, J.; Szymczyk, C.; Wierzgoń, J.; Maciejewski, A.; Chmielik, E.; Jonkisz, A.; Półtorak, Sław.; Dobosz, T. 2012: VDR gene single nucleotide polymorphisms and their association with risk of oral cavity carcinoma. Acta Biochimica Polonica 59(4): 627-630
Kuningas, M.; Mooijaart, S.P.; Jolles, J.; Slagboom, P.E.; Westendorp, R.G.J.; van Heemst, D. 2009: VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiology of Aging 30(3): 466-473
Chandel, N.; Husain, M.; Goel, H.; Salhan, D.; Lan, X.; Malhotra, A.; McGowan, J.; Singhal, P.C. 2013: VDR hypermethylation and HIV-induced T cell loss. Journal of Leukocyte Biology 93(4): 623-631
Essa, S.; Denzer, N.; Mahlknecht, U.; Klein, R.; Collnot, E.M.; Tilgen, W.; Reichrath, J. 2010: VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells. Journal of Steroid Biochemistry and Molecular Biology 121(1-2): 110-113
Canto-Cetina, T.; Cetina Manzanilla, Jé.Antonio.; González Herrera, L.; Rojano-Mejía, D.; Coral-Vázquez, Rón.Mauricio.; Coronel, Aín.; Canto, P. 2015: VDR polymorphisms are associated with bone mineral density in post-menopausal Mayan-Mestizo women. Annals of Human Biology 42(5): 470-475
Goeman, F.; De Nicola, F.; D'Onorio De Meo, P.; Pallocca, M.; Elmi, B.; Castrignanò, T.; Pesole, G.; Strano, S.; Blandino, G.; Fanciulli, M.; Muti, P. 2014: VDR primary targets by genome-wide transcriptional profiling. Journal of Steroid Biochemistry and Molecular Biology 143: 348-356
Zhang, Y.; Guo, Q.; Zhang, Z.; Bai, N.; Liu, Z.; Xiong, M.; Wei, Y.; Xiang, R.; Tan, X. 2014: VDR status arbitrates the prometastatic effects of tumor-associated macrophages. Molecular Cancer Research: Mcr 12(8): 1181-1191
Meyer, M.B.; Goetsch, P.D.; Pike, J.W. 2012: VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression. Molecular Endocrinology 26(1): 37-51
Cozzolino, M.; Brancaccio, D.; Cannella, G.; Messa, P.; Gesualdo, L.; Marangella, M.; LoDeserto, C.; Pozzato, M.; Rombolà, G.; Costanzo, A.M.; di Luzio Paparatti, U.; Mazzaferro, S.; Andreucci, V.E.; Bellinghieri, G.; Bigazzi, R.; Bolasco, P.; Bonomini, M.; Cancarini, G.; Caruso, M.R.; Cascone, C.; Di Luca, M.; Emiliani, G.; Lombardi, L.; Malberti, F.; Morosetti, M.; Panzetta, G.; Procaccini, D.A.; Procida, M.; Quarello, F.; Salvadori, M.; Schena, F.P.; Stefoni, S. 2012: VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 27(9): 3588-3594
Nayak, S.; Acharjya, B. 2012: VDRL test and its interpretation. Indian Journal of Dermatology 57(1): 3-8
Drake, M.R.; Ferraro, M.C. 1997: VDT ergonomics: upper extremity assessment requires a holistic approach. Work 8(1): 15-28
Wu, S.-P.; Yang, C.-H.; Ho, C.-P.; Jane, D.-H. 2009: VDT screen height and inclination effects on visual and musculoskeletal discomfort for Chinese wheelchair users with spinal cord injuries. Industrial Health 47(1): 89-93
Holden, C. 1983: VDT's No Threat to Vision. Science 221(4608): 344
Tebboune, C.El-Bachir.; Mebarki, B. 2012: VDU workstations and vision in post office and bank operators. Work 41 Suppl. 1: 3563-3567
Shin, D.; Jeon, J.-H.; Jeong, M.; Suh, H.-W.; Kim, S.; Kim, H.-C.; Moon, O.-S.; Kim, Y.-S.; Chung, J.W.; Yoon, S.R.; Kim, W.-H.; Choi, I. 2008: VDUP1 mediates nuclear export of HIF1alpha via CRM1-dependent pathway. Biochimica et Biophysica Acta 1783(5): 838-848
Zheng, Z.; Xu, W.; Mueller, K. 2010: VDVR: verifiable visualization of projection-based data. IEEE Transactions on Visualization and Computer Graphics 16(6): 1515-1524
Mazzei, E.M. 2013: VE debate. Australian Nursing Journal 21(1): 3
Wang, C.-H.; Hsieh, I.-C.; Chen, S.-J.; Wang, J.-S.; Cherng, W.-J.; Chen, C.-C.; Lam, I.-J.; Lin, S.-J. 2012: VE-Cadherin(low)α-smooth muscle actin+ component of vascular progenitor cells correlates with the coronary artery Gensini score. Circulation Journal: Official Journal of the Japanese Circulation Society 76(2): 477-484
Abraham, S.; Yeo, M.; Montero-Balaguer, M.; Paterson, H.; Dejana, E.; Marshall, C.J.; Mavria, G. 2009: VE-Cadherin-mediated cell-cell interaction suppresses sprouting via signaling to MLC2 phosphorylation. Current Biology: Cb 19(8): 668-674
Yuan, Y.; Luo, Y.; Chung, A.C.S. 2011: VE-LLI-VO: vessel enhancement using local line integrals and variational optimization. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 20(7): 1912-1924
Winderlich, M.; Keller, L.; Cagna, G.; Broermann, A.; Kamenyeva, O.; Kiefer, F.; Deutsch, U.; Nottebaum, A.F.; Vestweber, D. 2009: VE-PTP controls blood vessel development by balancing Tie-2 activity. Journal of Cell Biology 185(4): 657-671
Nottebaum, A.F.; Cagna, G.; Winderlich, M.; Gamp, A.C.; Linnepe, R.; Polaschegg, C.; Filippova, K.; Lyck, R.; Engelhardt, B.; Kamenyeva, O.; Bixel, M.G.; Butz, S.; Vestweber, D. 2008: VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. Journal of Experimental Medicine 205(12): 2929-2945
O'Leary, H.; Akers, S.M.; Piktel, D.; Walton, C.; Fortney, J.E.; Martin, K.H.; Craig, M.; Coad, J.; Gibson, L.F. 2010: VE-cadherin Regulates Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Sensitivity to Apoptosis. Cancer Microenvironment: Official Journal of the International Cancer Microenvironment Society 3(1): 67-81
Sidibé, A.; Polena, H.; Pernet-Gallay, K.; Razanajatovo, J.; Mannic, T.; Chaumontel, N.; Bama, S.; Maréchal, I.èn.; Huber, P.; Gulino-Debrac, D.; Bouillet, L.; Vilgrain, I. 2014: VE-cadherin Y685F knock-in mouse is sensitive to vascular permeability in recurrent angiogenic organs. American Journal of Physiology. Heart and Circulatory Physiology 307(3): H455-H463
Akers, S.M.; O'Leary, H.A.; Minnear, F.L.; Craig, M.D.; Vos, J.A.; Coad, J.E.; Gibson, L.F. 2010: VE-cadherin and PECAM-1 enhance ALL migration across brain microvascular endothelial cell monolayers. Experimental Hematology 38(9): 733-743
Giannotta, M.; Trani, M.; Dejana, E. 2013: VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Developmental Cell 26(5): 441-454
Bravi, L.; Dejana, E.; Lampugnani, M.G. 2014: VE-cadherin at a glance. Cell and Tissue Research 355(3): 515-522
Golovkine, G.; Faudry, E.; Bouillot, S.ép.; Voulhoux, R.é; Attrée, I.; Huber, P. 2014: VE-cadherin cleavage by LasB protease from Pseudomonas aeruginosa facilitates type IIi secretion system toxicity in endothelial cells. Plos Pathogens 10(3): E1003939
Oberlin, E.; Fleury, M.; Clay, D.; Petit-Cocault, L.; Candelier, J.-J.; Mennesson, B.ît.; Jaffredo, T.; Souyri, M.èl. 2010: VE-cadherin expression allows identification of a new class of hematopoietic stem cells within human embryonic liver. Blood 116(22): 4444-4455
Komarova, Y.A.; Huang, F.; Geyer, M.; Daneshjou, N.; Garcia, A.; Idalino, L.; Kreutz, B.; Mehta, D.; Malik, A.B. 2012: VE-cadherin signaling induces EB3 phosphorylation to suppress microtubule growth and assemble adherens junctions. Molecular Cell 48(6): 914-925
Monaghan-Benson, E.; Burridge, K. 2013: VE-cadherin status as an indicator of microvascular permeability. Methods in Molecular Biology 1046: 335-342
Bouillet, L.; Vilgrain, I. 2014: VE-cadherin, a potential marker for endothelial cell activation during hereditary angioedema attacks. Journal of Allergy and Clinical Immunology 134(1): 241
Hamilla, S.M.; Stroka, K.M.; Aranda-Espinoza, H. 2014: VE-cadherin-independent cancer cell incorporation into the vascular endothelium precedes transmigration. Plos one 9(10): E109748
Harris, E.S.; Nelson, W.J. 2010: VE-cadherin: at the front, center, and sides of endothelial cell organization and function. Current Opinion in Cell Biology 22(5): 651-658
Huang, C.; Yuan, X.; Wan, Y.; Liu, F.; Chen, X.; Zhan, X.; Li, X. 2014: VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network. International Journal of Clinical and Experimental Pathology 7(3): 1022-1031
Huang, C.; Yuan, X.; Li, Z.; Tian, Z.; Zhan, X.; Zhang, J.; Li, X. 2014: VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro. International Journal of Clinical and Experimental Pathology 7(3): 1077-1084
Le Bras, A.; Samson, C.; Trentini, M.; Caetano, B.; Lelievre, E.; Mattot, V.; Beermann, F.; Soncin, F. 2010: VE-statin/egfl7 expression in endothelial cells is regulated by a distal enhancer and a proximal promoter under the direct control of Erg and GATA-2. Plos one 5(8): E12156
Moore, B.; Brubaker, P.H.; Stewart, K.P.; Kitzman, D.W. 2007: VE/VCO2 slope in older heart failure patients with normal versus reduced ejection fraction compared with age-matched healthy controls. Journal of Cardiac Failure 13(4): 259-262
Mordes, D.A.; Lynch, K.; Campbell, S.; Dias-Santagata, D.; Nose, V.; Louis, D.N.; Hoang, M.P. 2014: VE1 antibody immunoreactivity in normal anterior pituitary and adrenal cortex without detectable BRAF V600E mutations. American Journal of Clinical Pathology 141(6): 811-815
Sajanti, S.; Sirniö, Päivi.; Väyrynen, J.P.; Tuomisto, A.; Klintrup, K.; Mäkelä, J.; Ristimäki, A.; Mäkinen, M.J. 2014: VE1 immunohistochemistry accurately detects BRAF V600E mutations in colorectal carcinoma and can be utilized in the detection of poorly differentiated colorectal serrated adenocarcinoma. Virchows Archiv: An International Journal of Pathology 464(6): 637-643
Sperveslage, J.; Gierke, M.; Capper, D.; Honegger, J.ür.; Sipos, B.; Beschorner, R.; Schittenhelm, J. 2013: VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation. Acta Neuropathologica 125(6): 911-912
Laskowski-Peak, M.C.; Calvo, A.M.; Rohrssen, J.; Smulian, A.G. 2012: VEA1 is required for cleistothecial formation and virulence in Histoplasma capsulatum. Fungal Genetics and Biology: Fg and B 49(10): 838-846
Potron, A.ïs.; Poirel, L.; Elhag, K.; Al Yaqoubi, F.; Nordmann, P. 2009: VEB-6 extended-spectrum beta-lactamase-producing Proteus mirabilis from Sultanate of Oman. International Journal of Antimicrobial Agents 34(5): 493-494
Archambault, D. 2008: VEBA is shifting Michigan's health care gears. Michigan Medicine 107(2): 10-12
Atkinson, W. 2008: VEBAs employers to unions: see if you can do better. Biotechnology Healthcare 5(4): 16-26
Mangold, M.; Wittwer, V.J.; Sieber, O.D.; Hoffmann, M.; Krestnikov, I.L.; Livshits, D.A.; Golling, M.; Südmeyer, T.; Keller, U. 2012: VECSEL gain characterization. Optics Express 20(4): 4136-4148
Anonymous 1948: VECTOR of scrub typhus in Bengal. Nature 162(4133): 107
Melcher, J.; Hu, S.; Raman, A. 2008: VEDA: a web-based virtual environment for dynamic atomic force microscopy. Review of Scientific Instruments 79(6): 061301
Linkin, V.M.; Kerzhanovich, V.V.; Lipatov, A.N.; Pichkadze, K.M.; Shurupov, A.A.; Terterashvili, A.V.; Ingersoli, A.P.; Crisp, D.; Grossman, A.W.; Young, R.E.; Seiff, A.; Ragent, B.; Blamont, J.E.; Elson, L.S.; Preston, R.A. 1986: VEGA Balloon Dynamics and Vertical Winds in the Venus Middle Cloud Region. Science 231(4744): 1417-1419
Kremnev, R.S.; Linkin, V.M.; Lipatov, A.N.; Pichkadze, K.M.; Shurupov, A.A.; Terterashvili, A.V.; Bakitko, R.V.; Blamont, J.E.; Malique, C.; Ragent, B.; Preston, R.A.; Elson, L.S.; Crisp, D. 1986: VEGA Balloon System and Instrumentation. Science 231(4744): 1408-1411
Kerr, R.A. 1986: VEGA's 1 and 2 Visit Halley: Soviet spacecraft obtain photos showing Halley is king of the comets. Science 231(4744): 1366
Morganella, S.; Cerulo, L.; Viglietto, G.; Ceccarelli, M. 2010: VEGA: variational segmentation for copy number detection. Bioinformatics 26(24): 3020-3027
McBride, T.H. 1885: VEGETABLE MORPHOLOGY a CENTURY AGO. -- Goethe. Science 6(132): 130-131
McBride, T.H. 1885: VEGETABLE MORPHOLOGY a CENTURY AGO.--Linne and Wolff. Science 5(123): 477-478
Reith, J.F.; Indemans, A.W.M.; Becker, W.R. 1948: The content of morphine and alkaloids in the puff of blue poppy seed varieties, cultivated in Dutch experimental fields in 1947. Pharmaceutisch Weekblad 83(29-30): 449-459
Anonymous 1946: VEGETABLE ghee. Current Science 15: 94
Guo, Q.; Dai, S.-B.; Shen, F.; Yu, D.; Shen, S.-T.; Zhang, Q.; Huang, J.-X.; Wu, Z.-D. 2014: VEGF +405G/C (rs2010963) polymorphisms and digestive system cancer risk: a meta-analysis. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(5): 4977-4982
Zhao, S.-F.; Zhan, P.; Yang, X.-D.; Lu, M.-X.; Sun, G.-W.; Wang, Y.-X.; Zhang, Y.-K.; Pu, Y.-M.; Tang, E.-Y. 2013: VEGF +936C/T and +460C/T gene polymorphisms and oral cancer risk: a meta-analysis. Molecular Biology Reports 40(12): 6637-6643
Xu, B.; Feng, N.-H.; Tong, N.; Wang, Z.-D.; Zhang, W.; Wu, H.-F.; Hua, L.-X. 2010: VEGF -460C>T polymorphism and cancer risk: a meta-analysis. Medical Oncology 27(4): 1031-1036
Tamura, T.; Kuwahara, A.; Yamamori, M.; Nishiguchi, K.; Nakamura, T.; Okuno, T.; Miki, I.; Manabe, Y.; Sakaeda, T. 2012: VEGF -634C/G genotype is predictive of long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. International Journal of Medical Sciences 9(10): 833-837
Qiu, M.; Xiong, W.; Liao, H.; Li, F. 2013: VEGF -634G>C polymorphism and diabetic retinopathy risk: a meta-analysis. Gene 518(2): 310-315
Rodrigues, C.G.; Plentz, R.D.M.; Dipp, T.; Salles, F.B.; Giusti, I.I.; Sant'Anna, R.T.; Eibel, B.; Nesralla, I.A.; Markoski, M.; Beyer, N.N.; Kalil, R.A.K. 2013: VEGF 165 gene therapy for patients with refractory angina: mobilization of endothelial progenitor cells. Arquivos Brasileiros de Cardiologia 101(2): 149-153
Wehrschuetz, M.; Schöllnast, H.; Wehrschuetz, E.; Renner, W.; Luschin, G. 2009: VEGF 936C > T Polymorphism and Association of BI-RADS Score in Women with Suspected Breast Cancer. Breast cancer: basic and clinical research 3: 77-81
Gu, D.; Wang, M. 2011: VEGF 936C>T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls. Breast Cancer Research and Treatment 125(2): 489-493
Liu, L.; Hua, F-Zhou.; Cao, J-Qing.; Zhu, P-Qian. 2011: VEGF 936C>T polymorphism and breast cancer risk: evidence needed further clarification. Breast Cancer Research and Treatment 127(2): 569-571
Cruz-González, F.; Cieza-Borrella, C.; Cabrillo-Estévez, L.; Cañete-Campos, C.; Escudero-Domínguez, F.; González-Sarmiento, R. 2013: VEGF a (rs699947 and rs833061) and VEGFR2 (rs2071559) gene polymorphisms are not associated with AMD susceptibility in a Spanish population. Current Eye Research 38(12): 1274-1277
Sakaeda, T.; Yamamori, M.; Kuwahara, A.; Hiroe, S.; Nakamura, T.; Okumura, K.; Okuno, T.; Miki, I.; Chayahara, N.; Okamura, N.; Tamura, T. 2008: VEGF G-1154A is predictive of severe acute toxicities during chemoradiotherapy for esophageal squamous cell carcinoma in Japanese patients. Therapeutic Drug Monitoring 30(4): 497-503
Hao, Q.; Zhu, Y.; Su, H.; Shen, F.; Yang, G.-Y.; Kim, H.; Young, W.L. 2010: VEGF Induces more Severe Cerebrovascular Dysplasia in Endoglin than in Alk1 Mice. Translational Stroke Research 1(3): 197-201
De Castro, L.F.; Maycas, M.; Bravo, B.; Esbrit, P.; Gortazar, A. 2015: VEGF Receptor 2 (VEGFR2) Activation Is Essential for Osteocyte Survival Induced by Mechanotransduction. Journal of Cellular Physiology 230(2): 278-285
Karali, E.; Bellou, S.; Stellas, D.; Klinakis, A.; Murphy, C.; Fotsis, T. 2014: VEGF Signals through ATF6 and PERK to promote endothelial cell survival and angiogenesis in the absence of ER stress. Molecular Cell 54(4): 559-572
Narasimhan, P.; Liu, J.; Song, Y.S.; Massengale, J.L.; Chan, P.H. 2009: VEGF Stimulates the ERK 1/2 signaling pathway and apoptosis in cerebral endothelial cells after ischemic conditions. Stroke 40(4): 1467-1473
Yamamori, M.; Taniguchi, M.; Maeda, S.; Nakamura, T.; Okamura, N.; Kuwahara, A.; Iwaki, K.; Tamura, T.; Aoyama, N.; Markova, S.; Kasuga, M.; Okumura, K.; Sakaeda, T. 2008: VEGF T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in Japanese. International Journal of Medical Sciences 5(2): 80-86
Becker, G.; Blum, H.E. 2012: VEGF Trap for the treatment of malignant ascites. LANCET. Oncology 13(2): 115-116
Gomez-Manzano, C.; Holash, J.; Fueyo, J.; Xu, J.; Conrad, C.A.; Aldape, K.D.; de Groot, J.F.; Bekele, B.N.; Yung, W.K.A. 2008: VEGF Trap induces antiglioma effect at different stages of disease. Neuro-Oncology 10(6): 940-945
Oliveira, H.B.; Sakimoto, T.; Javier, J.A.D.; Azar, D.T.; Wiegand, S.J.; Jain, S.; Chang, J.-H. 2010: VEGF Trap(R1R2) suppresses experimental corneal angiogenesis. European Journal of Ophthalmology 20(1): 48-54
Dixon, J.A.; Oliver, S.C.N.; Olson, J.L.; Mandava, N. 2009: VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration. Expert Opinion on Investigational Drugs 18(10): 1573-1580
Howell, K.R.; Hoda, M.N.; Pillai, A. 2013: VEGF activates NR2B phosphorylation through Dab1 pathway. Neuroscience Letters 552: 30-34
Yang, J.; Yao, Y.; Chen, T.; Zhang, T. 2014: VEGF ameliorates cognitive impairment in in vivo and in vitro ischemia via improving neuronal viability and function. Neuromolecular Medicine 16(2): 376-388
Farkas, L.; Farkas, D.; Ask, K.; Möller, A.; Gauldie, J.; Margetts, P.; Inman, M.; Kolb, M. 2009: VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. Journal of Clinical Investigation 119(5): 1298-1311
Sobczyńska-Rak, A.; Brodzki, A. 2014: VEGF and 17-β-estradiol levels after tamoxifen administration in canine hepatoid gland adenomas and hepatoid gland epitheliomas. In Vivo 28(5): 871-877
Wang, L.; Gao, W.; Xiong, K.; Hu, K.; Liu, X.; He, H. 2014: VEGF and BFGF Expression and Histological Characteristics of the Bone-Tendon Junction during Acute Injury Healing. Journal of Sports Science and Medicine 13(1): 15-21
Zhang, W.; Zhu, C.; Wu, Y.; Ye, D.; Wang, S.; Zou, D.; Zhang, X.; Kaplan, D.L.; Jiang, X. 2014: VEGF and BMP-2 promote bone regeneration by facilitating bone marrow stem cell homing and differentiation. European Cells and Materials 27: 1-11; Discussion: 11-12
Cui, F.; Wang, X.; Liu, X.; Dighe, A.S.; Balian, G.; Cui, Q. 2010: VEGF and BMP-6 enhance bone formation mediated by cloned mouse osteoprogenitor cells. Growth Factors 28(5): 306-317
Wang, D.; Weng, Q.; Zhang, L.; He, Q.; Yang, B. 2009: VEGF and Bcl-2 interact via MAPKs signaling pathway in the response to hypoxia in neuroblastoma. Cellular and Molecular Neurobiology 29(3): 391-401
Kukreja, I.; Kapoor, P.; Deshmukh, R.; Kulkarni, V. 2013: VEGF and CD 34: a correlation between tumor angiogenesis and microvessel density-an immunohistochemical study. Journal of Oral and Maxillofacial Pathology: Jomfp 17(3): 367-373
Stepan, D.; Simionescu, C.; Stepan, A.; Muntean, M.; Voinea, B. 2012: VEGF and CD105 immunoexpression in squamous cervical carcinomas and associated precancerous lesions. Romanian Journal of Morphology and Embryology 53(3): 585-589
Cristina, C.; Perez-Millan, Mía.Inés.; Luque, G.; Dulce, Rúl.Ariel.; Sevlever, G.; Berner, S.Inés.; Becu-Villalobos, D. 2010: VEGF and CD31 association in pituitary adenomas. Endocrine Pathology 21(3): 154-160
Melinte, R.; Jung, I.; Georgescu, L.; Gurzu, S. 2012: VEGF and CD31 expression in arthritic synovium and cartilage of human knee joints. Romanian Journal of Morphology and Embryology 53(4): 911-915
Zhou, Q.; Zhu, Y.; Deng, Z.; Long, H.; Zhang, S.; Chen, X. 2011: VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma. Surgical Oncology 20(1): 13-19
Stratman, A.N.; Davis, M.J.; Davis, G.E. 2011: VEGF and FGF prime vascular tube morphogenesis and sprouting directed by hematopoietic stem cell cytokines. Blood 117(14): 3709-3719
Bilgici, B.; Ecemis, G.C.; Tuncel, O.K.; Bayrak, I.K.; Kan, E.K.; Atmaca, A. 2014: VEGF and GM-CSF levels in nodular thyroid diseases. Endocrine 45(1): 61-66
Pierre, M.; Yoshimoto, M.; Huang, L.; Richardson, M.; Yoder, M.C. 2009: VEGF and IHH rescue definitive hematopoiesis in Gata-4 and Gata-6-deficient murine embryoid bodies. Experimental Hematology 37(9): 1038-1053
Rovina, N.; Hillas, G.; Dima, E.; Vlastos, F.; Loukides, S.; Veldekis, D.; Roussos, C.; Alhanatis, M.; Bakakos, P. 2011: VEGF and IL-18 in induced sputum of lung cancer patients. Cytokine 54(3): 277-281
Sobti, R.C.; Maithil, N.; Thakur, H.; Sharma, Y.; Talwar, K.K. 2010: VEGF and IL-4 gene variability and its association with the risk of coronary heart disease in north Indian population. Molecular and Cellular Biochemistry 341(1-2): 139-148
Georgiadou, D.; Sergentanis, T.N.; Sakellariou, S.; Filippakis, G.M.; Zagouri, F.; Vlachodimitropoulos, D.; Psaltopoulou, T.; Lazaris, A.C.; Patsouris, E.; Zografos, G.C. 2014: VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 40(10): 1331-1337
Kaku, M.; Motokawa, M.; Tohma, Y.; Tsuka, N.; Koseki, H.; Sunagawa, H.; Arturo Marquez Hernandes, R.; Ohtani, J.; Fujita, T.; Kawata, T.; Tanne, K. 2008: VEGF and M-CSF levels in periodontal tissue during tooth movement. Biomedical Research 29(4): 181-187
Boëck-Neto, R.J.; Artese, L.; Piattelli, A.; Shibli, J.A.; Perrotti, V.; Piccirilli, M.; Marcantonio, E. 2009: VEGF and MVD expression in sinus augmentation with autologous bone and several graft materials. Oral Diseases 15(2): 148-154
Hellström, M.; Phng, L.-K.; Gerhardt, H. 2007: VEGF and Notch signaling: the yin and yang of angiogenic sprouting. Cell Adhesion and Migration 1(3): 133-136
Kannan, R.; Sreekumar, P.G.; Hinton, D.R. 2011: VEGF and PEDF secretion in ARPE-19 and fhRPE cells. Investigative Ophthalmology and Visual Science 52(12): 9047
Combs, M.D.; Yutzey, K.E. 2009: VEGF and RANKL regulation of NFATc1 in heart valve development. Circulation Research 105(6): 565-574
Scartozzi, M.; Faloppi, L.; Svegliati Baroni, G.; Loretelli, C.; Piscaglia, F.; Iavarone, M.; Toniutto, P.; Fava, G.; De Minicis, S.; Mandolesi, A.; Bianconi, M.; Giampieri, R.; Granito, A.; Facchetti, F.; Bitetto, D.; Marinelli, S.; Venerandi, L.; Vavassori, S.; Gemini, S.; D'Errico, A.; Colombo, M.; Bolondi, L.; Bearzi, I.; Benedetti, A.; Cascinu, S. 2014: VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study. International Journal of Cancer 135(5): 1247-1256
Mărgăritescu, C.; Pirici, D.; Simionescu, C.; Mogoantă, L.; Raica, M.; Stîngă, A.; Ciurea, R.; Stepan, A.; Stîngă, A.; Ribatti, D. 2009: VEGF and VEGFRs expression in oral squamous cell carcinoma. Romanian Journal of Morphology and Embryology 50(4): 527-548
McKay, G.J.; Silvestri, G.; Orr, N.; Chakravarthy, U.; Hughes, A.E. 2009: VEGF and age-related macular degeneration. Ophthalmology 116(6): 1227.E1-3
Roscoe, W.A.; Welsh, M.E.; Carter, D.E.; Karlik, S.J. 2009: VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. Journal of Neuroimmunology 209(1-2): 6-15
Saharinen, P.; Eklund, L.; Pulkki, K.; Bono, P.; Alitalo, K. 2011: VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Trends in Molecular Medicine 17(7): 347-362
Sinnathamby, T.; Yun, J.; Clavet-Lanthier, M.-Él.; Cheong, C.; Sirois, M.G. 2015: VEGF and angiopoietins promote inflammatory cell recruitment and mature blood vessel formation in murine sponge/Matrigel model. Journal of Cellular Biochemistry 116(1): 45-57
Wróbel, T.; Mazur, G.; Dzietczenia, J.; Gębura, K.; Kuliczkowski, K.; Bogunia-Kubik, K. 2013: VEGF and bFGF gene polymorphisms in patients with non-Hodgkin's lymphoma. Biomed Research International 2013: 159813
Wang, L.; Ying, Y.-f.; Ouyang, Y.-l.; Wang, J.-f.; Xu, J. 2013: VEGF and bFGF increase survival of xenografted human ovarian tissue in an experimental rabbit model. Journal of Assisted Reproduction and Genetics 30(10): 1301-1311
Zhang, L.-Y.; Fan, Y.-Y.; Liu, Z. 2009: VEGF and central nervous system diseases. Zhejiang da Xue Xue Bao. Yi Xue Ban 38(6): 644-648
Wang, X.; Cao, W.; Mo, M.; Wang, W.; Wu, H.; Wang, J. 2010: VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer. Journal of Surgical Oncology 102(4): 325-330
Bhavina, K.; Radhika, J.; Pandian, S.S. 2014: VEGF and eNOS expression in umbilical cord from pregnancy complicated by hypertensive disorder with different severity. Biomed Research International 2014: 982159
Gerhardt, H. 2008: VEGF and endothelial guidance in angiogenic sprouting. Organogenesis 4(4): 241-246
Ciurea, R.; Mărgăritescu, C.; Simionescu, C.; Stepan, A.; Ciurea, M. 2011: VEGF and his R1 and R2 receptors expression in mast cells of oral squamous cells carcinomas and their involvement in tumoral angiogenesis. Romanian Journal of Morphology and Embryology 52(4): 1227-1232
Liu, Z.; Kobayashi, K.; van Dinther, M.; van Heiningen, S.H.; Valdimarsdottir, G.; van Laar, T.; Scharpfenecker, M.; Löwik, C.W.G.M.; Goumans, M.-J.é; Ten Dijke, P.; Pardali, E. 2009: VEGF and inhibitors of TGFbeta type-i receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression. Journal of Cell Science 122(Part 18): 3294-3302
Lin, J.; Li, G.; Den, X.; Xu, C.; Liu, S.; Gao, Y.; Liu, H.; Zhang, J.; Li, X.; Liang, S. 2010: VEGF and its receptor-2 involved in neuropathic pain transmission mediated by P2X₂(/)₃ receptor of primary sensory neurons. Brain Research Bulletin 83(5): 284-291
Allerstorfer, D.; Longato, S.; Schwarzer, C.; Fischer-Colbrie, R.; Hayman, A.R.; Blumer, M.J.F. 2010: VEGF and its role in the early development of the long bone epiphysis. Journal of Anatomy 216(5): 611-624
Faratzis, G.; Tsiambas, E.; Rapidis, A.D.; Machaira, A.; Xiromeritis, K.; Patsouris, E. 2009: VEGF and ki 67 expression in squamous cell carcinoma of the tongue: An immunohistochemical and computerized image analysis study. Oral Oncology 45(7): 584-588
Hamzaoui, K.; Ayed, K.; Hamza, M.'H.; Hamzaoui, A.ès. 2009: VEGF and mRNA VEGF expression in CSF from Behçet's disease with neurological involvement. Journal of Neuroimmunology 213(1-2): 148-153
Partyka, R.; Gonciarz, M.; Jałowiecki, P.ła.; Kokocińska, D.; Byrczek, T. 2012: VEGF and metalloproteinase 2 (MMP 2) expression in gastric cancer tissue. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 18(4): Br130-Br134
Salvolini, E.; Orciani, M.; Lucarini, G.; Vignini, A.; Tranquilli, A.L.; Di Primio, R. 2011: VEGF and nitric oxide synthase immunoexpression in Down's syndrome amniotic fluid stem cells. European Journal of Clinical Investigation 41(1): 23-29
Scheven, B.A.; Man, J.; Millard, J.L.; Cooper, P.R.; Lea, S.C.; Walmsley, A.D.; Smith, A.J. 2009: VEGF and odontoblast-like cells: stimulation by low frequency ultrasound. Archives of Oral Biology 54(2): 185-191
Mehrazma, M.; Mahjoob, F.; Rafsanjani, K.A.; Jafari, D.; Farahani, S.J.; Lahouti H, A. 2013: VEGF and p53 biomarkers in pediatric patients with Langerhans cell histiocytosis. Journal of Pediatric Hematology/Oncology 35(7): E292-E295
Lynn, K.D.; Roland, C.L.; Brekken, R.A. 2010: VEGF and pleiotrophin modulate the immune profile of breast cancer. Cancers 2(2): 970-988
Botelho, F.; Pina, F.; Lunet, N. 2010: VEGF and prostatic cancer: a systematic review. European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 19(5): 385-392
Jonas, J.B.; Tao, Y.; Neumaier, M.; Findeisen, P. 2010: VEGF and refractive error. Ophthalmology 117(11): 2234.E1
Simons, M. 2009: VEGF and restenosis: the rest of the story. Arteriosclerosis Thrombosis and Vascular Biology 29(4): 439-440
Wu, F.T.H.; Stefanini, M.O.; Mac Gabhann, F.; Kontos, C.D.; Annex, B.H.; Popel, A.S. 2010: VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model. American Journal of Physiology. Heart and Circulatory Physiology 298(6): H2174-H2191
Miura, Y.; Klettner, A.; Roider, J. 2010: VEGF antagonists decrease barrier function of retinal pigment epithelium in vitro: possible participation of intracellular glutathione. Investigative Ophthalmology and Visual Science 51(9): 4848-4855
Ghosh, S.; Maity, P. 2010: VEGF antibody plus cisplatin reduces angiogenesis and tumor growth in a xenograft model of ovarian cancer. Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 29(1): 17-30
Vourtsis, S.A.; Spyriounis, P.K.; Agrogiannis, G.D.; Ionac, M.; Papalois, A.E. 2012: VEGF application on rat skin flap survival. Journal of Investigative Surgery: the Official Journal of the Academy of Surgical Research 25(1): 14-19
Barak, V.; Pe'er, J.; Kalickman, I.; Frenkel, S. 2011: VEGF as a biomarker for metastatic uveal melanoma in humans. Current Eye Research 36(4): 386-390
Burstein, H.J.; Chen, Y.-H.; Parker, L.M.; Savoie, J.; Younger, J.; Kuter, I.; Ryan, P.D.; Garber, J.E.; Chen, H.; Campos, S.M.; Shulman, L.N.; Harris, L.N.; Gelman, R.; Winer, E.P. 2008: VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(23): 7871-7877
Yoon, M.S.; Nam, T.-K.; Lee, J.-S.; Cho, S.-H.; Song, J.-Y.; Ahn, S.-J.; Chung, I.-J.; Jeong, J.-U.; Chung, W.-K.; Nah, B.-S. 2011: VEGF as a predictor for response to definitive chemoradiotherapy and COX-2 as a prognosticator for survival in esophageal squamous cell carcinoma. Journal of Korean Medical Science 26(4): 513-520
Greenberg, J.I.; Cheresh, D.A. 2009: VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy. Expert Opinion on Biological Therapy 9(11): 1347-1356
Bellou, S.; Hink, M.A.; Bagli, E.; Panopoulou, E.; Bastiaens, P.I.H.; Murphy, C.; Fotsis, T. 2009: VEGF autoregulates its proliferative and migratory ERK1/2 and p38 cascades by enhancing the expression of DUSP1 and DUSP5 phosphatases in endothelial cells. American Journal of Physiology. Cell Physiology 297(6): C1477-C1489
Herzog, B.; Pellet-Many, C.; Britton, G.; Hartzoulakis, B.; Zachary, I.C. 2011: VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation. Molecular Biology of the Cell 22(15): 2766-2776
Yin, D.; Jia, T.; Gong, W.; Yu, H.; Wooley, P.H.; Mott, M.P.; Yang, S.-Y. 2008: VEGF blockade decelerates the growth of a murine experimental osteosarcoma. International Journal of Oncology 33(2): 253-259
Fan, X.; Krieg, S.; Kuo, C.J.; Wiegand, S.J.; Rabinovitch, M.; Druzin, M.L.; Brenner, R.M.; Giudice, L.C.; Nayak, N.R. 2008: VEGF blockade inhibits angiogenesis and reepithelialization of endometrium. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 22(10): 3571-3580
Zhang, J.; Silva, T.; Yarovinsky, T.; Manes, T.D.; Tavakoli, S.; Nie, L.; Tellides, G.; Pober, J.S.; Bender, J.R.; Sadeghi, M.M. 2010: VEGF blockade inhibits lymphocyte recruitment and ameliorates immune-mediated vascular remodeling. Circulation Research 107(3): 408-417
Ishida, S. 2010: VEGF blockers. Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 9): 304-309
Phillips, J.M.; Goodman, J.I. 2009: Multiple genes exhibit phenobarbital-induced constitutive active/androstane receptor-mediated DNA methylation changes during liver tumorigenesis and in liver tumors. Toxicological Sciences: An Official Journal of the Society of Toxicology 108(2): 273-289
Takyar, S.; Vasavada, H.; Zhang, J.-g.; Ahangari, F.; Niu, N.; Liu, Q.; Lee, C.G.; Cohn, L.; Elias, J.A. 2013: VEGF controls lung Th2 inflammation via the miR-1-Mpl (myeloproliferative leukemia virus oncogene)-P-selectin axis. Journal of Experimental Medicine 210(10): 1993-2010
Zhou, Q.; Liu, H.; Qiao, F.; Wu, Y.; Xu, J. 2010: VEGF deficit is involved in endothelium dysfunction in preeclampsia. Journal of Huazhong University of Science and Technology. Medical Sciences 30(3): 370-374
Luo, X.; Feng, M.; Zhu, X.; Li, Y.; Fei, J.; Zhang, Y. 2013: VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia. Hematology 18(6): 334-340
Ziogas, A.C.; Gavalas, N.G.; Tsiatas, M.; Tsitsilonis, O.; Politi, E.; Terpos, E.; Rodolakis, A.; Vlahos, G.; Thomakos, N.; Haidopoulos, D.; Antsaklis, A.; Dimopoulos, M.A.; Bamias, A. 2012: VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2. International Journal of Cancer 130(4): 857-864
Gonzalez-Moreno, O.; Lecanda, J.; Green, J.E.; Segura, V.; Catena, R.; Serrano, D.; Calvo, A. 2010: VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop. Experimental Cell Research 316(4): 554-567
Wang, Y.-Q.; Cui, H.-R.; Yang, S.-Z.; Sun, H.-P.; Qiu, M.-H.; Feng, X.-Y.; Sun, F.-Y. 2009: VEGF enhance cortical newborn neurons and their neurite development in adult rat brain after cerebral ischemia. Neurochemistry International 55(7): 629-636
Yang, Q.; McHugh, K.P.; Patntirapong, S.; Gu, X.; Wunderlich, L.; Hauschka, P.V. 2008: VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin. Matrix Biology: Journal of the International Society for Matrix Biology 27(7): 589-599
Cao, Y.; E, G.; Wang, E.; Pal, K.; Dutta, S.K.; Bar-Sagi, D.; Mukhopadhyay, D. 2012: VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression. Cancer Research 72(16): 3912-3918
Mărgăritescu, C.; Pirici, D.; Stîngă, A.; Simionescu, C.; Raica, M.; Mogoantă, L.; Stepan, A.; Ribatti, D. 2010: VEGF expression and angiogenesis in oral squamous cell carcinoma: an immunohistochemical and morphometric study. Clinical and Experimental Medicine 10(4): 209-214
Li, C.-R.; Sun, S.-G. 2010: VEGF expression and cell apoptosis in NOD mouse retina. International Journal of Ophthalmology 3(3): 224-227
Ganggaiswari, A.; Kresno, S.B.; Krisnuhoni, E. 2010: VEGF expression and desmoplastic reaction as potential progressive factors in young patients with colorectal cancer. Acta Medica Indonesiana 42(1): 6-11
Minardi, D.; Lucarini, G.; Santoni, M.; Mazzucchelli, R.; Burattini, L.; Pistelli, M.; Bianconi, M.; Di Primio, R.; Scartozzi, M.; Montironi, R.; Cascinu, S.; Muzzonigro, G. 2013: VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinoma. Anticancer Research 33(11): 5017-5022
Urick, M.E.; Giles, J.R.; Johnson, P.A. 2008: VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer. Gynecologic Oncology 110(3): 418-424
Bajpai, J.; Sharma, M.; Sreenivas, V.; Kumar, R.; Gamnagatti, S.; Khan, S.A.; Rastogi, S.; Malhotra, A.; Bakhshi, S. 2009: VEGF expression as a prognostic marker in osteosarcoma. Pediatric Blood and Cancer 53(6): 1035-1039
Mederle, O.; Mederle, N.; Bocan, E.V.; Ceauşu, R.; Raica, M. 2010: VEGF expression in dog mastocytoma. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 114(1): 185-188
Andrini, L.; Blanco, A.Fernandez.; Inda, A.; García, M.; Garcia, A.; Errecalde, A. 2011: VEGF expression in hepatectomized tumor-bearing mice. Journal of Immunoassay and Immunochemistry 32(4): 318-325
Mărgăritescu, O.; Pirici, D.; Mărgăritescu, C. 2011: VEGF expression in human brain tissue after acute ischemic stroke. Romanian Journal of Morphology and Embryology 52(4): 1283-1292
Liu, B.; Li, X.; Liang, G.; Liu, X. 2011: VEGF expression in mesenchymal stem cells promotes bone formation of tissue-engineered bones. Molecular Medicine Reports 4(6): 1121-1126
Scott, A.; Lian, Øy.; Bahr, R.; Hart, D.A.; Duronio, V. 2008: VEGF expression in patellar tendinopathy: a preliminary study. Clinical Orthopaedics and Related Research 466(7): 1598-1604
Wang, J.; Ikeda, R.; Che, X.-F.; Ooyama, A.; Yamamoto, M.; Furukawa, T.; Hasui, K.; Zheng, C.-L.; Tajitsu, Y.; Oka, T.; Tabata, S.; Nishizawa, Y.; Eizuru, Y.; Akiyama, S.-I. 2013: VEGF expression is augmented by hypoxia‑induced PGIS in human fibroblasts. International Journal of Oncology 43(3): 746-754
Koh, Y.; Lee, H.E.; Im, S.-A.; Kim, S.-H.; Kim, T.M.; Han, S.-W.; Oh, D.-Y.; Kim, J.H.; Lee, S.-H.; Kim, D.-W.; Kim, T.-Y.; Kim, W.-H.; Heo, D.S.; Bang, Y.-J. 2011: VEGF expression is related to good response and long progression-free survival in gastrointestinal stromal tumor patients treated with Sunitinib. Diagnostic Molecular Pathology: the American Journal of Surgical Pathology Part B 20(3): 143-147
Anonymous 1913: Wealth's Opportunity. Hospital 54(1402): 212
Fujii, T.; Yonemitsu, Y.; Onimaru, M.; Inoue, M.; Hasegawa, M.; Kuwano, H.; Sueishi, K. 2008: VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis. Atherosclerosis 200(1): 51-57
Tinahones, F.; Salas, J.; Mayas, M.ía.D.; Ruiz-Villalba, A.; Macias-Gonzalez, M.; Garrido-Sanchez, L.; DeMora, M.; Moreno-Santos, I.; Bernal, R.; Cardona, F.; El Bekay, R. 2009: VEGF gene expression in adult human thymus fat: a correlative study with hypoxic induced factor and cyclooxygenase-2. Plos one 4(12): E8213
Smirnikhina, S.A.; Lavrov, A.V.; Bochkov, N.P. 2011: VEGF gene expression in transfected human multipotent stromal cells. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 9: 54-57
Pabst, S.; Karpushova, A.; Diaz-Lacava, A.; Herms, S.; Walier, M.; Zimmer, S.; Cichon, S.; Nickenig, G.; Nöthen, M.M.; Wienker, T.F.; Grohé, C. 2010: VEGF gene haplotypes are associated with sarcoidosis. Chest 137(1): 156-163
Amoli, M.M.; Amiri, P.; Alborzi, A.; Larijani, B.; Saba, S.; Tavakkoly-Bazzaz, J. 2012: VEGF gene mRNA expression in patients with coronary artery disease. Molecular Biology Reports 39(9): 8595-8599
Nakata, I.; Yamashiro, K.; Nakanishi, H.; Tsujikawa, A.; Otani, A.; Yoshimura, N. 2011: VEGF gene polymorphism and response to intravitreal bevacizumab and triple therapy in age-related macular degeneration. Japanese Journal of Ophthalmology 55(5): 435-443
Veloso, C.E.d.R.; de Almeida, L.N.ão.F.; Recchia, F.M.; Pelayes, D.; Nehemy, M.ár.B. 2014: VEGF gene polymorphism and response to intravitreal ranibizumab in neovascular age-related macular degeneration. Ophthalmic Research 51(1): 1-8
Tavakkoly-Bazzaz, J.; Amoli, M.M.; Pravica, V.; Chandrasecaran, R.; Boulton, A.J.M.; Larijani, B.; Hutchinson, I.V. 2010: VEGF gene polymorphism association with diabetic neuropathy. Molecular Biology Reports 37(7): 3625-3630
Maltese, P.; Canestrari, E.; Ruzzo, A.; Graziano, F.; Falcone, A.; Loupakis, F.; Tonini, G.; Santini, D.; Magnani, M. 2009: VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population. International Journal of Colorectal Disease 24(2): 165-170
Formica, V.; Martano, L.; Palmirotta, R.; Ferroni, P.; Del Monte, G.; Guadagni, F.; Roselli, M. 2011: VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea. Annals of Oncology: Official Journal of the European Society for Medical Oncology 22(8): 1928-1929
Yang, S.L.; Yan, S.; Niu, R.L.; Lin, X.K. 2009: VEGF gene silencing by cytomegalovirus promoter driven shRNA expression vector results in vascular development defects in zebrafish. Genetika 45(9): 1187-1193
Enestvedt, C.K.; Hosack, L.; Winn, S.R.; Diggs, B.S.; Uchida, B.; O'Rourke, R.W.; Jobe, B.A. 2008: VEGF gene therapy augments localized angiogenesis and promotes anastomotic wound healing: a pilot study in a clinically relevant animal model. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 12(10): 1762-1770; Discussion: 1771-1772
Kalil, R.A.K.; Salles, F.B.d.; Giusti, I.I.ês.; Rodrigues, C.G.; Han, S.W.; Sant'Anna, R.T.; Ludwig, E.; Grossman, G.; Prates, P.R.L.; Sant'anna, J.ão.R.M.; Teixeira Filho, G.F.; Nardi, N.B.; Nesralla, I.A.ão. 2010: VEGF gene therapy for angiogenesis in refractory angina: phase I/Ii clinical trial. Revista Brasileira de Cirurgia Cardiovascular: Orgao Oficial da Sociedade Brasileira de Cirurgia Cardiovascular 25(3): 311-321
Sun, L.; Yuan, Q.; Cao, N.; Guo, W.; Yao, L.; Feng, J-Min.; Ma, J-Fei.; Wang, L-Ning. 2014: VEGF genetic polymorphisms may contribute to the risk of diabetic nephropathy in patients with diabetes mellitus: a meta-analysis. Thescientificworldjournal 2014: 624573
Fabre, P.J.; Charron, F.éd.ér. 2011: VEGF guides commissural axons: a classic blood vessel trophic factor on the nerve's service. Medecine Sciences: M/S 27(12): 1066-1068
Borroni, B.; Del Bo, R.; Goldwurm, S.; Archetti, S.; Bonvicini, C.; Agosti, C.; Bigni, B.; Papetti, A.; Ghezzi, S.; Sacilotto, G.; Pezzoli, G.; Gennarelli, M.; Bresolin, N.; Comi, G.P.; Padovani, A. 2010: VEGF haplotypes are associated with increased risk to progressive supranuclear palsy and corticobasal syndrome. Journal of Alzheimer's Disease: Jad 21(1): 87-94
Okuchi, Y.; Nagayama, S.; Mori, Y.; Kawamura, J.; Matsumoto, S.; Nishimura, T.; Yoshizawa, A.; Sakai, Y. 2010: VEGF hypersecretion as a plausible mechanism for pseudo-meigs' syndrome in advanced colorectal cancer. Japanese Journal of Clinical Oncology 40(5): 476-481
Pons, J.; Huang, Y.; Arakawa-Hoyt, J.; Washko, D.; Takagawa, J.; Ye, J.; Grossman, W.; Su, H. 2008: VEGF improves survival of mesenchymal stem cells in infarcted hearts. Biochemical and Biophysical Research Communications 376(2): 419-422
Wylegała, E.; Teper, S.ła.J. 2007: VEGF in age-related macular degeneration. Part I. Physiologic and pathologic role of VEGF. Klinika Oczna 109(1-3): 94-96
Wylegała, E.; Teper, S.ła.J. 2007: VEGF in age-related macular degeneration. Part II. VEGF inhibitors use in age-related macular degeneration treatment. Klinika Oczna 109(1-3): 97-100
Aguayo, A. 2013: VEGF in central nervous leukemia. Leukemia Research 37(4): 357-358
Aguayo, A. 2014: VEGF in chronic myeloid leukemia treated with interferon and imatinib. Leukemia Research 38(6): 660-661
Danese, S. 2008: VEGF in inflammatory bowel disease: a master regulator of mucosal immune-driven angiogenesis. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 40(8): 680-683
Chekhonin, V.P.; Shein, S.A.; Korchagina, A.A.; Gurina, O.I. 2012: VEGF in neoplastic angiogenesis. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2: 23-33
Shingyoji, M.; Ando, S.; Nishimura, H.; Nakajima, T.; Ishikawa, A.; Itakura, M.; Iizasa, T.; Kimura, H. 2009: VEGF in patients with non-small cell lung cancer during combination chemotherapy of carboplatin and paclitaxel. Anticancer Research 29(7): 2635-2639
Klein, M.; Catargi, B. 2007: VEGF in physiological process and thyroid disease. Annales d'Endocrinologie 68(6): 438-448
Schlich, R.; Willems, M.; Greulich, S.; Ruppe, F.; Knoefel, W.T.; Ouwens, D.M.; Maxhera, B.; Lichtenberg, A.; Eckel, J.ür.; Sell, H. 2013: VEGF in the crosstalk between human adipocytes and smooth muscle cells: depot-specific release from visceral and perivascular adipose tissue. Mediators of Inflammation 2013: 982458
Varet, J.; Douglas, S.K.; Gilmartin, L.; Medford, A.R.L.; Bates, D.O.; Harper, S.J.; Millar, A.B. 2010: VEGF in the lung: a role for novel isoforms. American Journal of Physiology. Lung Cellular and Molecular Physiology 298(6): L768-L774
Rosenstein, J.M.; Krum, J.M.; Ruhrberg, C. 2010: VEGF in the nervous system. Organogenesis 6(2): 107-114
Wernike, E.; Montjovent, M-O.; Liu, Y.; Wismeijer, D.; Hunziker, E.B.; Siebenrock, K-A.; Hofstetter, W.; Klenke, F.M. 2010: VEGF incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo. European Cells and Materials 19: 30-40
Ay, I.; Francis, J.W.; Brown, R.H. 2008: VEGF increases blood-brain barrier permeability to Evans blue dye and tetanus toxin fragment C but not adeno-associated virus in ALS mice. Brain Research 1234: 198-205
Miao, Z.; Dong, Y.; Fang, W.; Shang, D.; Liu, D.; Zhang, K.; Li, B.; Chen, Y.-H. 2014: VEGF increases paracellular permeability in brain endothelial cells via upregulation of EphA2. Anatomical Record 297(5): 964-972
Peppa, V.I.; Arsenopoulou, Z.V.; Zarogiannis, S.G.; Deligiorgi, T.; Jagirdar, R.; Makantasis, I.; Stefanidis, I.; Liakopoulos, V.; Molyvdas, P.-A.; Gourgoulianis, K.I.; Hatzoglou, C. 2014: VEGF increases the permeability of sheep pleura ex vivo through VEGFR2 stimulation. Cytokine 69(2): 284-288
Yang, L.; Guan, H.; He, J.; Zeng, L.; Yuan, Z.; Xu, M.; Zhang, W.; Wu, X.; Guan, J. 2012: VEGF increases the proliferative capacity and eNOS/NO levels of endothelial progenitor cells through the calcineurin/NFAT signalling pathway. Cell Biology International 36(1): 21-27
Findley, C.M.; Cudmore, M.J.; Ahmed, A.; Kontos, C.D. 2007: VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Arteriosclerosis Thrombosis and Vascular Biology 27(12): 2619-2626
Li, D.; Li, X.-P.; Wang, H.-X.; Shen, Q.-Y.; Li, X.-P.; Wen, L.; Qin, X.-J.; Jia, Q.-L.; Kung, H.-F.; Peng, Y. 2012: VEGF induces angiogenesis in a zebrafish embryo glioma model established by transplantation of human glioma cells. Oncology Reports 28(3): 937-942
Herr, D.; Sallmann, A.; Bekes, I.; Konrad, R.; Holzheu, I.; Kreienberg, R.; Wulff, C. 2012: VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of Claudin 5. Gynecologic Oncology 127(1): 210-216
Nourse, M.B.; Halpin, D.E.; Scatena, M.; Mortisen, D.J.; Tulloch, N.L.; Hauch, K.D.; Torok-Storb, B.; Ratner, B.D.; Pabon, L.; Murry, C.E. 2010: VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arteriosclerosis Thrombosis and Vascular Biology 30(1): 80-89
Sakai, Y.; Goodison, S.; Cao, W.; Urquidi, V.; Namiki, K.; Porvasnik, S.; Urbanek, C.; Rosser, C.J. 2009: VEGF induces expression of Bcl-2 and multiple signaling factors in microvascular endothelial cells in a prostate cancer model. World Journal of Urology 27(5): 659-666
English, B.C.; Price, D.K.; Figg, W.D. 2009: VEGF inhibition and metastasis: possible implications for antiangiogenic therapy. Cancer Biology and Therapy 8(13): 1214-1225
Nochy, D.; Lefaucheur, C.; Hill, G. 2008: VEGF inhibition and renal thrombotic microangiopathy. New England Journal of Medicine 359(2): 206; Author Reply 206-207
Grothey, A. 2013: VEGF inhibition beyond tumour progression. LANCET. Oncology 14(1): 2-3
Crawford, Y.; Ferrara, N. 2009: VEGF inhibition: insights from preclinical and clinical studies. Cell and Tissue Research 335(1): 261-269
Tak, Y.K.; Naoghare, P.K.; Han, E.; Song, J.M. 2011: VEGF inhibitor (Iressa) arrests histone deacetylase expression: single-cell cotransfection imaging cytometry for multi-target-multi-drug analysis. Journal of Cellular Physiology 226(8): 2115-2122
Jayson, G. 2011: VEGF inhibitors and advanced ovarian cancer. LANCET. Oncology 12(12): 1082-1083
Cury, C.E.; Rodrigues, E.B.; Meyer, C.H.; Farah, M.E. 2009: VEGF inhibitors and vitrectomy for diabetic vitreoretinopathy. Developments in Ophthalmology 44: 69-81
Barakat, M.R.; Kaiser, P.K. 2009: VEGF inhibitors for the treatment of neovascular age-related macular degeneration. Expert Opinion on Investigational Drugs 18(5): 637-646
Brastianos, P.K.; Batchelor, T.T. 2009: VEGF inhibitors in brain tumors. Clinical Advances in Hematology and Oncology: H&o 7(11): 753
Thys, J.; Dupont, G.; Rakic, J.M. 2009: VEGF inhibitors in ophthalmology. Revue Medicale de Liege 64(5-6): 323-326
Feltgen, N.; Stahl, A. 2013: VEGF inhibitors in vitreoretinal interventions. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 110(10): 926-934
Anderson, S.M.; Shergill, B.; Barry, Z.T.; Manousiouthakis, E.; Chen, T.T.; Botvinick, E.; Platt, M.O.; Iruela-Arispe, M.L.; Segura, T. 2011: VEGF internalization is not required for VEGFR-2 phosphorylation in bioengineered surfaces with covalently linked VEGF. Integrative Biology: Quantitative Biosciences from Nano to Macro 3(9): 887-896
Tögel, F.; Zhang, P.; Hu, Z.; Westenfelder, C. 2009: VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. Journal of Cellular and Molecular Medicine 13(8b): 2109-2114
Fushida, S.; Oyama, K.; Kinoshita, J.; Yagi, Y.; Okamoto, K.; Tajima, H.; Ninomiya, I.; Fujimura, T.; Ohta, T. 2013: VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody. Oncotargets and Therapy 6: 1445-1451
Coimbra, J.é C.-V. 2012: VEGF is clearly an exciting point of attack in the treatment of neovascular diseases of the retina and choroid. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 227(Suppl 1): 1
Markel, T.A.; Wang, Y.; Herrmann, J.L.; Crisostomo, P.R.; Wang, M.; Novotny, N.M.; Herring, C.M.; Tan, J.; Lahm, T.; Meldrum, D.R. 2008: VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. American Journal of Physiology. Heart and Circulatory Physiology 295(6): H2308-H2314
Oladipupo, S.; Hu, S.; Kovalski, J.; Yao, J.; Santeford, A.; Sohn, R.E.; Shohet, R.; Maslov, K.; Wang, L.V.; Arbeit, J.M. 2011: VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting. Proceedings of the National Academy of Sciences of the United States of America 108(32): 13264-13269
Siervo, M.; Tomatis, V.; Stephan, B.C.M.; Feelisch, M.; Bluck, L.J.C. 2012: VEGF is indirectly associated with NO production and acutely increases in response to hyperglycaemia(1). European Journal of Clinical Investigation 42(9): 967-973
Licht, T.; Eavri, R.; Goshen, I.; Shlomai, Y.; Mizrahi, A.; Keshet, E. 2010: VEGF is required for dendritogenesis of newly born olfactory bulb interneurons. Development 137(2): 261-271